sv3asr
As filed with the Securities and Exchange Commission on
June 22, 2009
Registration
No. 333-
UNITED STATES SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C.
20549
Form S-3
REGISTRATION
STATEMENT
UNDER
THE SECURITIES ACT OF
1933
RAMBUS INC.
(Exact name of registrant as
specified in its charter)
|
|
|
Delaware
|
|
94-3112828
|
(State or other jurisdiction
of
incorporation or organization)
|
|
(I.R.S. Employer
Identification Number)
|
4440 El Camino Real
Los Altos, California
94022
(650) 947-5000
(Address, including zip code,
and telephone number, including area code, of registrants
principal executive offices)
Thomas R. Lavelle
Senior Vice President and
General Counsel
Rambus Inc.
4440 El Camino Real
Los Altos, California
94022
(650) 947-5000
(Name, address, including zip
code, and telephone number, including area code, of agent for
service)
Copies to:
|
|
|
Aaron J. Alter
Julia Reigel
Wilson Sonsini Goodrich & Rosati
Professional Corporation
650 Page Mill Road
Palo Alto, California 94304
(650) 493-9300
|
|
Alan F. Denenberg
Mischa Travers
Davis Polk & Wardwell LLP
1600 El Camino Real
Menlo Park, California 94025
(650) 752-2111
|
Approximate date of commencement of proposed sale to the
public: From time to time after the effective
date of this registration statement.
If the only securities being registered on this Form are being
offered pursuant to dividend or interest reinvestment plans,
please check the following
box. o
If any of the securities being registered on this Form are to be
offered on a delayed or continuous basis pursuant to
Rule 415 under the Securities Act of 1933, other than
securities offered only in connection with dividend or interest
reinvestment plans, check the following
box. þ
If this Form is filed to register additional securities for an
offering pursuant to Rule 462(b) under the Securities Act,
please check the following box and list the Securities Act
registration statement number of the earlier effective
registration statement for the same
offering. o
If this Form is a post-effective amendment filed pursuant to
Rule 462(c) under the Securities Act, please check the
following box and list the Securities Act registration statement
number of the earlier effective registration statement for the
same
offering. o
If the Form is a registration statement pursuant to General
Instruction I.D. or a post-effective amendment thereto that
shall become effective upon filing with the Commission pursuant
to Rule 462(e) under the Securities Act, check the
following
box. þ
If this Form is a post-effective amendment to a registration
statement filed pursuant to General Instruction I.D. filed to
register additional securities or additional classes of
securities pursuant to Rule 413(b) under the Securities
Act, check the following
box. o
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated
filer, or a smaller reporting company. See the definitions of
large accelerated filer, accelerated
filer and smaller reporting company in
Rule 12b-2
of the Exchange Act. (Check one):
|
|
|
|
|
|
|
Large accelerated filer þ
|
|
Accelerated filer o
|
|
Non-accelerated filer o
|
|
Smaller reporting company o
|
|
|
|
|
(Do not check if a smaller reporting company)
|
|
|
CALCULATION OF REGISTRATION
FEE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proposed Maximum
|
|
|
Proposed Maximum
|
|
|
Amount of
|
Title of Each Class of
|
|
|
Amount to be
|
|
|
Offering Price
|
|
|
Aggregate
|
|
|
Registration
|
Securities to be Registered
|
|
|
Registered(1)(2)
|
|
|
per Unit(1)(2)
|
|
|
Offering Price(1)(2)
|
|
|
Fee(3)
|
Common Stock, $0.001 par value per share, (including the
associated rights to purchase shares of Series E preferred
stock)(4)(5)
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible Debt Securities
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
|
An indeterminate number of or
aggregate principal amount of the securities of each identified
class is being registered as may at various times be issued at
indeterminate prices.
|
|
(2)
|
|
Not applicable pursuant to General
Instruction II.D. of Form S-3 under the Securities Act of
1933.
|
|
(3)
|
|
In accordance with
Rules 456(b) and 457(r) under the Securities Act, the
registrant is deferring payment of all of the registration fee.
Any registration fees will be paid subsequently on a
pay-as-you-go basis in accordance with Rule 457(r).
|
|
(4)
|
|
In addition to any securities the
offer and sale of which may be registered hereunder, we are also
registering the offer and sale of an indeterminate number of
shares of common stock as may be issued upon conversion of the
securities issued directly hereunder. No separate consideration
will be received for any shares of common stock so issued upon
conversion.
|
|
(5)
|
|
This registration statement also
relates to rights to purchase shares of Rambus Inc.s
Series E preferred stock which are initially attached to
and trade together with the common stock. The value attributable
to the rights, if any, is reflected in the market price of the
common stock.
|
This
prospectus relates to an effective registration statement under
the Securities Act of 1933, but is not complete and may be
changed. This prospectus is not an offer to sell these
securities and it is not soliciting an offer to buy these
securities in any state where the offer or sale is not
permitted.
|
SUBJECT
TO COMPLETION PRELIMINARY PROSPECTUS, DATED JUNE 22,
2009
$150,000,000
% Convertible
Senior Notes due 2014
Rambus Inc. is
offering $150,000,000 of
its % Convertible Senior Notes
due 2014 (the notes). We will pay interest on the
notes semi-annually, in arrears, on each June 15 and
December 15, beginning on December 15, 2009, to the
holders of record at the close of business on the immediately
preceding June 1 and December 1, respectively. The notes
mature on June 15, 2014.
Holders may convert
their notes at their option at any time prior to March 15,
2014 only under the following circumstances: (1) during any
calendar quarter beginning after the calendar quarter ending
September 30, 2009, and only during such calendar quarter,
if the closing sale price of our common stock for 20 or more
trading days in the period of 30 consecutive trading days
ending on the last trading day of the immediately preceding
calendar quarter exceeds 130% of the conversion price in effect
on the last trading day of the immediately preceding calendar
quarter; (2) during the five business day period after any
10 consecutive trading day period in which the trading price per
$1,000 principal amount of notes for each trading day of such
10 consecutive trading day period was less than 98% of the
product of the closing sale price of our common stock for such
trading day and the applicable conversion rate; (3) upon
the occurrence of specified distributions to holders of our
common stock; (4) upon a fundamental change; or (5) if we
call any or all of the notes for redemption, at any time prior
to the close of business on the business day immediately
preceding the redemption date. On and after March 15, 2014,
holders may convert their notes at any time until the close of
business on the third business day prior to the maturity date,
regardless of the foregoing circumstances.
Upon conversion of
the notes, we will pay (1) cash equal to the lesser of the
aggregate principal amount and the conversion value of the notes
and (2) shares of our common stock for the remainder, if
any, of our conversion obligation, in each case based on a daily
conversion value calculated on a proportionate basis for each
trading day in the 20 trading day conversion reference period.
We may not redeem
any of the notes at our option prior to June 15, 2012. At
any time on or after June 15, 2012, we will have the right,
at our option, to redeem the notes in whole or in part for cash
in an amount equal to 100% of the principal amount of the notes
to be redeemed, together with accrued and unpaid interest, if
any, if the closing sale price of our common stock for at least
20 of the 30 consecutive trading days immediately prior to any
date we give a notice of redemption is greater than 130% of the
conversion price on the date of such notice.
Upon the occurrence
of a fundamental change, holders may require us to repurchase
some or all of their notes for cash at a price equal to 100% of
the principal amount of the notes being repurchased, plus
accrued and unpaid interest, if any. In addition, upon the
occurrence of certain fundamental changes, we may be required to
increase the conversion rate for any notes converted in
connection with such fundamental changes by a specified number
of shares of our common stock.
The notes will be
our general unsecured obligations, ranking equally in right of
payment to all of our existing and future senior indebtedness
and senior in right of payment to any of our future indebtedness
that is expressly subordinated to the notes. Our obligations
under the notes will not be guaranteed by any of our
subsidiaries, will be effectively subordinated in right of
payment to any of our future secured indebtedness to the extent
of the collateral securing such obligations and will be
structurally subordinated in right of payment to all existing
and future obligations of our subsidiaries, including trade
credit.
The notes are a new
issue of securities for which there currently is no market. Our
common stock is listed on the NASDAQ Global Select Market under
the symbol RMBS. The last reported sale price of our
common stock on the NASDAQ Global Select Market on June 19,
2009 was $18.70 per share.
The underwriters
have the option to purchase, within 12 days from the date
of the original issuance of the notes, up to an additional
$22,500,000 aggregate principal amount of the notes solely to
cover over-allotments, if any, on the terms described herein.
Investing in the
notes involves risks. See Risk Factors beginning on
page 21.
|
|
|
|
|
|
|
|
|
|
|
Underwriting
|
|
Proceeds to
|
|
|
Price to
|
|
Discounts and
|
|
Rambus (Before
|
|
|
Public(1)
|
|
Commissions
|
|
Expenses)
|
|
Per Note
|
|
%
|
|
%
|
|
%
|
Total
|
|
$
|
|
$
|
|
$
|
|
|
|
(1)
|
|
Plus accrued
interest, if any, from June , 2009.
|
Delivery of the
notes in book-entry form will be made only through The
Depository Trust Company (DTC) on or about
June , 2009.
Neither the
Securities and Exchange Commission nor any state securities
commission has approved or disapproved of these securities or
determined if this prospectus is truthful or complete. Any
representation to the contrary is a criminal offense.
|
|
Credit
Suisse |
J.P. Morgan |
The date of this
prospectus is June , 2009.
TABLE OF
CONTENTS
PROSPECTUS
You should rely only on the information contained or
incorporated by reference in this prospectus and any related
free writing prospectus that we authorize to be distributed to
you. We have not, and the underwriters have not, authorized
anyone to provide you with different information. If anyone
provides you with different or inconsistent information, you
should not rely on it. We are not, and the underwriters are not,
making an offer to sell these securities in any jurisdiction
where the offer or sale is not permitted. You should assume that
the information appearing in each of this prospectus, the
documents incorporated by reference in this prospectus and any
related free writing prospectus is accurate as of the respective
dates of those documents. Our business, financial condition,
results of operations and prospects may have changed since those
dates. To the extent that information in this prospectus or any
related free writing prospectus is inconsistent with the
information incorporated by reference in this prospectus, the
information in such document incorporated by reference is
superseded by the information in such document. You should read
this prospectus, the documents incorporated by reference in this
prospectus and any related free writing prospectus when making
your investment decision. You should also read and consider the
information in the documents we have referred you to in the
section of this prospectus entitled Where You Can Find
More Information.
i
SUMMARY
The following information should be read together with the
information contained or incorporated by reference in other
parts of this prospectus. This summary highlights selected
information contained elsewhere in this prospectus or the
documents incorporated by reference herein. Because the
following is only a summary, it does not contain all of the
information that you should consider before investing in the
notes. You should carefully read this entire prospectus,
including the section captioned Risk Factors
included in this prospectus and the financial statements and
other information incorporated by reference in this prospectus,
before making an investment decision. Unless we have indicated
otherwise, or the context otherwise requires, references in this
prospectus to Rambus, we, us
and our or similar terms are to Rambus Inc. and its
subsidiaries.
Rambus
Inc.
We design, develop and license chip interface technologies and
architectures that are foundational to nearly all digital
electronics products. Our chip interface technologies are
designed to improve the performance, power efficiency,
time-to-market and cost-effectiveness of our customers
semiconductor and system products for computing, gaming and
graphics, consumer electronics and mobile applications.
As of March 31, 2009, our chip interface technologies were
covered by more than 790 U.S. and foreign patents.
Additionally, we had approximately 550 patent applications
pending as of March 31, 2009. These patents and patent
applications cover important inventions in memory and logic chip
interfaces, in addition to other technologies. We believe that
our chip interface technologies provide our customers a means to
achieve higher performance, improved power efficiency, lower
risk, and greater cost-effectiveness in their semiconductor and
system products.
Our primary method of providing interface technologies to our
customers is through our patented innovations. We license our
broad portfolio of patented inventions to semiconductor and
system companies which use these inventions in the development
and manufacture of their own products. Such licensing agreements
may cover the license of part, or all, of our patent portfolio.
Patent license agreements are generally royalty bearing.
We also develop a range of solutions including
leadership (which are Rambus-proprietary interfaces
or architectures widely licensed to our customers) and
industry-standard chip interfaces that we provide to our
customers under license for incorporation into their
semiconductor and system products. Due to the often complex
nature of implementing state-of-the art chip interface
technology, we offer engineering services to our customers to
help them successfully integrate our chip interface solutions
into their semiconductors and systems. These technology license
agreements may have both a fixed price (non-recurring) component
and ongoing royalties. Engineering services are generally
offered on a fixed price basis. Further, under technology
licenses, our customers may receive licenses to our patents
necessary to implement the chip interface in their products with
specific rights and restrictions to the applicable patents
elaborated in their individual contracts with us.
As of March 31, 2009, we had approximately
200 employees in our engineering department, representing
approximately 60% of our total employees.
Recent
Developments
On June 22, 2009, we announced revised guidance for revenue and
expenses for the current second fiscal quarter of 2009. We
expect revenue for the quarter to be between $26.7 million
and $27.2 million. Adjusted operating expenses for the
quarter, excluding stock-based compensation expenses and any
stock-based compensation restatement expenses or benefits, are
expected to be between $42 million and $45 million,
which includes litigation expenses between $15 million and
$17 million. We initially provided revenue guidance for the
quarter in the range of between $27 million and
$30 million. We also initially provided adjusted operating
expenses guidance for the quarter, excluding stock-based
compensation expenses and any stock-based
1
compensation restatement expenses or benefits, of
$43 million to $48 million, which included litigation
expenses in the range of between $12 million and
$16 million.
Our presentation of guidance on adjusted operating expenses
excludes the generally accepted accounting principles
(GAAP) measures of stock-based compensation expenses
and any stock-based compensation restatement expenses or
benefits, which we are unable to estimate at this time. We
believe the presentation of adjusted operating expenses provides
management and investors with meaningful information to
understand and analyze our second quarter guidance. However,
this presentation should not be considered in isolation or as a
substitute for the comparable GAAP measurement, when available.
Litigation
Update
Historically, we have been involved in significant litigation
stemming from the unlicensed use of our inventions. Our
litigation expenses have been high and difficult to predict and
we anticipate future litigation expenses will continue to be
significant, volatile and difficult to predict. If we are
successful in our litigation
and/or
related licensing, our revenue could be substantially higher in
the future; if we are unsuccessful, our revenue likely would,
and the trading price of our common stock may, decline.
Furthermore, our success in litigation matters pending before
courts and regulatory bodies that relate to our intellectual
property rights has impacted and will likely continue to impact
our ability and the terms upon which we are able to negotiate
new or renegotiate existing licenses for our technology.
Hynix
Litigation
U.S
District Court of the Northern District of California
On August 29, 2000, Hynix (formerly Hyundai) and various
subsidiaries filed suit against Rambus in the U.S. District
Court for the Northern District of California. The complaint, as
amended and narrowed through motion practice, asserts claims for
fraud, violations of federal antitrust laws and deceptive
practices in connection with Rambus participation in a
standards setting organization called JEDEC, and seeks a
declaratory judgment that the Rambus
patents-in-suit
are unenforceable, invalid and not infringed by Hynix,
compensatory and punitive damages, and attorneys fees.
Rambus denied Hynixs claims and filed counterclaims for
patent infringement against Hynix.
The case was divided into three phases. In the first phase,
Hynix tried its unclean hands defense beginning on
October 17, 2005 and concluding on November 1, 2005.
In its January 4, 2006 Findings of Fact and Conclusions of
Law, the court held that Hynixs unclean hands defense
failed. Among other things, the court found that Rambus did not
adopt its document retention policy in bad faith, did not engage
in unlawful spoliation of evidence, and that while Rambus
disposed of some relevant documents pursuant to its document
retention policy, Hynix was not prejudiced by the destruction of
Rambus documents. On January 19, 2009, Hynix filed a motion
for reconsideration of the courts unclean hands order and
for summary judgment on the ground that the decision by the
Delaware court in the pending Micron-Rambus litigation
(described below) should be given preclusive effect. In its
motion Hynix requested alternatively that the courts
unclean hands order be certified for appeal and that the
remainder of the case be stayed. Rambus filed an opposition to
Hynixs motion on January 26, 2009, and a hearing was
held on January 30, 2009. On February 3, 2009, the
court denied Hynixs motions and restated its conclusions
that Rambus had not anticipated litigation until late 1999 and
that Hynix had not demonstrated any prejudice from any alleged
destruction of evidence.
The second phase of the Hynix-Rambus trial on patent
infringement, validity and damages began on
March 15, 2006, and was submitted to the jury on
April 13, 2006. On April 24, 2006, the jury returned a
verdict in favor of Rambus on all issues and awarded Rambus a
total of approximately $307 million in damages, excluding
prejudgment interest. Specifically, the jury found that each of
the ten selected patent claims was supported by the written
description, and was not anticipated or rendered obvious by
prior art; therefore, none of the patent claims were invalid.
The jury also found that Hynix infringed all eight of the patent
claims for which the jury was asked to determine infringement;
the court had previously determined on summary judgment that
Hynix infringed the other two claims at issue in the trial. On
July 14, 2006, the court granted Hynixs motion for a
new trial on the issue of damages unless Rambus agreed to a
reduction of the
2
total jury award to approximately $134 million. The court
found that the record supported a maximum royalty rate of 1% for
SDR SDRAM and 4.25% for DDR SDRAM, which the court applied to
the stipulated U.S. sales of infringing Hynix products
through December 31, 2005. On July 27, 2006, Rambus
elected remittitur of the jurys award to approximately
$134 million. On August 30, 2006, the court awarded
Rambus prejudgment interest for the period June 23, 2000
through December 31, 2005. Hynix filed a motion on
July 7, 2008 to reduce the amount of remitted damages and
any supplemental damages that the court may award, as well as to
limit the products that could be affected by any injunction that
the court may grant, on the grounds of patent exhaustion.
Following a hearing on August 29, 2008, the court denied
Hynixs motion. In separate orders issued December 2,
2008, January 16, 2009, and January 27, 2009, the
court denied Hynixs post-trial motions for judgment as a
matter of law and new trial on infringement and validity.
On June 24, 2008, the court heard oral argument on
Rambus motion to supplement the damages award and for
equitable relief related to Hynixs infringement of Rambus
patents. On February 23, 2009, the court issued an order
(1) granting Rambus motion for supplemental damages
and prejudgment interest for the period after December 31,
2005, at the same rates ordered for the prior period;
(2) denying Rambus motion for an injunction; and
(3) ordering the parties to begin negotiations regarding
the terms of a compulsory license regarding Hynixs
continued manufacture, use, and sale of infringing devices.
The third phase of the Hynix-Rambus trial involved Hynixs
affirmative JEDEC-related antitrust and fraud allegations
against Rambus. On April 24, 2007, the court ordered a
coordinated trial of certain common JEDEC-related claims alleged
by the manufacturer parties (i.e., Hynix, Micron, Nanya and
Samsung) and defenses asserted by Rambus in Hynix v Rambus,
Case No. C
00-20905
RMW, and three other cases pending before the same court
(Rambus Inc. v. Samsung Electronics Co. Ltd. et al.,
Case
No. 05-02298
RMW, Rambus Inc. v. Hynix Semiconductor Inc., et
al., Case
No. 05-00334,
and Rambus Inc. v. Micron Technology, Inc., et al.,
Case No. C
06-00244
RMW, each described in further detail below). On
December 14, 2007, the court excused Samsung from the
coordinated trial based on Samsungs agreement to certain
conditions, including trial of its claims against Rambus by the
court within six months following the conclusion of the
coordinated trial. The coordinated trial involving Rambus,
Hynix, Micron and Nanya began on January 29, 2008, and was
submitted to the jury on March 25, 2008. On March 26,
2008, the jury returned a verdict in favor of Rambus and against
Hynix, Micron, and Nanya on each of their claims. Specifically,
the jury found that Hynix, Micron, and Nanya failed to meet
their burden of proving that: (1) Rambus engaged in
anticompetitive conduct; (2) Rambus made important
representations that it did not have any intellectual property
pertaining to the work of JEDEC and intended or reasonably
expected that the representations would be heard by or repeated
to others including Hynix, Micron or Nanya; (3) Rambus
uttered deceptive half-truths about its intellectual property
coverage or potential coverage of products compliant with
synchronous DRAM standards then being considered by JEDEC by
disclosing some facts but failing to disclose other important
facts; or (4) JEDEC members shared a clearly defined
expectation that members would disclose relevant knowledge they
had about patent applications or the intent to file patent
applications on technology being considered for adoption as a
JEDEC standard. Hynix, Micron, and Nanya filed motions for a new
trial and for judgment on certain of their equitable claims and
defenses. A hearing on those motions was held on May 1,
2008. A further hearing on the equitable claims and defenses was
held on May 27, 2008. On July 24, 2008, the court
issued an order denying Hynix, Micron, and Nanyas motions
for new trial.
On March 3, 2009, the court issued an order rejecting
Hynix, Micron, and Nanyas equitable claims and defenses
that had been tried during the coordinated trial. The court
concluded (among other things) that (1) Rambus did not have
an obligation to disclose pending or anticipated patent
applications and had sound reasons for not doing so;
(2) the evidence supported the jurys finding that
JEDEC members did not share a clearly defined expectation that
members would disclose relevant knowledge they had about patent
applications or the intent to file patent applications on
technology being considered for adoption as a JEDEC standard;
(3) the written JEDEC disclosure policies did not clearly
require members to disclose information about patent
applications and the intent to file patent applications in the
future; (4) there was no clearly understood or legally
enforceable agreement of JEDEC members to disclose information
about patent applications or the intent to seek patents relevant
to standards being discussed at JEDEC; (5) during the time
Rambus attended JEDEC meetings, Rambus did not have any patent
application pending that covered a JEDEC standard, and
3
none of the patents in suit was applied for until well after
Rambus resigned from JEDEC; (6) Rambuss conduct at
JEDEC did not constitute an estoppel or waiver of its rights to
enforce its patents; (7) Hynix, Micron, and Nanya failed to
carry their burden to prove their asserted waiver and estoppel
defenses not directly based on Rambuss conduct at JEDEC;
(8) the evidence did not support a finding of any material
misrepresentation, half truths or fraudulent concealment by
Rambus related to JEDEC upon which Nanya relied; (9) the
manufacturers failed to establish that Rambus violated unfair
competition law by its conduct before JEDEC; (10) the
evidence related to Rambuss patent prosecution did not
establish that Rambus unduly delayed in prosecuting the claims
in suit; (11) Rambus did not unreasonably delay bringing
its patent infringement claims; and (12) there is no basis
for any unclean hands defense or unenforceability claim arising
from Rambuss conduct.
On March 10, 2009, the court entered final judgment against
Hynix in the amount of approximately $397 million as
follows: approximately $134 million for infringement
through December 31, 2005; approximately $215 million
for infringement from January 1, 2006 through
January 31, 2009; and approximately $48 million in
pre-judgment interest. Post-judgment interest will accrue at the
statutory rate. In addition, the judgment orders Hynix to pay
Rambus royalties on net sales for U.S. infringement after
January 31, 2009 and before April 18, 2010 of 1% for
SDR SDRAM and 4.25% for DDR DDR2, DDR3, GDDR, GDDR2 and GDDR3
SDRAM memory devices. On April 9, 2009, Rambus submitted
its cost bill in the amount of approximately $0.85 million.
On March 24, 2009, Hynix filed a motion under Rule 62
seeking relief from the requirement that it post a supersedeas
bond in the full amount of the final judgment in order to stay
its execution pending an appeal. Rambus filed a brief opposing
Hynixs motion on April 10, 2009. A hearing on
Hynixs motion was heard on May 8, 2009. On
May 14, 2009, the court granted Hynixs motion in part
and ordered that execution of the judgment be stayed on the
condition that, within 45 days, Hynix post a supersedeas
bond in the amount of $250 million and provide Rambus with
documentation establishing a lien in Rambuss favor on
property owned by Hynix in Korea in the amount of the judgment
not covered by the supersedeas bond. The court also ordered that
Hynix pay the ongoing royalties set forth in the final judgment
into an escrow account to be arranged by the parties, with the
escrowed funds to be released only upon agreement of the parties
or further order of the court.
On April 6, 2009, Hynix filed its notice of appeal. On
April 17, 2009, Rambus filed its notice of cross appeal.
The parties opening briefs are not yet due.
Micron
Litigation
U.S
District Court in Delaware: Case
No. 00-792-SLR
On August 28, 2000, Micron filed suit against Rambus in the
U.S. District Court for Delaware. The suit asserts
violations of federal antitrust laws, deceptive trade practices,
breach of contract, fraud and negligent misrepresentation in
connection with Rambus participation in JEDEC. Micron
seeks a declaration of monopolization by Rambus, compensatory
and punitive damages, attorneys fees, a declaratory
judgment that eight Rambus patents are invalid and not
infringed, and the award to Micron of a royalty-free license to
the Rambus patents. Rambus has filed an answer and counterclaims
disputing Microns claims and asserting infringement by
Micron of 12 U.S. patents.
This case has been divided into three phases in the same general
order as in the Hynix
00-20905
action: (1) unclean hands; (2) patent infringement;
and (3) antitrust, equitable estoppel, and other
JEDEC-related issues. A bench trial on Microns unclean
hands defense began on November 8, 2007 and concluded on
November 15, 2007. The court ordered post-trial briefing on
the issue of when Rambus became obligated to preserve documents
because it anticipated litigation. A hearing on that issue was
held on May 20, 2008. The court ordered further post-trial
briefing on the remaining issues from the unclean hands trial,
and a hearing on those issues was held on September 19,
2008.
On January 9, 2009, the court issued an opinion in which it
determined that Rambus had engaged in spoliation of evidence by
failing to suspend general implementation of a document
retention policy after the court determined that litigation was
reasonably foreseeable. The court issued an accompanying order
declaring the 12 patents in suit unenforceable against Micron
(the Delaware Order). On February 9, 2009, the
court
4
stayed all other proceedings pending appeal of the Delaware
Order. On February 10, 2009, judgment was entered against
Rambus and in favor of Micron on Rambus patent
infringement claims and Microns corresponding claims for
declaratory relief. On March 11, 2009, Rambus filed its
notice of appeal. Rambus opening brief is not yet due.
U.S.
District Court of the Northern District of California
On January 13, 2006, Rambus filed suit against Micron in
the U.S. District Court for the Northern District of
California. Rambus alleges that 14 Rambus patents are infringed
by Microns DDR2, DDR3, GDDR3, and other advanced memory
products. Rambus seeks compensatory and punitive damages,
attorneys fees, and injunctive relief. Micron has denied
Rambus allegations and is alleging counterclaims for
violations of federal antitrust laws, unfair trade practices,
equitable estoppel, fraud and negligent misrepresentation in
connection with Rambus participation in JEDEC. Micron
seeks a declaration of monopolization by Rambus, injunctive
relief, compensatory and punitive damages, attorneys fees,
and a declaratory judgment of invalidity, unenforceability, and
noninfringement of the 14 patents in suit.
As explained above, the court ordered a coordinated trial
(without Samsung) of certain common JEDEC-related claims and
defenses asserted in Hynix v Rambus, Case No. C
00-20905
RMW, Rambus Inc. v. Samsung Electronics Co. Ltd. et al.,
Case
No. 05-02298
RMW, Rambus Inc. v. Hynix Semiconductor Inc., et
al., Case
No. 05-00334,
and Rambus Inc. v. Micron Technology, Inc., et al.,
Case No. C
06-00244
RMW. The coordinated trial involving Rambus, Hynix, Micron and
Nanya began on January 29, 2008, and was submitted to the
jury on March 25, 2008. On March 26, 2008, the jury
returned a verdict in favor of Rambus and against Hynix, Micron,
and Nanya on each of their claims. Specifically, the jury found
that Hynix, Micron, and Nanya failed to meet their burden of
proving that: (1) Rambus engaged in anticompetitive
conduct; (2) Rambus made important representations that it
did not have any intellectual property pertaining to the work of
JEDEC and intended or reasonably expected that the
representations would be heard by or repeated to others
including Hynix, Micron or Nanya; (3) Rambus uttered
deceptive half-truths about its intellectual property coverage
or potential coverage of products compliant with synchronous
DRAM standards then being considered by JEDEC by disclosing some
facts but failing to disclose other important facts; or
(4) JEDEC members shared a clearly defined expectation that
members would disclose relevant knowledge they had about patent
applications or the intent to file patent applications on
technology being considered for adoption as a JEDEC standard.
Hynix, Micron, and Nanya filed motions for a new trial and for
judgment on certain of their equitable claims and defenses. A
hearing on those motions was held on May 1, 2008. A further
hearing on the equitable claims and defenses was held on
May 27, 2008. On July 24, 2008, the court issued an
order denying Hynix, Micron, and Nanyas motions for new
trial.
On March 3, 2009, the court issued an order rejecting
Hynix, Micron, and Nanyas equitable claims and defenses
that had been tried during the coordinated trial. The court
concluded (among other things) that (1) Rambus did not have
an obligation to disclose pending or anticipated patent
applications and had sound reasons for not doing so;
(2) the evidence supported the jurys finding that
JEDEC members did not share a clearly defined expectation that
members would disclose relevant knowledge they had about patent
applications or the intent to file patent applications on
technology being considered for adoption as a JEDEC standard;
(3) the written JEDEC disclosure policies did not clearly
require members to disclose information about patent
applications and the intent to file patent applications in the
future; (4) there was no clearly understood or legally
enforceable agreement of JEDEC members to disclose information
about patent applications or the intent to seek patents relevant
to standards being discussed at JEDEC; (5) during the time
Rambus attended JEDEC meetings, Rambus did not have any patent
application pending that covered a JEDEC standard, and none of
the patents in suit was applied for until well after Rambus
resigned from JEDEC; (6) Rambuss conduct at JEDEC did
not constitute an estoppel or waiver of its rights to enforce
its patents; (7) Hynix, Micron, and Nanya failed to carry
their burden to prove their asserted waiver and estoppel
defenses not directly based on Rambuss conduct at JEDEC;
(8) the evidence did not support a finding of any material
misrepresentation, half truths or fraudulent concealment by
Rambus related to JEDEC upon which Nanya relied; (9) the
manufacturers failed to establish that Rambus violated unfair
competition law by its conduct before JEDEC; (10) the
evidence related to Rambuss patent prosecution did not
establish that Rambus unduly
5
delayed in prosecuting the claims in suit; (11) Rambus did
not unreasonably delay bringing its patent infringement claims;
and (12) there is no basis for any unclean hands defense or
unenforceability claim arising from Rambuss conduct.
In these cases (except for the Hynix
00-20905
action), a hearing on claim construction and the parties
cross-motions for summary judgment on infringement and validity
was held on June 4 and 5, 2008. On July 10, 2008, the court
issued its claim construction order relating to the
Farmwald/Horowitz patents in suit and denied Hynix, Micron,
Nanya and Samsungs (collectively, the
Manufacturers) motions for summary judgment of
noninfringement and invalidity based on their proposed claim
construction. The court issued claim construction orders
relating to the Ware patents in suit on July 25 and
August 27, 2008, and denied the Manufacturers motion
for summary judgment of noninfringement of certain claims. On
September 4, 2008, at the courts direction, Rambus
elected to proceed to trial on 12 patent claims, each from the
Farmwald/Horowitz family. On September 16, 2008, Rambus
granted a covenant not to assert any claim of patent
infringement against the Manufacturers under the Ware patents in
suit (U.S. Patent Nos. 6,493,789 and 6,496,897), and each
partys claims relating to those patents were dismissed
with prejudice. On November 21, 2008, the court entered an
order clarifying certain aspects of its July 10, 2008,
claim construction order. On November 24, 2008, the court
granted Rambus motion for summary judgment of direct
infringement with respect to claim 16 of Rambus
U.S. Patent No. 6,266,285 by the Manufacturers
DDR2, DDR3, gDDR2, GDDR3, GDDR4 memory chip products (except for
Nanyas DDR3 memory chip products). In the same order, the
court denied the remainder of Rambus motion for summary
judgment of infringement.
On January 19, 2009, Micron filed a motion for summary
judgment on the ground that the Delaware Order should be given
preclusive effect. Rambus filed an opposition to Microns
motion on January 26, 2009, and a hearing was held on
January 30, 2009. On February 3, 2009, the court
entered a stay of this action pending resolution of Rambus
appeal of the Delaware Order.
European
Patent Infringement Cases
On September 11, 2000, Rambus filed suit against Micron in
multiple European jurisdictions for infringement of its European
patent, EP 0 525 068 (the 068 patent) which
was later revoked. Additional suits were filed pertaining to a
second Rambus patent, EP 1 022 642 (the 642
patent) and a third Rambus patent, EP 1 004 956 (the
956 patent). Rambus suit against Micron
for infringement of the 642 patent in Mannheim, Germany,
has not been active. The Mannheim court issued an Order of Cost
with respect to the 068 proceeding requiring Rambus to
reimburse Micron attorneys fees in the amount of
$0.45 million. This amount has since been paid. One
proceeding in Italy relating to the 642 patent was
adjourned at a hearing on June 15, 2007, each party bearing
its own costs. Two other proceedings in Italy relating to the
956 patent remain ongoing.
DDR2,
DDR3, gDDR2, GDDR3, GDDR4 Litigation
(DDR2)
U.S
District Court in the Northern District of California
On January 25, 2005, Rambus filed a patent infringement
suit in the U.S. District Court for the Northern District
of California court against Hynix, Infineon, Nanya and Inotera.
Infineon and Inotera were subsequently dismissed from this
litigation and Samsung was added as a defendant. Rambus alleges
that certain of its patents are infringed by certain of the
defendants SDRAM, DDR, DDR2, DDR3, gDDR2, GDDR3, GDDR4 and
other advanced memory products. Hynix, Samsung and Nanya have
denied Rambus claims and asserted counterclaims against
Rambus for, among other things, violations of federal antitrust
laws, unfair trade practices, equitable estoppel, and fraud in
connection with Rambus participation in JEDEC.
As explained above, the court ordered a coordinated trial of
certain common JEDEC-related claims and defenses asserted in
Hynix v Rambus, Case No. C
00-20905
RMW, Rambus Inc. v. Samsung Electronics Co. Ltd. et
al., Case
No. 05-02298
RMW, Rambus Inc. v. Hynix Semiconductor Inc., et
al., Case
No. 05-00334,
and Rambus Inc. v. Micron Technology, Inc., et al.,
Case No. C
06-00244
RMW. The court subsequently excused Samsung from the coordinated
trial on December 14, 2007, based on Samsungs
agreement to certain conditions, including trial of its claims
against Rambus within six months following the conclusion of the
6
coordinated trial. The coordinated trial involving Rambus,
Hynix, Micron and Nanya began on January 29, 2008, and was
submitted to the jury on March 25, 2008. On March 26,
2008, the jury returned a verdict in favor of Rambus and against
Hynix, Micron, and Nanya on each of their claims. Specifically,
the jury found that Hynix, Micron, and Nanya failed to meet
their burden of proving that: (1) Rambus engaged in
anticompetitive conduct; (2) Rambus made important
representations that it did not have any intellectual property
pertaining to the work of JEDEC and intended or reasonably
expected that the representations would be heard by or repeated
to others including Hynix, Micron or Nanya; (3) Rambus
uttered deceptive half-truths about its intellectual property
coverage or potential coverage of products compliant with
synchronous DRAM standards then being considered by JEDEC by
disclosing some facts but failing to disclose other important
facts; or (4) JEDEC members shared a clearly defined
expectation that members would disclose relevant knowledge they
had about patent applications or the intent to file patent
applications on technology being considered for adoption as a
JEDEC standard. Hynix, Micron, and Nanya filed motions for a new
trial and for judgment on certain of their equitable claims and
defenses. A hearing on those motions was held on May 1,
2008. A further hearing on the equitable claims and defenses was
held on May 27, 2008. On July 24, 2008, the court
issued an order denying Hynix, Micron, and Nanyas motions
for new trial.
On March 3, 2009, the court issued an order rejecting
Hynix, Micron, and Nanyas equitable claims and defenses
that had been tried during the coordinated trial. The court
concluded (among other things) that (1) Rambus did not have
an obligation to disclose pending or anticipated patent
applications and had sound reasons for not doing so;
(2) the evidence supported the jurys finding that
JEDEC members did not share a clearly defined expectation that
members would disclose relevant knowledge they had about patent
applications or the intent to file patent applications on
technology being considered for adoption as a JEDEC standard;
(3) the written JEDEC disclosure policies did not clearly
require members to disclose information about patent
applications and the intent to file patent applications in the
future; (4) there was no clearly understood or legally
enforceable agreement of JEDEC members to disclose information
about patent applications or the intent to seek patents relevant
to standards being discussed at JEDEC; (5) during the time
Rambus attended JEDEC meetings, Rambus did not have any patent
application pending that covered a JEDEC standard, and none of
the patents in suit was applied for until well after Rambus
resigned from JEDEC; (6) Rambuss conduct at JEDEC did
not constitute an estoppel or waiver of its rights to enforce
its patents; (7) Hynix, Micron, and Nanya failed to carry
their burden to prove their asserted waiver and estoppel
defenses not directly based on Rambuss conduct at JEDEC;
(8) the evidence did not support a finding of any material
misrepresentation, half truths or fraudulent concealment by
Rambus related to JEDEC upon which Nanya relied; (9) the
manufacturers failed to establish that Rambus violated unfair
competition law by its conduct before JEDEC; (10) the
evidence related to Rambuss patent prosecution did not
establish that Rambus unduly delayed in prosecuting the claims
in suit; (11) Rambus did not unreasonably delay bringing
its patent infringement claims; and (12) there is no basis
for any unclean hands defense or unenforceability claim arising
from Rambuss conduct.
In these cases (except for the Hynix
00-20905
action), a hearing on claim construction and the parties
cross-motions for summary judgment on infringement and validity
was held on June 4 and 5, 2008. On July 10, 2008, the court
issued its claim construction order relating to the
Farmwald/Horowitz patents in suit and denied the
Manufacturers motions for summary judgment of
noninfringement and invalidity based on their proposed claim
construction. The court issued claim construction orders
relating to the Ware patents in suit on July 25 and
August 27, 2008, and denied the Manufacturers motion
for summary judgment of noninfringement of certain claims. On
September 4, 2008, at the courts direction, Rambus
elected to proceed to trial on 12 patent claims, each from the
Farmwald/Horowitz family. On September 16, 2008, Rambus
granted a covenant not to assert any claim of patent
infringement against the Manufacturers under U.S. Patent
Nos. 6,493,789 and 6,496,897, and each partys claims
relating to those patents were dismissed with prejudice. On
November 21, 2008, the court entered an order clarifying
certain aspects of its July 10, 2008, claim construction
order. On November 24, 2008, the court granted
Rambuss motion for summary judgment of direct infringement
with respect to claim 16 of Rambuss U.S. Patent
No. 6,266,285 by the Manufacturers DDR2, DDR3, gDDR2,
GDDR3, GDDR4 memory chip products (except for Nanyas DDR3
memory chip products). In the same order, the court denied the
remainder of Rambuss motion for summary judgment of
infringement.
7
On January 19, 2009, Samsung, Nanya and Hynix filed motions
for summary judgment on the ground that the Delaware Order
should be given preclusive effect. Rambus filed opposition
briefs to these motions on January 26, 2009, and a hearing
was held on January 30, 2009. On February 3, 2009, the
court entered a stay of this action pending resolution of
Rambus appeal of the Delaware Order.
Samsung
Litigation
U.S
District Court in the Northern District of California
On June 6, 2005, Rambus filed a patent infringement suit
against Samsung in the U.S. District Court for the Northern
District of California alleging that Samsungs SDRAM and
DDR SDRAM parts infringe nine of Rambus patents. Samsung
has denied Rambus claims and asserted counterclaims for
non-infringement, invalidity and unenforceability of the
patents, violations of various antitrust and unfair competition
statutes, breach of license, and breach of duty of good faith
and fair dealing. Samsung has also counterclaimed that Rambus
aided and abetted breach of fiduciary duty and intentionally
interfered with Samsungs contract with a former employee
by knowingly hiring a former Samsung employee who allegedly
misused proprietary Samsung information. Rambus has denied
Samsungs counterclaims.
As explained above, the court ordered a coordinated trial of
certain common JEDEC-related claims and defenses asserted in
Hynix v Rambus, Case No. C
00-20905
RMW, Rambus Inc. v. Samsung Electronics Co. Ltd. et
al., Case
No. 05-02298
RMW, Rambus Inc. v. Hynix Semiconductor Inc., et
al., Case
No. 05-00334,
and Rambus Inc. v. Micron Technology, Inc., et al.,
Case No. C
06-00244
RMW. The court subsequently excused Samsung from the coordinated
trial on December 14, 2007, based on Samsungs
agreement to certain conditions, including trial of its claims
against Rambus within six months following the conclusion of the
coordinated trial (see below). In these cases (except for the
Hynix
00-20905
action), a hearing on claim construction and the parties
cross-motions for summary judgment on infringement and validity
was held on June 4 and 5, 2008. On July 10, 2008, the court
issued its claim construction order relating to the
Farmwald/Horowitz
patents in suit and denied the Manufacturers motions for
summary judgment of noninfringement and invalidity based on
their proposed claim construction. The court issued claim
construction orders relating to the Ware patents in suit on July
25 and August 27, 2008, and denied the Manufacturers
motion for summary judgment of noninfringement of certain
claims. On September 4, 2008, at the courts
direction, Rambus elected to proceed to trial on 12 patent
claims, each from the Farmwald/Horowitz family. On
September 16, 2008, Rambus granted a covenant not to assert
any claim of patent infringement against the Manufacturers under
U.S. Patent Nos. 6,493,789 and 6,496,897, and each
partys claims relating to those patents were dismissed
with prejudice. On November 21, 2008, the court entered an
order clarifying certain aspects of its July 10, 2008,
claim construction order. On November 24, 2008, the court
granted Rambuss motion for summary judgment of direct
infringement with respect to claim 16 of Rambuss
U.S. Patent No. 6,266,285 by the Manufacturers
DDR2, DDR3, gDDR2, GDDR3, GDDR4 memory chip products (except for
Nanyas DDR3 memory chip products). In the same order, the
court denied the remainder of Rambuss motion for summary
judgment of infringement.
On January 19, 2009, Samsung filed a motion for summary
judgment on the ground that the Delaware Order should be given
preclusive effect. Rambus filed an opposition brief to this
motion on January 26, 2009, and a hearing was held on
January 30, 2009. On February 3, 2009, the court
entered a stay of this action pending resolution of Rambus
appeal of the Delaware Order.
On August 11, 2008, the court granted summary judgment in
Rambus favor on Samsungs claims for aiding and
abetting a breach of fiduciary duty, intentional interference
with contract, and certain aspects of Samsungs unfair
competition claim. On September 16, 2008, the court entered
a stipulation and order of dismissal with prejudice of certain
of Samsungs claims and defenses (including those based on
Rambus alleged JEDEC conduct) and Rambus defenses
corresponding to Samsungs claims. A bench trial on the
remaining claims and defenses that are unique to Samsung (breach
of license, breach of duty of good faith and fair dealing, and
estoppel based on those claims), as well as Samsungs
claims and defenses related to its allegations that Rambus
spoliated evidence, was held between September 22 and
October 1, 2008. On April 27, 2009, the court issued
Findings of Fact and Conclusions of Law holding that:
(1) the parties 2000 SDR/DDR
8
license agreement did not cover DDR2 and future generation
products; (2) the license did not entitle Samsung to most
favored licensee benefits in any renewal or subsequent
agreement; (3) Rambus did not fail to negotiate an
extension or renewal license in good faith, and Samsung would
not have been entitled to damages for any such failure;
(4) Samsungs equitable estoppel defense failed;
(5) Rambus breached the license by not offering Samsung the
benefit to which it was entitled under the license (for the
second quarter of 2005 only) of the royalty in the March 2005
settlement agreement between Rambus and Infineon;
(6) Rambus failed to prove that Samsung breached certain
audit provisions in the license, and therefore Rambuss
termination of the license less than one month before it was due
to expire was improper; and (7) Rambuss actions did
not cause the parties failure to reach agreement on an
extension or renewal of the license. No decision has issued to
date regarding Samsungs spoliation allegations.
Federal
Trade Commision Complaint
On June 19, 2002, the Federal Trade Commission
(FTC) filed a complaint against Rambus. The FTC
alleged that through Rambus action and inaction at JEDEC,
Rambus violated Section 5 of the FTC Act in a way that
allowed Rambus to obtain monopoly power in or that
by acting with intent to monopolize it created a dangerous
probability of monopolization in synchronous DRAM
technology markets. The FTC also alleged that Rambus
action and practices at JEDEC constituted unfair methods of
competition in violation of Section 5 of the FTC Act. As a
remedy, the FTC sought to enjoin Rambus right to enforce
patents with priority dates prior to June 1996 as against
products made pursuant to certain existing and future JEDEC
standards.
On February 17, 2004, the FTC Chief Administrative Law
Judge issued his initial decision dismissing the FTCs
complaint against Rambus on multiple independent grounds (the
Initial Decision). The FTCs Complaint Counsel
appealed this decision.
On August 2, 2006, the FTC released its July 31, 2006,
opinion and order reversing and vacating the Initial Decision
and determining that Rambus violated Section 5 of the
Federal Trade Commission Act. Following further briefing and
oral argument on issues relating to remedy, the FTC released its
opinion and order on remedy on February 5, 2007. The remedy
order set the maximum royalty rate that Rambus could collect on
the manufacture, use or sale in the United States of certain
JEDEC-compliant parts after the effective date of the Order. The
order also mandated that Rambus offer a license for these
products at rates no higher than the maximums set by the FTC,
including a further cap on rates for the affected non-memory
products. The order further required Rambus to take certain
steps to comply with the terms of the order and applicable
disclosure rules of any standard setting organization of which
it may become a member.
The FTCs order explicitly did not set maximum rates or
other conditions with respect to Rambus royalty rates for
DDR2 SDRAM, other post-DDR JEDEC standards, or for
non-JEDEC-standardized technologies such as those used in RDRAM
or XDR DRAM.
On March 16, 2007, the FTC issued an order granting in part
and denying in part Rambus motion for a stay of the
remedy pending appeal. The March 16, 2007 order permitted Rambus
to acquire rights to royalty payments for use of the patented
technologies affected by the February 2 remedy order during the
period of the stay in excess of the FTC-imposed maximum royalty
rates on SDRAM and DDR SDRAM products, provided that funds above
the maximum allowed rates be either placed into an escrow
account to be distributed, or payable pursuant a contingent
contractual obligation, in accordance with the ultimate decision
of the court of appeals. In an opinion accompanying its order,
the FTC clarified that it intended its remedy to be
forward-looking and prospective only,
and therefore unlikely to be construed to require Rambus to
refund royalties already paid or to restrict Rambus from
collecting royalties for the use of its technologies during past
periods.
On April 27, 2007, the FTC issued an order granting in part
and denying in part Rambus petition for
reconsideration of the remedy order. The FTCs order and
accompanying opinion on Rambus petition for
reconsideration clarified the remedy order in certain respects.
For example, (1) the FTC explicitly stated that the remedy
order did not require Rambus to make refunds or prohibit it from
collecting royalties in excess of maximum allowable royalties
that accrue up to the effective date of the remedy order;
(2) the remedy order
9
was modified to specifically permit Rambus to seek damages in
litigation up to three times the specified maximum allowable
royalty rates on the ground of willful infringement and any
allowable attorneys fees; and (3) under the remedy
order, licensees were permitted to pay Rambus a flat fee in lieu
of running royalties, even if such an arrangement resulted in
payments above the FTCs rate caps in certain circumstances.
Rambus appealed the FTCs liability and remedy orders to
the U.S. Court of Appeals for the District of Columbia (the
CADC). Oral argument was heard February 14,
2008. On April 22, 2008, the CADC issued an opinion which
requires vacatur of the FTCs orders. The CADC held that
the FTC failed to demonstrate that Rambus conduct was
exclusionary, and thus failed to establish its allegation that
Rambus unlawfully monopolized any relevant market. The
CADCs opinion set aside the FTCs orders and remanded
the matter to the FTC for further proceedings consistent with
the opinion. Regarding the chance of further proceedings on
remand, the CADC expressed serious concerns about the strength
of the evidence relied on to support some of the FTCs
crucial findings regarding the scope of JEDECs patent
disclosure policies and Rambus alleged violation of those
policies. On August 26, 2008, the CADC denied the
FTCs petition to rehear the case en banc. On
October 16, 2008, the FTC issued an order explicitly
authorizing Rambus to receive amounts above the maximum rates
allowed by the FTCs now-vacated order payable pursuant to
any contingent contractual obligation.
On November 24, 2008, the FTC filed a petition seeking
review of the CADC decision by the U.S. Supreme Court.
Rambus filed an opposition to the FTCs petition on
January 23, 2009, and the FTC filed a reply on
February 4, 2009. On February 23, 2009, the United
States Supreme Court denied the FTCs petition. On
May 12, 2009, the FTC issued an order dismissing the
complaint, finding that further litigation in this matter would
not be in the public interest.
Indirect
Purchaser Class Action
On August 10, 2006, the first of nine class action lawsuits were
filed against Rambus in alleging violations of federal and state
antitrust laws, violations of state consumer protection laws,
and various common law claims based almost entirely on the same
conduct which was the subject of the FTCs July 31, 2006
opinion. Three of these lawsuits filed outside of California
were dismissed pursuant to agreement of the parties. The
remaining six of these cases were consolidated under the
caption, In re Rambus Antitrust Litigation, 06-4852 RMW
(N.D. Cal.). The consolidated complaint sought injunctive and
declaratory relief, disgorgement, restitution and compensatory
and punitive damages in an unspecified amount, and
attorneys fees and costs. On March 28, 2007, Rambus filed
a motion to dismiss the consolidated complaint. On July 27,
2007, the court heard oral argument on Rambus motion and
took the matter under submission. Before the court issued a
decision on Rambus motion to dismiss, the parties agreed
that the case should be dismissed. On April 8, 2009, the court
entered a stipulation and order dismissing the case, each party
bearing its own costs.
European
Commission Competition Directorate-General
On or about April 22, 2003, Rambus was notified by the
European Commission Competition Directorate-General
(Directorate) (the European Commission) that it had
received complaints from Infineon and Hynix alleging violations
of the European Union competition law. Rambus answered the
ensuing requests for information prompted by those complaints on
June 16, 2003. Rambus obtained a copy of Infineons
complaint to the European Commission in late July 2003, and on
October 8, 2003, at the request of the European Commission,
filed its response. The European Commission sent Rambus a
further request for information on December 22, 2006, which
Rambus answered on January 26, 2007. On August 1,
2007, Rambus received a statement of objections from the
European Commission. The statement of objections alleges that
through Rambus participation in the JEDEC standards
setting organization and subsequent conduct, Rambus violated
European Union competition law. Rambus filed a response to the
statement of objections on October 31, 2007, and a hearing
was held on December 4 and 5, 2007. The matter is currently
under submission by the European Commission.
On June 12, 2009, the European Commission announced that it
has reached a tentative settlement with Rambus to resolve the
pending case. Under the proposed resolution, the European
Commission would make no finding of liability relative to
JEDEC-related charges, and no fine would be assessed against
Rambus. In addition, Rambus would commit to offer licenses with
maximum royalty rates for certain memory types and memory
10
controllers on a forward-going basis (the
Commitment). The Commitment is expressly made
without any admission by Rambus of the allegations asserted
against it. The Commitment also does not resolve any existing
claims of infringement prior to the signing of any license with
a prospective licensee, nor does it release or excuse any of the
prospective licensees from damages or royalty obligations
through the date of signing a license. In accordance with
European Commission antitrust procedures, interested third
parties have been invited to submit comments on the proposed
Commitment to the European Commission within one month of the
announcement. No final decision will issue until after the end
of this comment period. Under the proposed resolution, Rambus
would offer licenses with maximum royalty rates for five-year
worldwide licenses of 1.5% for DDR2, DDR3, GDDR3 and GDDR4 SDRAM
memory types. Licensees who ship less than 10% of their DRAM
products in the older SDR and DDR DRAM types would be entitled
to a royalty holiday for those older types, subject to
compliance with the terms of the license. In addition, Rambus
would offer licenses with maximum royalty rates for five-year
worldwide licenses of 1.5% per unit for SDR memory controllers
through April 2010, dropping to 1.0% thereafter, and royalty
rates of 2.65% per unit for DDR, DDR2, DDR3, GDDR3 and GDDR4
memory controllers through April 2010, then dropping to 2.0%.
The Commitment to license at the above rates would be valid for
a period of five years from the adoption date of the Commitment
decision. All royalty rates would be applicable to future
shipments only and does not affect liability, if any, for
damages or royalties that accrued up to the time of the license
grant.
Superior
Court of California for the County of
San Francisco
On May 5, 2004, Rambus filed a lawsuit against Micron,
Hynix, Infineon and Siemens in San Francisco Superior Court
(the San Francisco court) seeking damages for
conspiring to fix prices (California Bus. & Prof. Code
§§ 16720 et seq.), conspiring to
monopolize under the Cartwright Act (California Bus. &
Prof. Code §§ 16720 et seq.), intentional
interference with prospective economic advantage, and unfair
competition (California Bus. & Prof. Code
§§ 17200 et seq.). This lawsuit alleges
that there were concerted efforts beginning in the 1990s to
deter innovation in the DRAM market and to boycott Rambus
and/or deter
market acceptance of Rambus RDRAM product. Subsequently,
Infineon and Siemens were dismissed from this action (as a
result of a settlement with Infineon) and three Samsung-related
entities were added as defendants.
A hearing on Rambus motion for summary judgment on the
grounds that Microns cross-complaint is barred by the
statute of limitations was held on August 1, 2008. At the
hearing, the San Francisco court granted Rambus
motion as to Microns first cause of action (alleged
violation of Californias Cartwright Act) and continued the
motion as to Microns second and third causes of action
(alleged violation of unfair business practices act and alleged
intentional interference with prospective economic advantage).
No further order has issued on Rambus motion.
On November 25, 2008, Micron, Samsung, and Hynix filed
eight motions for summary judgment on various grounds. On
January 26, 2009, Rambus filed briefs in opposition to all
eight motions. A hearing on these motions for summary judgment
was held on March 4-6 and
16-17, 2009.
The court denied seven of the eight motions and permitted Hynix
to submit further briefing on the remaining motion. The hearing
on the remaining motion was continued to June 29, 2009. On
June 17, 2009, Micron, Samsung, and Hynix filed a petition
requesting that the court of appeal issue a writ directing the
trial court to vacate one of the denials of the summary judgment
motions and enter an order granting the motion. No decision has
issued to date on the writ.
On March 10, 2009, defendants filed motions requesting that
Rambus case be dismissed on the ground that the Delaware
Order should be given preclusive effect. Rambus filed a brief
opposing this request. The parties filed further briefs on the
preclusive effect, if any, of the Delaware Order on April 3 and
April 17, 2009. The parties submitted briefs on their
allegations regarding alleged spoliation of evidence on
April 20, 2009. A hearing on these issues was held on April
27 and the hearing was continued to June 1, 2009, at the
conclusion of which the court denied defendants motion for
issue preclusion and terminating sanctions.
Trial is scheduled to begin on September 28, 2009.
Stock
Option Investigation Related Claims
On May 30, 2006, the Audit Committee commenced an internal
investigation of the timing of past stock option grants and
related accounting issues.
11
On May 31, 2006, the first of three stockholder derivative
actions was filed in the U.S. District Court for the
Northern District of California against Rambus (as a nominal
defendant) and certain current and former executives and board
members. These actions have been consolidated for all purposes
under the caption, In re Rambus Inc. Derivative Litigation,
Master File
No. C-06-3513-JF
(N.D. Cal.), and Howard Chu and Gaetano Ruggieri were appointed
lead plaintiffs. The consolidated complaint, as amended, alleges
violations of certain federal and state securities laws as well
as other state law causes of action. The complaint seeks
disgorgement and damages in an unspecified amount, unspecified
equitable relief, and attorneys fees and costs.
On August 22, 2006, another stockholder derivative action
was filed in Delaware Chancery Court against Rambus (as a
nominal defendant) and certain current and former executives and
board members (Bell v. Tate et al., 2366-N (Del.
Chancery)). On May 16, 2008, this case was dismissed
pursuant to a notice filed by the plaintiff.
On October 18, 2006, the Board of Directors formed a
Special Litigation Committee (the SLC) to evaluate
potential claims or other actions arising from the stock option
granting activities. The Board of Directors appointed J. Thomas
Bentley, Chairman of the Audit Committee, and Abraham Sofaer, a
retired U.S. federal judge and Chairman of our Legal
Affairs Committee, both of whom joined the Rambus Board of
Directors in 2005, to comprise the SLC.
On August 24, 2007, the final written report setting forth
the findings of the SLC was filed with the court. As set forth
in its report, the SLC determined that all claims should be
terminated and dismissed against the named defendants in In
re Rambus Inc. Derivative Litigation with the exception of
claims against named defendant Ed Larsen, who served as Vice
President, Human Resources from September 1996 until December
1999, and then Senior Vice President, Administration until July
2004. The SLC entered into settlement agreements with certain
former officers of Rambus. These settlements were conditioned
upon the dismissal of the claims asserted against these
individuals in In re Rambus Inc. Derivative Litigation.
The aggregate value of the settlements to Rambus exceeded
$5.3 million in cash as well as substantial additional
value to Rambus relating to the relinquishment of claims to over
2.7 million stock options. The SLC was disbanded in
February 2009.
On August 30, 2007, another stockholder derivative action
was filed in the U.S. District Court for the Southern
District of New York against Rambus (as a nominal defendant) and
PricewaterhouseCoopers LLP (Francl v.
PricewaterhouseCoopers LLP et al.,
No. 07-Civ.
7650 (GBD)). On November 21, 2007, the New York court
granted PricewaterhouseCoopers LLPs motion to transfer the
action to the Northern District of California.
The parties have settled In re Rambus Inc. Derivative
Litigation and Francl v. PricewaterhouseCoopers LLP
et al.,
No. 07-Civ.
7650 (GBD). The settlement provided for a payment by Rambus of
$2.0 million and dismissal with prejudice of all claims
against all defendants, with the exception of claims against Ed
Larsen, in these actions. The $2.0 million was accrued for
during the quarter ended June 30, 2008 within accrued
litigation expenses. A final approval hearing was held on
January 16, 2009, and an order of final approval was
entered on January 20, 2009.
On July 17, 2006, the first of six class action lawsuits
was filed in the U.S. District Court for the Northern
District of California against Rambus and certain current and
former executives and board members. These lawsuits were
consolidated under the caption, In re Rambus Inc. Securities
Litigation, C-06-4346-JF (N.D. Cal.). The settlement of this
action was preliminarily approved by the court on March 5,
2008. Pursuant to the settlement agreement, Rambus paid
$18.3 million into a settlement fund on March 17,
2008. Some alleged class members requested exclusion from the
settlement. A final fairness hearing was held on May 14,
2008. That same day the court entered an order granting final
approval of the settlement agreement and entered judgment
dismissing with prejudice all claims against all defendants in
the consolidated class action litigation.
On March 1, 2007, a pro se lawsuit was filed in the
U.S. District Court for the Northern District of California
by two alleged Rambus stockholders against Rambus, certain
current and former executives and board members, and
PricewaterhouseCoopers LLP (Kelley et al. v. Rambus,
Inc. et al. C-07-01238-JF (N.D. Cal.)). This action was
consolidated with a substantially identical pro se lawsuit filed
by another purported Rambus stockholder against the same
parties. The consolidated complaint against Rambus alleges
12
violations of federal and state securities laws, and state law
claims for fraud and breach of fiduciary duty. Following several
rounds of motions to dismiss, on April 17, 2008, the court
dismissed all claims with prejudice except for plaintiffs
claims under sections 14(a) and 18(a) of the Securities and
Exchange Act of 1934 as to which leave to amend was granted. On
June 2, 2008, plaintiffs filed an amended complaint
containing substantially the same allegations as the prior
complaint although limited to claims under sections 14(a)
and 18(a) of the Securities and Exchange Act of 1934.
Rambus motion to dismiss the amended complaint was heard
on September 12, 2008. On December 9, 2008, the court
granted Rambus motion and entered judgment in favor of
Rambus. Plaintiffs filed a notice of appeal on December 15,
2008. Plaintiffs filed their opening brief on
April 13, 2009. Rambus opposed on May 29, 2009, and
plaintiffs filed a reply brief on June 12, 2009. No date
has been set for oral argument.
On September 11, 2008, the same pro se plaintiffs filed a
separate lawsuit in Santa Clara County Superior Court
against Rambus, certain current and former executives and board
members, and PricewaterhouseCoopers LLP (Kelley et
al. v. Rambus, Inc. et al., Case
No. 1-08-CV-122444).
The complaint alleges violations of certain California state
securities statutes as well as fraud and negligent
misrepresentation based on substantially the same underlying
factual allegations contained in the pro se lawsuit filed in
federal court. On November 24, 2008, Rambus filed a motion
to dismiss or, in the alternative, stay this case in light of
the first-filed federal action. On January 12, 2009, Rambus
filed a demurrer to plaintiffs complaint on the ground
that it was barred by the doctrine of claim preclusion. A
hearing on Rambus motions was held on February 27,
2009. The court granted Rambuss motion to stay the case
pending the outcome of the appeal in the federal action and
denied the remainder of the motions without prejudice.
On August 25, 2008, an amended complaint was filed by
certain individuals and entities in Santa Clara County
Superior Court against Rambus, certain current and former
executives and board members, and PricewaterhouseCoopers LLP
(Steele et al. v. Rambus Inc. et al., Case
No. 1-08-CV-113682).
The amended complaint alleges violations of certain California
state securities statutes as well as fraud and negligent
misrepresentation. On October 10, 2008, Rambus filed a
demurrer to the amended complaint. A hearing was held on
January 9, 2009. On January 12, 2009, the court
sustained Rambus demurrer without prejudice. Plaintiffs
filed a second amended complaint on February 13, 2009,
containing the same causes of action as the previous complaint.
On March 17, 2009, Rambus filed a demurrer to the second
amended complaint. A hearing was held on May 22, 2009. On
May 26, 2009, the court sustained in part and overruled in
part Rambuss demurrer. On June 5, 2009, Rambus
filed an answer denying plaintiffs remaining allegations.
Discovery is ongoing.
NVIDIA
Litigation
U.S
District Court in the Northern District of California
On July 10, 2008, Rambus filed suit against NVIDIA
Corporation (NVIDIA) in the U.S. District Court
for the Northern District of California alleging that
NVIDIAs products with memory controllers for at least the
SDR, DDR, DDR2, DDR3, GDDR and GDDR3 technologies infringe 17
patents. On September 16, 2008, Rambus granted a covenant
not to assert any claim of patent infringement against NVIDIA
under U.S. Patent Nos. 6,493,789 and 6,496,897; accordingly
15 patents remain in suit. On August 29, 2008, NVIDIA filed
a motion to dismiss or strike the complaint, or in the
alternative, for more definite statement. On November 13,
2008, the Court denied NVIDIAs motion. On December 4,
2008, NVIDIA filed a motion to stay this action in its entirety.
On December 30, 2008, the court granted NVIDIAs
motion to stay this case as to Rambus claims that
NVIDIAs products infringe nine patents that are also the
subject of proceedings in front of the International Trade
Commission (described below), and denied NVIDIAs motion to
stay the remainder of Rambus patent infringement claims.
On January 16, 2009, NVIDIA filed a motion to dismiss on
the ground that Rambus claims not subject to the stay are
precluded due to the Delaware Order. On February 6, 2009,
NVIDIA filed a motion to lift the partial stay and for summary
judgment on the ground that certain of Rambus patent
infringement claims subject to the stay are precluded due to the
Delaware Order. On February 20, 2009, Rambus filed a
consolidated opposition to both motions. A hearing on
NVIDIAs motions was held on March 13, 2009. On
March 20, 2009, a
follow-up
hearing was held regarding how the case should proceed. On
April 2, 2009, NVIDIA filed another motion to stay. On
April 13, 2009, the court denied each of
13
NVIDIAs motions. Certain limited discovery is proceeding
and a case management conference is scheduled for
August 21, 2009.
On July 11, 2008, one day after Rambus filed suit, NVIDIA
filed its own action against Rambus in the U.S. District
Court for the Middle District of North Carolina alleging that
Rambus committed antitrust violations of the Sherman Act;
committed antitrust violations of North Carolina law; and
engaged in unfair and deceptive practices in violation of North
Carolina law. NVIDIA seeks injunctive relief, damages, and
attorneys fees and costs. On February 2, 2009,
NVIDIAs suit against Rambus, originally filed in the
U.S. District Court for the Middle District of North
Carolina (see below) was transferred and consolidated into
Rambus patent infringement case. Rambus filed a motion to
dismiss NVIDIAs claims prior to transfer of the action to
California, and no decision has issued to date.
U.S.
District Court in the Middle District of North
Carolina
On July 11, 2008, one day after Rambus filed suit, NVIDIA
filed its own action against Rambus in the U.S. District
Court for the Middle District of North Carolina alleging that
Rambus committed antitrust violations of the Sherman Act,
committed antitrust violations of North Carolina law and engaged
in unfair and deceptive practices in violation of North Carolina
law. NVIDIA seeks injunctive relief, damages, and
attorneys fees and costs. On September 8, 2008,
Rambus filed a motion to dismiss the complaint. On
September 17, 2008, Rambus filed a motion to transfer this
action to the Northern District of California, where
Rambus first-filed patent infringement suit is pending
against NVIDIA. On December 1, 2008, the Court granted
Rambus motion to transfer, and the case was consolidated
into Rambus first-filed action on February 2, 2009.
International
Trade Commission
On November 6, 2008, Rambus filed a complaint with the
U.S. International Trade Commission (the ITC)
requesting the commencement of an investigation pertaining to
NVIDIA products. The complaint seeks an exclusion order barring
the importation, sale for importation, or sale after importation
of products that infringe nine Rambus patents from the Ware and
Barth families of patents. The accused products include NVIDIA
products that incorporate DDR, DDR2, DDR3, LPDDR, GDDR, GDDR2,
and GDDR3 memory controllers, including graphics processors, and
media and communications processors. The complaint names NVIDIA
as a proposed respondent, as well as companies whose products
incorporate accused NVIDIA products and are imported into the
United States. Additional respondents include: Asustek Computer
Inc. and Asus Computer International, BFG Technologies, Biostar
Microtech and Biostar Microtech International Corp., Diablotek
Inc., EVGA Corp., G.B.T. Inc. and Giga-Byte Technology Co.,
Hewlett-Packard, MSI Computer Corp. and Micro-Star International
Co., Palit Multimedia Inc. and Palit Microsystems Ltd., Pine
Technology Holdings, and Sparkle Computer Co.
On December 4, 2008, the ITC instituted the investigation.
On February 12, 2009, NVIDIA filed a motion to stay the
investigation pending resolution of Rambus appeal of the
Delaware Order. On February 23, 2009, Rambus and the
ITCs Investigative Staff filed briefs in opposition to
NVIDIAs motion. On March 4, 2009, the ITCs
administrative law judge denied NVIDIAs motion. A hearing
on claim construction was held on March 24, 2009. On
June 5, 2009, Rambus moved to withdraw from the
investigation four of the asserted patents and certain claims of
a fifth asserted patent in order to simplify the investigation,
streamline the final hearing, and conserve ITC resources. A
final hearing before the administrative law judge is scheduled
for August 31 through September 11, 2009.
Potential
Future Litigation
In addition to the litigation described above, participants in
the DRAM and controller markets continue to adopt Rambus
technologies into various products. Rambus has notified many of
these companies of their use of Rambus technology and continues
to evaluate how to proceed on these matters. There can be no
assurance that any ongoing or future litigation will be
successful. Rambus spends substantial company resources
defending its intellectual property in litigation, which may
continue for the foreseeable future given the multiple pending
litigations. The outcomes of these litigations as
well as any delay in their resolution could affect
Rambus ability to license its intellectual property in the
future.
14
The Company records a contingent liability when it is probable
that a loss has been incurred and the amount is reasonably
estimable in accordance with SFAS No. 5,
Accounting for Contingencies.
We were originally incorporated in 1990. In 1997, we were
reincorporated in Delaware. Our executive offices are located at
4440 El Camino Real, Los Altos, California. Our telephone number
is
(650) 947-5000
and our internet address is www.rambus.com. The information
contained or incorporated in our website is not part of this
prospectus.
15
The
Offering
The following summary contains basic information about the
notes and is not a complete description of the offering. Thus,
it does not contain all the information that is important to
you. For a more detailed description of the notes you should
read the section titled Description of the Notes.
For purposes of this summary of the offering and the
Description of the Notes, references to
we, us, our, the
Company and Rambus refer solely to Rambus Inc.
and not to its subsidiaries.
|
|
|
Issuer |
|
Rambus Inc. |
|
Notes Offered |
|
$150,000,000 million aggregate principal amount (or
$172,500,000 million aggregate principal amount, if the
underwriters exercise in full their option to purchase
additional notes solely to cover over-allotments, if any)
of % Convertible Senior Notes
due 2014. |
|
Maturity Date |
|
June 15, 2014, unless earlier redeemed, repurchased or
converted. |
|
Interest Payment Dates |
|
December 15 and June 15 of each year, beginning on
December 15, 2009. |
|
Interest |
|
% per annum, payable semiannually,
in arrears. Interest will be computed on the basis of a
360-day year
comprised of twelve
30-day
months. |
|
Ranking |
|
The notes will be our general unsecured obligations and will: |
|
|
|
rank equal in right of payment to all of our
existing and future senior indebtedness;
|
|
|
|
rank senior in right of payment to all of our future
indebtedness that is expressly subordinated to the notes;
|
|
|
|
be effectively subordinated in right of payment to
all of our existing and future secured obligations to the extent
of the collateral securing those obligations; and
|
|
|
|
be structurally subordinated in right of payment to
all existing and future indebtedness and other liabilities of
our subsidiaries, including trade credit.
|
|
|
|
At March 31, 2009, we had approximately $137 million
aggregate principal amount of unsecured senior indebtedness
outstanding (excluding the notes offered hereby, but including
our zero coupon convertible senior notes due 2010 (the
existing notes)), and our subsidiaries had
approximately $1.4 million of liabilities outstanding,
excluding inter-company obligations. We and our subsidiaries are
not prohibited under the indenture from incurring additional
other indebtedness. See Description of the
Notes General. |
|
Right to Convert |
|
Holders may convert their notes at their option at any time
prior to March 15, 2014, only under the following
circumstances: |
|
|
|
during any calendar quarter beginning after the
calendar quarter ending September 30, 2009, and only during
such calendar quarter, if the closing sale price of our common
stock for 20 or more trading days in the period of 30
consecutive trading days ending on the last trading day of the
immediately preceding calendar quarter exceeds 130% of the
conversion price in effect on the last trading day of the
immediately preceding calendar quarter;
|
16
|
|
|
|
|
during the five business day period after any 10
consecutive trading day period in which the trading price per
$1,000 principal amount of notes for each trading day of such 10
consecutive trading day period was less than 98% of the product
of the closing sale price of our common stock for such trading
day and the applicable conversion rate;
|
|
|
|
upon the occurrence of specified distributions to
holders of our common stock;
|
|
|
|
upon a fundamental change; or
|
|
|
|
if we call any or all of the notes for redemption,
at any time prior to the close of business on the business day
immediately preceding the redemption date.
|
|
|
|
On and after March 15, 2014, holders may convert their
notes at any time until the close of business on the third
business day prior to the maturity date, regardless of the
foregoing circumstances. |
|
|
|
The initial conversion rate of the notes
is per $1,000 principal amount of
notes, subject to adjustment as described under
Description of the Notes Conversion of
Notes Conversion Rate Adjustments
Adjustment Events. The initial conversion rate is
equivalent to a conversion price of approximately
$ per share. In addition, upon the
occurrence of certain fundamental changes, we may be required to
increase the conversion rate, as described under
Description of the Notes Conversion of
Notes Adjustment to Conversion Rate upon Certain
Fundamental Changes. |
|
|
|
Except as described in Description of the
Notes Conversion of Notes, upon any
conversion, holders will not receive any separate cash payment
representing accrued and unpaid interest, including additional
interest, if any. |
|
Optional Redemption |
|
We may not redeem any of the notes at our option prior to
June 15, 2012. At any time on or after June 15, 2012,
we will have the right, at our option, to redeem the notes in
whole or in part for cash if the closing sale price of our
common stock for at least 20 of the 30 consecutive trading
days immediately prior to any date we give a notice of
redemption is greater than 130% of the conversion price on the
date of such notice. The redemption price will equal 100% of the
principal amount of the notes to be redeemed, together with
accrued and unpaid interest, if any, on the principal amount of
the notes redeemed, to but excluding the date of redemption.
However, if the redemption date falls after a record date and on
or prior to the corresponding interest payment date, we will pay
the full amount of accrued and unpaid interest (including
additional interest, if any), if any, due on such interest
payment date to the holder of record at the close of business on
the corresponding record date, and not to the holder submitting
the notes for redemption, if different. We will make at least
six semi-annual interest payments (including the interest
payments due on December 15, 2009 and June 15,
2012) in the full amount required by the indenture before
we redeem the notes at our option. See Description of the
Notes Optional Redemption. |
17
|
|
|
Fundamental Change |
|
In the event of a fundamental change, each holder may require us
to repurchase some or all of its notes for cash at a price equal
to 100% of the principal amount of the notes being repurchased,
plus accrued and unpaid interest, if any, in each case to, but
excluding, the date of repurchase. See Description of the
Notes Repurchase of Notes at the Option of Holders
upon a Fundamental Change. |
|
Conversion Rate Adjustment upon Certain Fundamental Changes
|
|
If certain fundamental changes occur, we may be required to
increase the conversion rate for any notes converted in
connection with such fundamental changes by a specified number
of shares of our common stock. A description of how the
conversion rate would be increased and a table showing the
conversion rate that would apply at various stock prices and
fundamental change adjustment dates are set forth under
Description of the Notes Conversion of
Notes Adjustment to Conversion Rate upon Certain
Fundamental Changes. |
|
Sinking Fund |
|
None. |
|
Use of Proceeds |
|
We estimate that the net proceeds to us from the sale of the
notes will be approximately
$ million (or
$ million if the underwriters
exercise their over-allotment option in full), after deducting
underwriters discounts and commissions and estimated
offering expenses payable by us. |
|
|
|
We intend to use the net proceeds from this offering for general
corporate purposes, which may include financing potential
acquisitions and strategic transactions, repayment of our
existing notes, and working capital. See Use of
Proceeds. |
|
Trustee and Paying Agent |
|
U.S. Bank National Association. |
|
DTC Eligibility |
|
The notes will be issued in book-entry form and will be
represented by permanent global certificates deposited with, or
on behalf of, The Depository Trust Company
(DTC), and registered in the name of a nominee of
DTC. Beneficial interests in the notes will be shown on, and
transfers will be effected only through, records maintained by
DTC or its nominee, and any such interest may not be exchanged
for certificated securities, except in limited circumstances.
See Description of the Notes Book-Entry
Delivery and Form. |
|
Listing and Trading |
|
The notes will not be listed on any securities exchange. Our
common stock is listed on the NASDAQ Global Select Market under
the symbol RMBS. |
|
Governing Law |
|
The indenture and the notes provide that they will be governed
by, and construed in accordance with, the laws of the State of
New York. |
|
Risk Factors |
|
An investment in the notes involves risks. You should carefully
consider the information set forth in the sections of this
prospectus entitled Risk Factors, as well as other
information included in or incorporated by reference into this
prospectus and before deciding whether to invest in the notes. |
18
Summary
Consolidated Financial Data
The summary consolidated statement of operations data below for
the years ended December 31, 2006, 2007 and 2008 have been
derived from our audited consolidated financial statements that
are incorporated by reference in this prospectus, and are
qualified by reference to such financial statements. The summary
consolidated statement of operations data below for the three
months ended March 31, 2008 and 2009, and the summary
consolidated balance sheet data as of March 31, 2009, have
been derived from our unaudited consolidated financial
statements that are incorporated by reference in this
prospectus. In the opinion of management, such unaudited
quarterly financial data contains all adjustments necessary for
the fair statement of our financial position and results of
operations as of and for such periods. Operating results for the
three months ended March 31, 2009 are not necessarily
indicative of results that may be expected for the full year or
future periods.
The as adjusted balance sheet data column gives effect to the
issuance and sale of the notes in this offering, after deducting
the underwriting discounts and commissions and estimated
offering expenses payable by us (assuming no exercise of the
underwriters over-allotment option to purchase additional
notes), as if such event took place on March 31, 2009. The
data should be read in conjunction with the consolidated
financial statements, related notes and other financial
information incorporated by reference in this prospectus.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years Ended December 31,
|
|
|
Three Months Ended March 31,
|
|
|
|
2006
|
|
|
2007
|
|
|
2008
|
|
|
2008
|
|
|
2009
|
|
|
|
|
|
|
|
|
|
|
|
|
(Unaudited)
|
|
|
|
(In thousands, except per share data)
|
|
|
Consolidated Statement of Operations Data(1):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Royalties
|
|
$
|
168,916
|
|
|
$
|
154,306
|
|
|
$
|
126,910
|
|
|
$
|
33,093
|
|
|
$
|
26,169
|
|
Contract revenue
|
|
|
26,408
|
|
|
|
25,634
|
|
|
|
15,584
|
|
|
|
6,645
|
|
|
|
1,165
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenue
|
|
|
195,324
|
|
|
|
179,940
|
|
|
|
142,494
|
|
|
|
39,738
|
|
|
|
27,334
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Costs and expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of contract revenue
|
|
|
30,392
|
|
|
|
27,124
|
|
|
|
21,303
|
|
|
|
7,233
|
|
|
|
2,183
|
|
Research and development
|
|
|
68,977
|
|
|
|
82,877
|
|
|
|
76,222
|
|
|
|
21,502
|
|
|
|
17,837
|
|
Marketing, general and administrative
|
|
|
104,561
|
|
|
|
120,597
|
|
|
|
124,077
|
|
|
|
33,321
|
|
|
|
37,156
|
|
Restructuring costs
|
|
|
|
|
|
|
|
|
|
|
4,185
|
|
|
|
|
|
|
|
|
|
Impairment of intangible assets
|
|
|
|
|
|
|
|
|
|
|
2,158
|
|
|
|
|
|
|
|
|
|
Costs (recovery) of restatement and related legal activities
|
|
|
31,436
|
|
|
|
19,457
|
|
|
|
3,262
|
|
|
|
912
|
|
|
|
(13,639
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total costs and expenses
|
|
|
235,366
|
|
|
|
250,055
|
|
|
|
231,207
|
|
|
|
62,968
|
|
|
|
43,537
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating loss
|
|
|
(40,042
|
)
|
|
|
(70,115
|
)
|
|
|
(88,713
|
)
|
|
|
(23,230
|
)
|
|
|
(16,203
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income and other income (expense), net(1)
|
|
|
17,495
|
|
|
|
21,759
|
|
|
|
15,199
|
|
|
|
4,595
|
|
|
|
1,440
|
|
Interest expense(2)
|
|
|
(10,196
|
)
|
|
|
(11,011
|
)
|
|
|
(11,805
|
)
|
|
|
(2,888
|
)
|
|
|
(2,670
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest and other income (expense), net
|
|
|
7,299
|
|
|
|
10,748
|
|
|
|
3,394
|
|
|
|
1,707
|
|
|
|
(1,230
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss before income taxes
|
|
|
(32,743
|
)
|
|
|
(59,367
|
)
|
|
|
(85,319
|
)
|
|
|
(21,523
|
)
|
|
|
(17,433
|
)
|
Provision for (benefit from) income taxes(1)
|
|
|
(14,737
|
)
|
|
|
(25,146
|
)
|
|
|
113,791
|
|
|
|
(7,169
|
)
|
|
|
(7
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$
|
(18,006
|
)
|
|
$
|
(34,221
|
)
|
|
$
|
(199,110
|
)
|
|
$
|
(14,354
|
)
|
|
$
|
(17,426
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
(0.17
|
)
|
|
$
|
(0.33
|
)
|
|
$
|
(1.90
|
)
|
|
$
|
(0.14
|
)
|
|
$
|
(0.17
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$
|
(0.17
|
)
|
|
$
|
(0.33
|
)
|
|
$
|
(1.90
|
)
|
|
$
|
(0.14
|
)
|
|
$
|
(0.17
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares used in per share calculation:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
103,048
|
|
|
|
104,056
|
|
|
|
104,574
|
|
|
|
104,683
|
|
|
|
104,376
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
|
103,048
|
|
|
|
104,056
|
|
|
|
104,574
|
|
|
|
104,683
|
|
|
|
104,376
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
19
|
|
|
(1) |
|
Reflects the implementation of Financial Accounting Standards
Board Staff Position (FSP)
APB 14-1,
Accounting for Convertible Debt Instruments that May be
Settled in Cash upon Conversion (Including Partial Cash
Settlement), or
FSP APB 14-1.
See Note 1, Basis of Presentation, and
Note 15, Convertible Notes, to our unaudited
condensed consolidated financial statements, which appear in our
Quarterly Report on
Form 10-Q
for the three months ended March 31, 2009 and Note 2A,
Retrospective Adoption of New Accounting
Pronouncement, to our audited consolidated financial
statements which appear in our Current Report on Form
8-K filed
with the Securities and Exchange Commission on June 22,
2009. |
|
(2) |
|
Non-cash interest expense is a result of adoption of
FSP APB 14-1. |
|
|
|
|
|
|
|
|
|
|
|
As of March 31, 2009
|
|
|
Actual
|
|
As Adjusted(2)
|
|
|
(In thousands)
|
|
|
(Unaudited)
|
|
Consolidated Balance Sheet Data(1):
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
125,838
|
|
|
$
|
|
|
Other current assets
|
|
|
231,251
|
|
|
|
|
|
Total assets
|
|
|
395,292
|
|
|
|
|
|
Total liabilities
|
|
|
167,045
|
|
|
|
|
|
Stockholders equity
|
|
|
228,247
|
|
|
|
|
|
|
|
|
(1) |
|
Reflects the implementation of
FSP APB 14-1.
See Note 1, Basis of Presentation, and
Note 15, Convertible Notes, to our unaudited
condensed consolidated financial statements, which appear in our
Quarterly Report on
Form 10-Q
for the three months ended March 31, 2009 and Note 2A,
Retrospective Adoption of New Accounting
Pronouncement, to our audited consolidated financial
statements which appear in our Current Report on
Form 8-K
filed with the Securities and Exchange Commission on
June 22, 2009. |
|
(2) |
|
Certain of the as adjusted amounts shown are estimates that
reflect the application of FSP APB
14-1, which
requires issuers to separately account for the debt and equity
components of convertible debt instruments that allow for cash
settlement. |
20
RISK
FACTORS
Investing in the notes and our common stock involves a high
degree of risk. In addition to the other information contained
in this prospectus and in documents that we incorporate by
reference, you should carefully consider the risks discussed
below before making a decision about investing in our
securities. The risks and uncertainties discussed below are not
the only ones facing us. Additional risks and uncertainties not
presently known to us, or that we currently see as immaterial,
may also harm our business. If any of these risks occur, our
business, financial condition and operating results could be
harmed, the market value of the notes and the trading price of
our common stock could decline and you could lose part or all of
your investment.
Litigation,
Regulation and Business Risks Related to our Intellectual
Property
We
face current and potential adverse determinations in litigation
stemming from our efforts to protect and enforce our patents and
intellectual property, which could broadly impact our
intellectual property rights, distract our management and cause
a substantial decline in our revenue and stock
price.
We seek to diligently protect our intellectual property rights.
In connection with the extension of our licensing program to SDR
SDRAM-compatible and DDR SDRAM-compatible products, we became
involved in litigation related to such efforts against different
parties in multiple jurisdictions. In each of these cases, we
have claimed infringement of certain of our patents, while the
manufacturers of such products have generally sought damages and
a determination that the patents in suit are invalid,
unenforceable, and not infringed. Among other things, the
opposing parties have alleged that certain of our patents are
unenforceable because we engaged in document spoliation,
litigation misconduct
and/or acted
improperly during our 1991 to 1995 participation in the JEDEC
standard setting organization (including allegations of
antitrust violations and unfair competition). See
Summary Litigation Updates.
There can be no assurance that any or all of the opposing
parties will not succeed, either at the trial or appellate
level, with such claims or counterclaims against us or that they
will not in some other way establish broad defenses against our
patents, achieve conflicting results, or otherwise avoid or
delay paying royalties for the use of our patented technology.
Moreover, there is a risk that if one party prevails against us,
other parties could use the adverse result to defeat or limit
our claims against them; conversely, there can be no assurance
that if we prevail against one party, we will succeed against
other parties on similar claims, defenses, or counterclaims. In
addition, there is the risk that the pending litigations and
other circumstances may cause us to accept less than what we now
believe to be fair consideration in settlement.
Any of these matters, whether or not determined in our favor or
settled by us, is costly, may cause delays (including delays in
negotiating licenses with other actual or potential licensees),
will tend to discourage future design partners, will tend to
impair adoption of our existing technologies and divert the
efforts and attention of our management and technical personnel
from other business operations. In addition, we may be
unsuccessful in our litigation if we have difficulty obtaining
the cooperation of former employees and agents who were involved
in our business during the relevant periods related to our
litigation and are now needed to assist in cases or testify on
our behalf. Furthermore, any adverse determination or other
resolution in litigation could result in our losing certain
rights beyond the rights at issue in a particular case,
including, among other things: our being effectively barred from
suing others for violating certain or all of our intellectual
property rights; our patents being held invalid or unenforceable
or not infringed; our being subjected to significant
liabilities; our being required to seek licenses from third
parties; our being prevented from licensing our patented
technology; or our being required to renegotiate with current
licensees on a temporary or permanent basis. Even if we are
successful in our litigation, there is no guarantee that the
applicable opposing parties will be able to pay any damages
awards timely or at all as a result of financial difficulties or
otherwise. Delay or any or all of these adverse results could
cause a substantial decline in our revenue and stock price.
21
An
adverse resolution by or with a governmental agency, such as the
European Commission or patent offices, could result in severe
limitations on our ability to protect and license our
intellectual property, and would cause our revenue to decline
substantially.
From time to time, we are subject to proceedings by government
agencies. These proceedings, or one by any other governmental
agency, may result in adverse determinations against us or in
other outcomes that could limit our ability to enforce or
license our intellectual property, and could cause our revenue
to decline substantially.
In addition, third parties have and may attempt to use adverse
findings by a government agency to limit our ability to enforce
or license our patents in private litigations and to assert
claims for monetary damages against us. Although we have
successfully defeated certain attempts to do so, there can be no
assurance that other third parties will not be successful in the
future or that additional claims or actions arising out of
adverse findings by a government agency will not be asserted
against us.
Further, third parties have sought and may seek review and
reconsideration of the patentability of inventions claimed in
certain of our patents by U.S. Patent and Trademark Office
(PTO)
and/or the
European Patent Office (the EPO). Currently, we are
subject to several re-examination proceedings, including
proceedings initiated by NVIDIA, Samsung, Hynix and Micron as a
defensive action in connection with our litigation against those
companies. An adverse decision by the PTO or EPO could
invalidate some or all of these patent claims and could also
result in additional adverse consequences affecting other
related U.S. or European patents, including in our
intellectual property litigation. If a sufficient number of such
patents are impaired, our ability to enforce or license our
intellectual property would be significantly weakened and this
could cause our revenue to decline substantially.
The pendency of any governmental agency acting as described
above may impair our ability to enforce or license our patents
or collect royalties from existing or potential licensees, as
our litigation opponents may attempt to use such proceedings to
delay or otherwise impair any pending cases and our existing or
potential licensees may await the final outcome of any
proceedings before agreeing to new licenses or pay royalties.
Litigation
or other third-party claims of intellectual property
infringement could require us to expend substantial resources
and could prevent us from developing or licensing our technology
on a cost-effective basis.
Our research and development programs are in highly competitive
fields in which numerous third parties have issued patents and
patent applications with claims closely related to the subject
matter of our research and development programs. We have also
been named in the past, and may in the future be named, as a
defendant in lawsuits claiming that our technology infringes
upon the intellectual property rights of third parties. In the
event of a third-party claim or a successful infringement action
against us, we may be required to pay substantial damages, to
stop developing and licensing our infringing technology, to
develop non-infringing technology, and to obtain licenses, which
could result in our paying substantial royalties or our granting
of cross licenses to our technologies. Threatened or ongoing
third-party claims or infringement actions may prevent us from
pursuing additional development and licensing arrangements for
some period. For example, we may discontinue negotiations with
certain customers for additional licensing of our patents due to
the uncertainty caused by our ongoing litigation on the terms of
such licenses or of the terms of such licenses on our
litigation. We may not be able to obtain licenses from other
parties at a reasonable cost, or at all, which could cause us to
expend substantial resources, or result in delays in, or the
cancellation of, new product.
If we
are unable to successfully protect our inventions through the
issuance and enforcement of patents, our operating results could
be adversely affected.
We have an active program to protect our proprietary inventions
through the filing of patents. There can be no assurance,
however, that:
|
|
|
|
|
any current or future U.S. or foreign patent applications
will be approved and not be challenged by third parties;
|
22
|
|
|
|
|
our issued patents will protect our intellectual property and
not be challenged by third parties;
|
|
|
|
the validity of our patents will be upheld;
|
|
|
|
our patents will not be declared unenforceable;
|
|
|
|
the patents of others will not have an adverse effect on our
ability to do business;
|
|
|
|
Congress or the U.S. courts or foreign countries will not
change the nature or scope of rights afforded patents or patent
owners or alter in an adverse way the process for seeking
patents;
|
|
|
|
changes in law will not be implemented that will affect our
ability to protect and enforce our patents and other
intellectual property;
|
|
|
|
new legal theories and strategies utilized by our competitors
will not be successful; or
|
|
|
|
others will not independently develop similar or competing chip
interfaces or design around any patents that may be issued to us.
|
If any of the above were to occur, our operating results could
be adversely affected.
Our
inability to protect and own the intellectual property we create
would cause our business to suffer.
We rely primarily on a combination of license, development and
nondisclosure agreements, trademark, trade secret and copyright
law, and contractual provisions to protect our non-patentable
intellectual property rights. If we fail to protect these
intellectual property rights, our licensees and others may seek
to use our technology without the payment of license fees and
royalties, which could weaken our competitive position, reduce
our operating results and increase the likelihood of costly
litigation. The growth of our business depends in large part on
the use of our intellectual property in the products of third
party manufacturers, and our ability to enforce intellectual
property rights against them to obtain appropriate compensation.
In addition, effective trade secret protection may be
unavailable or limited in certain foreign countries. Although we
intend to protect our rights vigorously, if we fail to do so,
our business will suffer.
We
rely upon the accuracy on our licensees recordkeeping, and
any inaccuracies or payment disputes for amounts owed to us
under our licensing agreements may harm our results of
operations.
Many of our license agreements require our licensees to document
the manufacture and sale of products that incorporate our
technology and report this data to us on a quarterly basis.
While licenses with such terms give us the right to audit books
and records of our licensees to verify this information, audits
rarely are undertaken because they can be expensive, time
consuming, and potentially detrimental to our ongoing business
relationship with our licensees. Therefore, we rely on the
accuracy of the reports from licensees without independently
verifying the information in them. Our failure to audit our
licensees books and records may result in our receiving
more or less royalty revenue than we are entitled to under the
terms of our license agreements. If we conduct royalty audits in
the future, such audits may trigger disagreements over contract
terms with our licensees and such disagreements could hamper
customer relations, divert the efforts and attention of our
management from normal operations and impact our business
operations and financial condition.
We may
not be able to satisfy, and Qimonda may avoid, the requirements
under the Qimonda settlement and license agreement that would
require Qimonda to pay us up to an additional
$100.0 million in royalty payments.
On March 21, 2005, we entered into a settlement and patent
license agreement with Infineon (and its former parent Siemens),
which was assigned to Qimonda (formerly Infineons DRAM
operations) in October 2006 in connection with Infineons
spin-off of Qimonda. The agreement, among other things, provides
that if we enter into licenses with certain other DRAM
manufacturers, Qimonda will be required to make certain
additional payments to us that may aggregate up to
$100.0 million. As we have not yet succeeded in entering
into these additional license agreements necessary to trigger
Qimondas obligations, Qimondas quarterly payment
ceased as of the first quarter of 2008. The quarterly payments
with Qimonda will not recommence until we enter into additional
license agreements with certain other DRAM manufacturers. We may
not succeed in entering into these additional license
23
agreements necessary to trigger Qimondas obligations under
the settlement and patent license agreement to pay to us
additional amounts, thereby reducing the value of the settlement
and license agreement to us.
In addition, Qimonda commenced insolvency proceedings in Germany
in January 2009, with the intent to restructure Qimonda and its
affiliates. On June 8, 2009, Rambus received written notice
from the court appointed administrator in the insolvency
proceedings of Qimonda (the Administrator) of the
Administrators election of Non-Performance under
Section 103 of the German Insolvency Code with respect to
the license agreement. According to this notice, the
Administrator has determined the license agreement is no longer
enforceable by either party as of April 1, 2009.
Furthermore, the notice states that the Administrator has
terminated the license agreement. The Administrator has
indicated that he is commencing a liquidation of Qimondas
assets. As a result of the Administrators actions, we may
be unable to obtain any future payment from Qimonda or its
successors.
An
acquisition by Qimonda of a third party DRAM manufacturer could
make it more difficult for us to obtain royalty rates we believe
are appropriate and could reduce the number of companies in our
antitrust litigation.
On or about July 8, 2008, we amended our patent license
agreement with Qimonda. As discussed above, while the status and
enforceability of the amended agreement is unclear due to
Qimondas insolvency proceedings, the amended agreement
grants a supplemental term license of approximately the same
scope as the original term license originally provided for in
the agreement, but specifies that in the event Infineon ceases
to control or otherwise own a majority of Qimonda shares,
certain competitors would not accede to this license upon such
competitors acquisition of control of Qimonda.
Furthermore, such acquiring competitor would not receive the
benefit of a release from Rambus for past damages, including
past infringement of Rambus patent portfolio. To the
extent that Qimonda acquires another company, including such
certain competitors, the acquired company would accede to the
license and would be eligible to receive the benefit of the
release from Rambus for past damages. Following such an
acquisition by Qimonda, the combined entity would be required to
pay a stepped up payment calculated in accordance with the
percentage increase in the DRAM volume brought about by the
acquisition. Such an increase in the payments could make it more
difficult for us to obtain the royalties we believe are
appropriate from the market as a whole. Such an acquisition by
Qimonda of any of the certain competitors would in addition
reduce the number of companies from which we may seek
compensation for the antitrust injury alleged by us in our
pending price-fixing action in San Francisco. Except in the
case of the certain competitors, the extension of any such
benefits to a third party entity, whether acquiring control or
otherwise a majority of shares of Qimonda or being acquired by
Qimonda, could, in addition, result in the release of claims to
such third party entity, thus reducing the number of companies
from which we may seek compensation for patent damages.
Any
dispute regarding our intellectual property may require us to
indemnify certain licensees, the cost of which could severely
hamper our business operations and financial
condition.
In any potential dispute involving our patents or other
intellectual property, our licensees could also become the
target of litigation. While we generally do not indemnify our
licensees, some of our license agreements provide limited
indemnities, some require us to provide technical support and
information to a licensee that is involved in litigation
involving use of our technology, and we may agree to indemnify
others in the future. Our indemnification and support
obligations could result in substantial expenses. In addition to
the time and expense required for us to indemnify or supply such
support to our licensees, a licensees development,
marketing and sales of licensed semiconductors could be severely
disrupted or shut down as a result of litigation, which in turn
could severely hamper our business operations and financial
condition.
Risks
Associated With Our Business, Industry and Market
Conditions
If
market leaders do not adopt our innovations, our results of
operations could decline.
An important part of our strategy is to penetrate market
segments for chip interfaces by working with leaders in those
market segments. This strategy is designed to encourage other
participants in those segments
24
to follow such leaders in adopting our chip interfaces. If a
high profile industry participant adopts our chip interfaces but
fails to achieve success with its products or adopts and
achieves success with a competing chip interface, our reputation
and sales could be adversely affected. In addition, some
industry participants have adopted, and others may in the future
adopt, a strategy of disparaging our memory solutions adopted by
their competitors or a strategy of otherwise undermining the
market adoption of our solutions.
We target system companies to adopt our chip interface
technologies, particularly those that develop and market high
volume business and consumer products, which have traditionally
been focused on PCs, including PC graphics processors, and video
game consoles, but also are expanding to include HDTVs, cellular
and digital phones, PDAs, digital cameras and other consumer
electronics that incorporate all varieties of memory and chip
interfaces. In particular, our strategy includes gaining
acceptance of our technology in high volume consumer
applications, including video game consoles, such as the Sony
PlayStation®2
and Sony
PLAYSTATION®3,
HDTVs and set top boxes. We are subject to many risks beyond our
control that influence whether or not a particular system
company will adopt our chip interfaces, including, among others:
|
|
|
|
|
competition faced by a system company in its particular industry;
|
|
|
|
the timely introduction and market acceptance of a system
companys products;
|
|
|
|
the engineering, sales and marketing and management capabilities
of a system company;
|
|
|
|
technical challenges unrelated to our chip interfaces faced by a
system company in developing its products;
|
|
|
|
the financial and other resources of the system company;
|
|
|
|
the supply of semiconductors from our licensees in sufficient
quantities and at commercially attractive prices;
|
|
|
|
the ability to establish the prices at which the chips
containing our chip interfaces are made available to system
companies; and
|
|
|
|
the degree to which our licensees promote our chip interfaces to
a system company.
|
There can be no assurance that consumer products that currently
use our technology will continue to do so, nor can there be any
assurance that the consumer products that incorporate our
technology will be successful in their segments thereby
generating expected royalties, nor can there be any assurance
that any of our technologies selected for licensing will be
implemented in a commercially developed or distributed product.
If any of these events occur and market leaders do not
successfully adopt our technologies, our strategy may not be
successful and, as a result, our results of operations could
decline.
We
operate in an industry that is highly cyclical and in which the
number of our potential customers may be in decline as a result
of industry consolidation, and we face intense competition that
may cause our results of operations to suffer.
The semiconductor industry is intensely competitive and has been
impacted by price erosion, rapid technological change, short
product life cycles, cyclical market patterns and increasing
foreign and domestic competition. As the semiconductor industry
is highly cyclical, significant economic downturns characterized
by diminished demand, erosion of average selling prices,
production overcapacity and production capacity constraints
could affect the semiconductor industry. We are currently
experiencing such a period of economic downturn. As a result, we
may face a reduced number of licensing wins, tightening of
customers operating budgets, difficulty or inability of
our customers to pay our licensing fees, extensions of the
approval process for new licenses, as discussed below, and
consolidation among our customers, all of which may adversely
affect the demand for our technology and may cause us to
experience substantial
period-to-period
fluctuations in our operating results.
25
Many of our customers operate in industries that have
experienced significant declines as a result of the current
economic downturn. In particular, DRAM manufacturers, which make
up a majority of our existing and potential licensees, have
suffered material losses and other adverse effects to their
businesses. These factors may result in industry consolidation
as companies seek to reduce costs and improve profitability
through business combinations. Consolidation among our existing
DRAM and other customers may result in loss of revenues under
existing license agreements. Consolidation among companies in
the DRAM and other industries within which we license our
technology may reduce the number of future licensees for our
products and services. In either case, consolidation in the DRAM
and other industries in which we operate may negatively impact
our short-term and long-term business prospects, licensing
revenues and results of operations.
Some semiconductor companies have developed and support
competing logic chip interfaces including their own serial link
chip interfaces and parallel bus chip interfaces. We also face
competition from semiconductor and intellectual property
companies who provide their own DDR memory chip interface
technology and solutions. In addition, most DRAM manufacturers,
including our XDR licensees, produce versions of DRAM such as
SDR, DDRx and GDDRx SDRAM which compete with XDR chips. We
believe that our principal competition for memory chip
interfaces may come from our licensees and prospective
licensees, some of which are evaluating and developing products
based on technologies that they contend or may contend will not
require a license from us. In addition, our competitors are also
taking a system approach similar to ours in seeking to solve the
application needs of system companies. Many of these companies
are larger and may have better access to financial, technical
and other resources than we possess. Wider applications of other
developing memory technologies, including FLASH memory, may also
pose competition to our licensed memory solutions.
JEDEC has standardized what it calls extensions of DDR, known as
DDR2 and DDR3. Other efforts are underway to create other
products including those sometimes referred to as GDDR4 and
GDDR5, as well as new ways to integrate products such as
system-in-package
DRAM. To the extent that these alternatives might provide
comparable system performance at lower or similar cost than XDR
memory chips, or are perceived to require the payment of no or
lower royalties, or to the extent other factors influence the
industry, our licensees and prospective licensees may adopt and
promote alternative technologies. Even to the extent we
determine that such alternative technologies infringe our
patents, there can be no assurance that we would be able to
negotiate agreements that would result in royalties being paid
to us without litigation, which could be costly and the results
of which would be uncertain. In the industry standard and
leadership serial link chip interface business, we face
additional competition from semiconductor companies that sell
discrete transceiver chips for use in various types of systems,
from semiconductor companies that develop their own serial link
chip interfaces, as well as from competitors, such as ARM and
Synopsys, which license similar serial link chip interface
products and digital controllers. At the 10 Gb/s speed,
competition will also come from optical technology sold by
system and semiconductor companies. There are standardization
efforts under way or completed for serial links from standard
bodies such as PCI-SIG and OIF. We may face increased
competition from these types of consortia in the future that
could negatively impact our serial link chip interface business.
In the FlexIO processor bus chip interface market segment, we
face additional competition from semiconductor companies who
develop their own parallel bus chip interfaces, as well as
competitors who license similar parallel bus chip interface
products. We may also see competition from industry consortia or
standard setting bodies that could negatively impact our FlexIO
processor bus chip interface business.
As with our memory chip interface products, to the extent that
competitive alternatives to our serial or parallel logic chip
interface products might provide comparable system performance
at lower or similar cost, or are perceived to require the
payment of no or lower royalties, or to the extent other factors
influence the industry, our licensees and prospective licensees
may adopt and promote alternative technologies, which could
negatively impact our memory and logic chip interface business.
If for any of these reasons we cannot effectively compete in
these primary market segments, our results of operations could
suffer.
26
In
order to grow, we may have to invest more resources in research
and development than anticipated, which could increase our
operating expenses and negatively impact our operating
results.
If new competitors, technological advances by existing
competitors, our entry into new markets, or other competitive
factors require us to invest significantly greater resources
than anticipated in our research and development efforts, our
operating expenses would increase. For the three months ended
March 31, 2009 and 2008, research and development expenses
were $17.8 million and $21.5 million, respectively,
including stock-compensation of approximately $2.7 million
and $3.9 million, respectively. If we are required to
invest significantly greater resources than anticipated in
research and development efforts without an increase in revenue,
our operating results could decline. Research and development
expenses are likely to fluctuate from time to time to the extent
we make periodic incremental investments in research and
development, and these investments may be independent of our
level of revenue. In order to grow, which may include entering
new markets, we anticipate that we will continue to devote
substantial resources to research and development. We expect
these expenses to increase in absolute dollars in the
foreseeable future due to the increased complexity and the
greater number of products under development as well as
selectively hiring additional employees.
Our
revenue is concentrated in a few customers, and if we lose any
of these customers, our revenue may decrease
substantially.
We have a high degree of revenue concentration, with our top
five licensees representing approximately 79% and 67% of our
revenues for the three months ended March 31, 2009 and
2008, respectively. For the three months ended March 31,
2009, revenues from Fujitsu, NEC, AMD and Panasonic each
accounted for 10% or more of our total revenue. For the three
months ended March 31, 2008, revenues from Elpida, Fujitsu
and Sony each accounted for 10% or more of our total revenue. We
may continue to experience significant revenue concentration for
the foreseeable future.
In addition, some of our commercial agreements require us to
provide certain customers with the lowest royalty rate that we
provide to other customers for similar technologies, volumes and
schedules. These clauses may limit our ability to effectively
price differently among our customers, to respond quickly to
market forces, or otherwise to compete on the basis of price.
The particular licensees which account for revenue concentration
have varied from period to period as a result of the addition of
new contracts, expiration of existing contracts, industry
consolidation, the expiration of deferred revenue schedules
under existing contracts, and the volumes and prices at which
the licensees have recently sold licensed semiconductors to
system companies. These variations are expected to continue in
the foreseeable future, although we anticipate that revenue will
continue to be concentrated in a limited number of licensees.
We are in negotiations with licensees and prospective licensees
to reach patent license agreements for DRAM devices and DRAM
controllers. We expect that patent license royalties will
continue to vary from period to period based on our success in
renewing existing license agreements and adding new licensees,
as well as the level of variation in our licensees
reported shipment volumes, sales price and mix, offset in part
by the proportion of licensee payments that are fixed. A number
of our material license agreements are scheduled to expire
throughout 2010, including those of three licensees, each of
which accounted for more than 10% of our revenue in 2008. We are
currently in discussions with those licensees whose agreements
are scheduled to expire in 2010. However, we cannot provide any
assurance that we will reach agreement on renewal terms or that
the royalty rates we will be entitled to receive under the new
agreements will be as favorable to us as our current agreements.
If we are unsuccessful in renewing any of these patent license
agreements, our results of operations may decline significantly.
Weakening
global economic conditions may adversely affect demand for our
products and services.
Our operations and performance depend significantly on worldwide
economic conditions, and the U.S. and world economies are
undergoing a period of recession. Uncertainty about current
global economic conditions poses a risk as consumers and
businesses may postpone spending in response to tighter credit,
negative financial news and declines in income or asset values,
which could have a material negative effect on the demand for
the products of our licensees in the foreseeable future. Other
factors that could influence demand
27
include continuing increases in fuel and energy costs,
competitive pressures, including pricing pressures, from
companies that have competing products, changes in the credit
market, conditions in the residential real estate and mortgage
markets, consumer confidence, and other macroeconomic factors
affecting consumer spending behavior. If our licensees
experience reduced demand for their products as a result of
economic conditions or otherwise, our business and results of
operations could be harmed. In addition, a continuation of
current conditions in credit markets could limit our ability to
obtain external financing to fund our operations and capital
expenditures.
If our
commercial counterparties are unable to fulfill their financial
and other obligations to us, our business and results of
operations may be affected adversely.
The downturn in worldwide economic conditions threatens the
financial health of our commercial counterparties, including
companies with whom we have entered into licensing arrangements
and litigation settlements that provide for ongoing payments to
us, and their ability to fulfill their financial and other
obligations to us. As discussed in further detail above, we are
a party to a settlement and licensing agreement with Qimonda,
which provides that, subject to certain conditions that have not
yet been fulfilled, Qimonda may be required to make additional
royalty payments to us of up to $100.0 million. In January
2009, Qimonda filed for bankruptcy, and in June 2009, we
terminated their license. On June 8, 2009, Rambus received
notice that the Qimonda Administrator has determined that the
license agreement is no longer enforceable by either party as of
April 1, 2009. In addition, Spansion, which was one of our
licensees and owes us an immaterial amount, filed a voluntary
petition for Chapter 11 reorganization relief in Delaware
federal court in March 2009, and is now operating as
debtors-in-possession
under the jurisdiction of the bankruptcy court. Because
bankruptcy courts have the power to modify or cancel contracts
of the petitioner which remain subject to future performance and
alter or discharge payment obligations related to pre-petition
debts, we may receive less than all of the payments that we
would otherwise be entitled to receive from Qimonda or Spansion
as a result of their bankruptcy proceedings. If we are unable to
collect all of such payments owed to us, or if other of our
commercial counterparties enter into bankruptcy or otherwise
seek to renegotiate their financial obligations to us as a
result of the deterioration of their financial health, our
business and results of operations may be affected adversely.
Our
business and operating results may be harmed if we undertake any
restructuring activities or if we are unable to manage growth in
our business.
From time to time, we may undertake to restructure our business,
such as the reduction in our workforce that we announced in
August 2008. There are several factors that could cause a
restructuring to have an adverse effect on our business,
financial condition and results of operations. These include
potential disruption of our operations, the development of our
technology, the deliveries to our customers and other aspects of
our business. Employee morale and productivity could also suffer
and we may lose employees whom we want to keep. Loss of sales,
service and engineering talent, in particular, could damage our
business. Any restructuring would require substantial management
time and attention and may divert management from other
important work. Employee reductions or other restructuring
activities also cause us to incur restructuring and related
expenses such as severance expenses. Moreover, we could
encounter delays in executing any restructuring plans, which
could cause further disruption and additional unanticipated
expense.
Our business historically has experienced periods of rapid
growth that have placed, and may continue to place, significant
demands on our managerial, operational and financial resources.
In managing this growth, we must continue to improve and expand
our management, operational and financial systems and controls.
We also need to continue to expand, train and manage our
employee base. We cannot assure you that we will be able to
timely and effectively meet demand and maintain the quality
standards required by our existing and potential customers and
licensees. If we ineffectively manage our growth or we are
unsuccessful in recruiting and retaining personnel, our business
and operating results will be harmed.
28
If we
cannot respond to rapid technological change in the
semiconductor industry by developing new innovations in a timely
and cost effective manner, our operating results will
suffer.
The semiconductor industry is characterized by rapid
technological change, with new generations of semiconductors
being introduced periodically and with ongoing improvements. We
derive most of our revenue from our chip interface technologies
that we have patented. We expect that this dependence on our
fundamental technology will continue for the foreseeable future.
The introduction or market acceptance of competing chip
interfaces that render our chip interfaces less desirable or
obsolete would have a rapid and material adverse effect on our
business, results of operations and financial condition. The
announcement of new chip interfaces by us could cause licensees
or system companies to delay or defer entering into arrangements
for the use of our current chip interfaces, which could have a
material adverse effect on our business, financial condition and
results of operations. We are dependent on the semiconductor
industry to develop test solutions that are adequate to test our
chip interfaces and to supply such test solutions to our
customers and us.
Our continued success depends on our ability to introduce and
patent enhancements and new generations of our chip interface
technologies that keep pace with other changes in the
semiconductor industry and which achieve rapid market
acceptance. We must continually devote significant engineering
resources to addressing the ever increasing need for higher
speed chip interfaces associated with increases in the speed of
microprocessors and other controllers. The technical innovations
that are required for us to be successful are inherently complex
and require long development cycles, and there can be no
assurance that our development efforts will ultimately be
successful. In addition, these innovations must be:
|
|
|
|
|
completed before changes in the semiconductor industry render
them obsolete;
|
|
|
|
available when system companies require these
innovations; and
|
|
|
|
sufficiently compelling to cause semiconductor manufacturers to
enter into licensing arrangements with us for these new
technologies.
|
Finally, significant technological innovations generally require
a substantial investment before their commercial viability can
be determined. There can be no assurance that we have accurately
estimated the amount of resources required to complete the
projects, or that we will have, or be able to expend, sufficient
resources required for these types of projects. In addition,
there is market risk associated with these products, and there
can be no assurance that unit volumes, and their associated
royalties, will occur. If our technology fails to capture or
maintain a portion of the high volume consumer market, our
business results could suffer.
If we cannot successfully respond to rapid technological changes
in the semiconductor industry by developing new products in a
timely and cost effective manner our operating results will
suffer.
Some
of our revenue is subject to the pricing policies of our
licensees over whom we have no control.
We have no control over our licensees pricing of their
products and there can be no assurance that licensee products
using or containing our chip interfaces will be competitively
priced or will sell in significant volumes. One important
requirement for our memory chip interfaces is for any premium
charged by our licensees in the price of memory and controller
chips over alternatives to be reasonable in comparison to the
perceived benefits of the chip interfaces. If the benefits of
our technology do not match the price premium charged by our
licensees, the resulting decline in sales of products
incorporating our technology could harm our operating results.
Our
licensing cycle is lengthy and costly and our marketing and
licensing efforts may be unsuccessful.
The process of persuading customers to adopt and license our
chip interface technologies can be lengthy and, even if
successful, there can be no assurance that our chip interfaces
will be used in a product that is ultimately brought to market,
achieves commercial acceptance, or results in significant
royalties to us. We generally incur significant marketing and
sales expenses prior to entering into our license agreements,
generating a license fee and establishing a royalty stream from
each licensee. The length of time it takes to
29
establish a new licensing relationship can take many months. In
addition, our ongoing intellectual property litigation and
regulatory actions have and will likely continue to have an
impact on our ability to enter into new licenses and renewals of
licenses. As such, we may incur costs in any particular period
before any associated revenue stream begins. If our marketing
and sales efforts are very lengthy or unsuccessful, then we may
face a material adverse effect on our business and results of
operations as a result of delay or failure to obtain royalties.
Future
revenue is difficult to predict for several reasons, and our
failure to predict revenue accurately may cause us to miss
analysts estimates and result in our stock price
declining.
Our lengthy and costly license negotiation cycle makes our
future revenue difficult to predict because we may not be
successful in entering into licenses with our customers on our
estimated timelines.
While some of our license agreements provide for fixed,
quarterly royalty payments, many of our license agreements
provide for volume-based royalties. The sales volume and prices
of our licensees products in any given period can be
difficult to predict. As a result, our actual results may differ
substantially from analyst estimates or our forecasts in any
given quarter.
In addition, a portion of our revenue comes from development and
support services provided to our licensees. Depending upon the
nature of the services, a portion of the related revenue may be
recognized ratably over the support period, or may be recognized
according to contract accounting. Contract revenue accounting
may result in deferral of the service fees to the completion of
the contract, or may be recognized over the period in which
services are performed on a
percentage-of-completion
basis. There can be no assurance that the product development
schedule for these projects will not be changed or delayed. All
of these factors make it difficult to predict future licensing
revenue and may result in our missing previously announced
earnings guidance or analysts estimates which would likely
cause our stock price to decline.
Our
quarterly and annual operating results are unpredictable and
fluctuate, which may cause our stock price to be volatile and
decline.
Since many of our revenue components fluctuate and are difficult
to predict, and our expenses are largely independent of revenue
in any particular period, it is difficult for us to accurately
forecast revenue and profitability. Factors other than those set
forth above, which are beyond our ability to control or assess
in advance, that could cause our operating results to fluctuate
include:
|
|
|
|
|
semiconductor and system companies acceptance of our chip
interface products;
|
|
|
|
the success of high volume consumer applications, such as the
Sony
PLAYSTATION®3;
|
|
|
|
the dependence of our royalties upon fluctuating sales volumes
and prices of licensed chips that include our technology;
|
|
|
|
the seasonal shipment patterns of systems incorporating our chip
interface products;
|
|
|
|
the loss of any strategic relationships with system companies or
licensees;
|
|
|
|
semiconductor or system companies discontinuing major products
incorporating our chip interfaces;
|
|
|
|
the unpredictability of litigation results and the timing and
amount of any litigation expenses;
|
|
|
|
changes in our chip and system company customers
development schedules and levels of expenditure on research and
development;
|
|
|
|
our licensees terminating or failing to make payments under
their current contracts or seeking to modify such contracts,
whether voluntarily or as a result of financial difficulties;
|
|
|
|
changes in our strategies, including changes in our licensing
focus and/or
possible acquisitions of companies with business models
different from our own; and
|
30
|
|
|
|
|
changes in the economy and credit market and their effects upon
demand for our technology and the products of our licensees.
|
For the three months ended March 31, 2009 and 2008,
royalties accounted for 96% and 83%, respectively, of our total
revenue.
We believe that royalties will continue to represent a majority
of total revenue for the foreseeable future. Royalties are
generally recognized in the quarter in which we receive a report
from a licensee regarding the sale of licensed chips in the
prior quarter; however, royalties are recognized only if
collectability is assured. As a result of these uncertainties
and effects being outside of our control, royalty revenue is
difficult to predict and makes it difficult to develop accurate
financial forecasts, which could cause our stock price to become
volatile and decline.
A
substantial portion of our revenue is derived from sources
outside of the United States and this revenue and our business
generally are subject to risks related to international
operations that are often beyond our control.
For the three months ended March 31, 2009 and 2008, revenue
from our sales to international customers constituted
approximately 81% and 83% of our total revenue, respectively. We
currently have international operations in India (design), Japan
(business development), Taiwan (business development) and
Germany (business development). As a result of our continued
focus on international markets, we expect that future revenue
derived from international sources will continue to represent a
significant portion of our total revenue.
To date, all of the revenue from international licensees has
been denominated in U.S. dollars. However, to the extent
that such licensees sales to systems companies are not
denominated in U.S. dollars, any royalties which are based
as a percentage of the customers sales that we receive as
a result of such sales could be subject to fluctuations in
currency exchange rates. In addition, if the effective price of
licensed semiconductors sold by our foreign licensees were to
increase as a result of fluctuations in the exchange rate of the
relevant currencies, demand for licensed semiconductors could
fall, which in turn would reduce our royalties. We do not use
financial instruments to hedge foreign exchange rate risk.
Our international operations and revenue are subject to a
variety of risks which are beyond our control, including:
|
|
|
|
|
export controls, tariffs, import and licensing restrictions and
other trade barriers;
|
|
|
|
profits, if any, earned abroad being subject to local tax laws
and not being repatriated to the United States or, if
repatriation is possible, limited in amount;
|
|
|
|
changes to tax codes and treatment of revenue from international
sources, including being subject to foreign tax laws and
potentially being liable for paying taxes in that foreign
jurisdiction;
|
|
|
|
foreign government regulations and changes in these regulations;
|
|
|
|
social, political and economic instability;
|
|
|
|
lack of protection of our intellectual property and other
contract rights by jurisdictions in which we may do business to
the same extent as the laws of the United States;
|
|
|
|
changes in diplomatic and trade relationships;
|
|
|
|
cultural differences in the conduct of business both with
licensees and in conducting business in our international
facilities and international sales offices;
|
|
|
|
operating centers outside the United States;
|
|
|
|
hiring, maintaining and managing a workforce remotely and under
various legal systems; and
|
|
|
|
geo political issues.
|
31
We and our licensees are subject to many of the risks described
above with respect to companies which are located in different
countries, particularly home video game console and PC
manufacturers located in Asia and elsewhere. There can be no
assurance that one or more of the risks associated with our
international operations could not result in a material adverse
effect on our business, financial condition or results of
operations.
We may
make future acquisitions or enter into mergers, strategic
transactions or other arrangements that could cause our business
to suffer.
As part of our strategic initiatives, we currently are
evaluating, and expect to continue to engage in, investments in
or acquisitions of companies, products or technologies, and the
entry into strategic transactions or other arrangements. These
acquisitions, investments, transactions or arrangements are
likely to range in size, some of which may be significant. If we
make an acquisition, we may experience difficulty integrating
that companys or divisions personnel and operations,
which could negatively affect our operating results. In addition:
|
|
|
|
|
the key personnel of the acquired company may decide not to work
for us;
|
|
|
|
we may experience additional financial and accounting challenges
and complexities in areas such as tax planning, cash management
and financial reporting;
|
|
|
|
our ongoing business may be disrupted or receive insufficient
management attention;
|
|
|
|
we may not be able to recognize the cost savings or other
financial benefits we anticipated; and
|
|
|
|
our increasing international presence resulting from
acquisitions may increase our exposure to international
currency, tax and political risks.
|
In connection with future acquisitions or mergers, strategic
transactions or other arrangements, we may incur substantial
expenses regardless of whether the transaction occurs. In
addition, we may be required to assume the liabilities of the
companies we acquire. By assuming the liabilities, we may incur
liabilities such as those related to intellectual property
infringement or indemnification of customers of acquired
businesses for similar claims, which could materially and
adversely affect our business. We may have to incur debt or
issue equity securities to pay for any future acquisition, the
issuance of which could involve restrictive covenants or be
dilutive to our existing stockholders.
Unanticipated
changes in our tax rates or in the tax laws and regulations
could expose us to additional income tax liabilities which could
affect our operating results and financial
condition.
We are subject to income taxes in both the United States and
various foreign jurisdictions. Significant judgment is required
in determining our worldwide provision (benefit) for income
taxes and, in the ordinary course of business, there are many
transactions and calculations where the ultimate tax
determination is uncertain. Our effective tax rate could be
adversely affected by changes in the mix of earnings in
countries with differing statutory tax rates, changes in the
valuation of deferred tax assets and liabilities, changes in tax
laws and regulations as well as other factors. For example, the
state of California has enacted regulations which limit the use
of net operating losses and certain tax credits, including
research and development credits, that apply for 2008 and 2009,
which could lead to an increase in our effective tax rate. Our
tax determinations are regularly subject to audit by tax
authorities and developments in those audits could adversely
affect our income tax provision. Although we believe that our
tax estimates are reasonable, the final determination of tax
audits or tax disputes may be different from what is reflected
in our historical income tax provisions which could affect our
operating results.
Our
results of operations could vary as a result of the methods,
estimates, and judgments we use in applying our accounting
policies.
The methods, estimates, and judgments we use in applying our
accounting policies have a significant impact on our results of
operations, as described elsewhere in this report. Such methods,
estimates, and judgments are, by their nature, subject to
substantial risks, uncertainties, and assumptions, and factors
may arise over time that lead us to change our methods,
estimates, and judgments.
32
Changes in those methods, estimates, and judgments could
significantly affect our results of operations. In particular,
the calculation of share-based compensation expense under
Statement of Financial Accounting Standards No. 123(R)
(SFAS No. 123(R)) requires us to use
valuation methodologies and a number of assumptions, estimates,
and conclusions regarding matters such as expected forfeitures,
expected volatility of our share price, and the exercise
behavior of our employees. Furthermore, there are no means,
under applicable accounting principles, to compare and adjust
our expense if and when we learn about additional information
that may affect the estimates that we previously made, with the
exception of changes in expected forfeitures of share-based
awards. Factors may arise that lead us to change our estimates
and assumptions with respect to future share-based compensation
arrangements, resulting in variability in our share-based
compensation expense over time. Changes in forecasted
stock-based compensation expense could impact our cost of
contract revenue, research and development expenses, marketing,
general and administrative expenses and our effective tax rate,
which could have an adverse impact on our results of operations.
If we
are unable to attract and retain qualified personnel, our
business and operations could suffer.
Our success is dependent upon our ability to identify, attract,
compensate, motivate and retain qualified personnel, especially
engineers, who can enhance our existing technologies and
introduce new technologies. Competition for qualified personnel,
particularly those with significant industry experience, is
intense, in particular in the San Francisco Bay Area where
we are headquartered and in the area of Bangalore, India where
we have a design center. We are also dependent upon our senior
management personnel. The loss of the services of any of our
senior management personnel, or key sales personnel in critical
markets, or critical members of staff, or of a significant
number of our engineers could be disruptive to our development
efforts or business relationships and could cause our business
and operations to suffer.
Decreased
effectiveness of equity-based compensation could adversely
affect our ability to attract and retain
employees.
We have historically used stock options and other forms of
stock-based compensation as key components of our employee
compensation program in order to align employees interests
with the interests of our stockholders, encourage employee
retention and provide competitive compensation and benefit
packages. As a result of changes in previous accounting
principles, we have incurred increased compensation costs
associated with our stock-based compensation programs. In
addition, if we face any difficulty relating to obtaining
stockholder approval of our equity compensation plans, it could
make it harder or more expensive for us to grant stock-based
payments to employees in the future. As a result of these
factors leading to lower equity compensation of our employees,
we may find it difficult to attract, retain and motivate
employees, and any such difficulty could materially adversely
affect our business.
Our
operations are subject to risks of natural disasters, acts of
war, terrorism or widespread illness at our domestic and
international locations, any one of which could result in a
business stoppage and negatively affect our operating
results.
Our business operations depend on our ability to maintain and
protect our facility, computer systems and personnel, which are
primarily located in the San Francisco Bay Area. The
San Francisco Bay Area is in close proximity to known
earthquake fault zones. Our facility and transportation for our
employees are susceptible to damage from earthquakes and other
natural disasters such as fires, floods and similar events.
Should an earthquake or other catastrophes, such as fires,
floods, power loss, communication failure or similar events
disable our facilities, we do not have readily available
alternative facilities from which we could conduct our business,
which stoppage could have a negative effect on our operating
results. Acts of terrorism, widespread illness and war could
also have a negative effect at our international and domestic
facilities.
Compliance
with changing regulation of corporate governance and public
disclosure may result in additional expenses.
Changing laws, regulations and standards relating to corporate
governance and public disclosure, including new Securities and
Exchange Commission (the SEC), regulations and
Nasdaq rules, are creating
33
uncertainty for companies such as ours. These new or changed
laws, regulations and standards are subject to varying
interpretations in many cases due to their lack of specificity,
and as a result, their application in practice may evolve over
time as new guidance is provided by regulatory and governing
bodies, which could result in continuing uncertainty regarding
compliance matters and higher costs necessitated by ongoing
revisions to disclosure and governance practices. We intend to
invest resources to comply with evolving laws, regulations and
standards, and this investment may result in increased general
and administrative expenses and a diversion of management time
and attention from revenue generating activities to compliance
activities. If our efforts to comply with new or changed laws,
regulations and standards differ from the activities intended by
regulatory or governing bodies due to ambiguities related to
practice, our reputation may be harmed.
We
have been party to, and may in the future be subject to,
lawsuits relating to securities law matters which may result in
unfavorable outcomes and significant judgments, settlements and
legal expenses which could cause our business, financial
condition and results of operations to suffer.
In connection with our stock option investigation, we and
certain of our current and former officers and directors, as
well as our current auditors, were subject to several
stockholder derivative actions, securities fraud class actions
and/or
individual lawsuits filed in federal court against us and
certain of our current and former officers and directors. The
complaints generally allege that the defendants violated the
federal and state securities laws and state law claims for fraud
and breach of fiduciary duty. While we have settled the
derivative and securities fraud class actions, the individual
lawsuits continue to be adjudicated. For more information about
the historic litigation described above, see
Summary Litigation Updates. The amount
of time to resolve these current and any future lawsuits is
uncertain, and these matters could require significant
management and financial resources which could otherwise be
devoted to the operation of our business. Although we have
expensed or accrued for certain liabilities that we believe will
result from certain of these actions, the actual costs and
expenses to defend and satisfy all of these lawsuits and any
potential future litigation may exceed our current estimated
accruals, possibly significantly. Unfavorable outcomes and
significant judgments, settlements and legal expenses in the
litigation related to our past stock option granting practices
and in any future litigation concerning securities law claims
could have material adverse impacts on our business, financial
condition, results of operations, cash flows and the trading
price of our common stock.
Risks
Related to the Notes, Our Common Stock and this
Offering
Although
the notes are referred to as senior notes, they will be
effectively subordinated to any secured debt we may incur and
structurally subordinated to the liabilities of our
subsidiaries.
The notes are not secured by our assets. The notes are unsecured
and will be effectively subordinated to any future secured
indebtedness to the extent of the assets securing that
indebtedness. In the event of our insolvency, bankruptcy,
liquidation, reorganization, dissolution or winding up, or upon
acceleration of the notes due to an event of default under the
indenture and in certain other events, our assets will be
available to pay obligations on the notes only after all
obligations on our secured debt have been satisfied. As a
result, there may not be sufficient assets remaining to pay
amounts due on any or all of the outstanding notes.
The notes are obligations exclusively of Rambus. Our
subsidiaries are separate and distinct entities and have no
obligation to pay amounts due on the notes or to provide us with
funds for our payment obligations, whether by dividends,
distributions, loans or other payments. Any payment of
dividends, distributions, loans or advances by our subsidiaries
will also be contingent upon our subsidiaries earnings and
could be subject to contractual restrictions. In the event of
the insolvency, bankruptcy, liquidation, reorganization,
dissolution or winding up of the business of any of our
subsidiaries, creditors of our subsidiaries generally will have
the right to be paid in full before any distribution is made to
us or the holders of the notes. In addition, even if we were a
creditor of any of our subsidiaries, our rights as a creditor
would be subordinate to any security interest in the assets of
our subsidiaries and any indebtedness of our subsidiaries senior
to that held by us. Accordingly, holders of the notes are
structurally subordinated to the claims of our
subsidiaries creditors, including trade creditors, to the
extent of the assets of the indebted subsidiary. This
subordination could adversely affect our ability to pay our
obligations on the notes. As of March 31, 2009, our
subsidiaries had approximately
34
$1.4 million of liabilities, excluding inter-company
obligations, to which the notes would be structurally
subordinated.
We are
leveraged financially, which could adversely affect our ability
to adjust our business to respond to competitive pressures and
to obtain sufficient funds to satisfy our future research and
development needs, and to defend our intellectual
property.
We have indebtedness. On February 1, 2005, we issued
$300 million aggregate principal amount of the existing
notes, of which $137 million aggregate principal amount
remained outstanding as of March 31, 2009. Upon the
completion of the offering of the notes under this prospectus,
we will also issue an estimated $150 million aggregate
principal amount of new notes (or $172.5 million if the
underwriters exercise their over-allotment option in full).
The degree to which we are leveraged could have important
consequences, including, but not limited to, the following:
|
|
|
|
|
our ability to obtain additional financing in the future for
working capital, capital expenditures, acquisitions, general
corporate or other purposes may be limited;
|
|
|
|
a substantial portion of our cash flows from operations will be
dedicated to the payment of the principal of our indebtedness as
we are required to pay the principal amount of our convertible
notes in cash when due, including the remaining
$137 million aggregate principal amount of the existing
notes upon their maturity in February 2010;
|
|
|
|
if upon conversion of our notes we are requested to satisfy our
conversion obligation with shares of our common stock or we are
required to pay a make-whole premium with shares of
our common stock, our existing stockholders interest in us
would be diluted; and
|
|
|
|
we may be more vulnerable to economic downturns, less able to
withstand competitive pressures and less flexible in responding
to changing business and economic conditions.
|
A failure to comply with the covenants and other provisions of
our debt instruments could result in events of default under
such instruments, which could permit acceleration of our notes.
Any required repayment of our notes as a result of an
acceleration would lower our current cash on hand such that we
would not have those funds available for use in our business.
If we are at any time unable to generate sufficient cash flow
from operations to service our indebtedness when payment is due,
we may be required to attempt to renegotiate the terms of the
instruments relating to the indebtedness, seek to refinance all
or a portion of the indebtedness or obtain additional financing.
There can be no assurance that we will be able to successfully
renegotiate such terms, that any such refinancing would be
possible or that any additional financing could be obtained on
terms that are favorable or acceptable to us.
The
indenture does not restrict us or our subsidiaries from
incurring more debt, and the notes are not protected by
financial or other restrictive covenants.
The indenture does not restrict us or our subsidiaries from
incurring additional debt, including secured debt. In addition,
the indenture does not contain any financial covenants, restrict
our ability to repurchase our securities, pay dividends or make
restricted payments or contain covenants or other provisions to
afford holders protection in the event of a transaction that
substantially increases our level of indebtedness. Furthermore,
the indenture contains only limited protections in the event of
a fundamental change as defined below under
Description of the Notes Repurchase of Notes
at the Option of Holders upon a Fundamental Change. We
could engage in many types of transactions, such as
acquisitions, refinancing or recapitalizations that could
substantially affect our capital structure and the value of the
notes and our common stock but would not constitute a
fundamental change permitting holders to require us to
repurchase their notes under the indenture.
35
We may
not have the ability to repurchase the notes in cash upon the
occurrence of a fundamental change as required by the indenture
governing the notes.
Holders of the notes will have the right to require us to
repurchase the notes upon the occurrence of a fundamental change
as described under Description of the Notes
Repurchase of Notes at the Option of Holders upon a Fundamental
Change. We may not have sufficient funds to repurchase the
notes in cash or to make the required repayment at such time or
have the ability to arrange necessary financing on acceptable
terms. A fundamental change may also constitute an event of
default under, or result in the acceleration of the maturity of,
our then-existing indebtedness. Our ability to repurchase the
notes in cash may be limited by law or the terms of other
agreements relating to our indebtedness outstanding at the time.
Our failure to repurchase the notes when required would result
in an event of default with respect to the notes. Our inability
to pay for your notes that are tendered for repurchase could
result in your receiving substantially less than the principal
amount of the notes.
Some
significant restructuring transactions may not constitute a
fundamental change, in which case we would not be obligated to
offer to repurchase the notes.
Upon the occurrence of a fundamental change, you will have the
right to require us to repurchase the notes. However, the
fundamental change provisions will not afford protection to
holders of notes in the event of certain transactions. For
example, any leveraged recapitalization, refinancing,
restructuring, or acquisition initiated by us will generally not
constitute a fundamental change requiring us to repurchase the
notes. In addition, changes in the composition of our board of
directors, in and of themselves, also will not constitute a
fundamental change. In the event of any such transaction,
holders of the notes will not have the right to require us to
repurchase the notes, even though any of these transactions
could increase the amount of our indebtedness, or otherwise
adversely affect our capital structure or any credit ratings,
thereby adversely affecting the holders of notes.
Upon
conversion of the notes, we will pay a settlement amount
consisting of cash and shares of our common stock, if any, based
upon a specified conversion reference period.
Generally, we will satisfy our conversion obligation to holders
by paying cash and by delivering shares of our common stock
based on a daily settlement amount calculated on a proportionate
basis for each day of the 20 trading day conversion reference
period. Accordingly, upon conversion of a note, holders might
not receive any shares of our common stock, or they might
receive fewer shares of common stock relative to the conversion
value of the note as of the conversion date. In addition,
because of the 20 trading day conversion reference period,
settlement will be delayed until at least the 22nd trading
day following the related conversion date. See Description
of the Notes Conversion Rights Payment
upon Conversion. Upon conversion of the notes, you may
receive less proceeds than expected because the value of our
common stock may decline (or not appreciate as much as you may
expect) between the conversion date and the day the settlement
amount of your notes is determined. In addition, the manner in
which we calculate the settlement amount upon conversion of the
notes may:
|
|
|
|
|
result in holders receiving no shares upon conversion or fewer
shares relative to the conversion value of the notes;
|
|
|
|
reduce our liquidity;
|
|
|
|
delay holders receipt of the consideration due upon
conversion; and
|
|
|
|
subject holders to the market risks of our shares before
receiving any shares upon conversion.
|
Our failure to convert the notes into cash or, if applicable, a
combination of cash and shares of our common stock upon exercise
of a holders conversion right in accordance with the
provisions of the indenture would constitute a default under the
indenture. In addition, a default under the indenture could lead
to a default under existing and future agreements governing our
indebtedness, including the indenture governing our existing
notes. If, due to a default, the repayment of related
indebtedness were to be accelerated after any applicable notice
or grace periods, we may not have sufficient funds to repay such
indebtedness and the notes.
36
Provisions
of the notes could discourage an acquisition of us by a third
party.
Certain provisions of the notes could make it more difficult or
more expensive for a third party to acquire us. Upon the
occurrence of certain transactions constituting a fundamental
change, holders of the notes will have the right, at their
option, to require us to repurchase, at a cash repurchase price
equal to 100% of the principal amount plus accrued and unpaid
interest on the notes, all of their notes or any portion of the
principal amount of such notes in multiples of $1,000. We may
also be required to issue additional shares of our common stock
upon conversion of such notes in the event of certain
fundamental changes, as described under Description of the
Notes Conversion of Notes Adjustment to
Conversion Rate upon Certain Fundamental Changes.
The
conversion rate of the notes may not be adjusted for all
dilutive events.
The conversion rate of the notes is subject to adjustment upon
certain events, including the issuance of stock dividends on our
common stock, the issuance of rights or warrants, subdivisions,
combinations, distributions of capital stock, indebtedness or
assets, cash dividends or distributions and issuer tender or
exchange offers as described under Description of the
Notes Conversion Rights Conversion Rate
Adjustments. The conversion rate will not be adjusted for
certain other events, including, for example, upon the issuance
of additional shares of stock for cash, any of which may
adversely affect the trading price of the notes or the common
stock issuable upon conversion of the notes. Even if the
conversion price is adjusted for a dilutive event, such as a
leveraged recapitalization, it may not fully compensate you for
your economic loss.
You
may not be able to convert your notes before March 15,
2014.
Prior to March 15, 2014, the notes are convertible only if
specified conditions are met. These conditions may not be met.
If these conditions for conversion are not met, you will not be
able to convert your notes and you may not be able to receive
the value of the common stock into which the notes would
otherwise be convertible.
The
adjustment to the conversion rate upon the occurrence of certain
fundamental changes may not adequately compensate you for the
lost option time value of your notes as a result of such
fundamental change.
If certain fundamental changes occur prior to the maturity date
of the notes, we may be required to adjust the conversion rate
of the notes to increase the number of shares issuable upon
conversion. The number of additional shares to be added to the
conversion rate will be determined based on the date on which
the fundamental change becomes effective and the price paid per
share of our common stock in the fundamental change as described
under Description of the Notes Conversion of
Notes Adjustment to Conversion Rate upon Certain
Fundamental Changes. Although this adjustment is designed
to compensate you for the lost option value of your notes as a
result of the fundamental change, the adjustment is only an
approximation of such lost value based upon assumptions made on
the date of this prospectus and may not adequately compensate
you for such loss. In addition, if the price paid per share of
our common stock in the fundamental change is less than
$ or more than
$ (subject to adjustment), there
will be no such adjustment. Moreover, in no event will the total
number of additional shares issuable upon conversion as a result
of this adjustment exceed per
$1,000 principal amount of the notes, subject to adjustment in
the same manner as the conversion rate set forth under
Description of the Notes Conversion of
Notes Conversion Rate Adjustments.
The
notes may not have an active market and their price may be
volatile. You may be unable to sell your notes at the price you
desire or at all.
There is no existing trading market for the notes. As a result,
there can be no assurance that a liquid market will develop or
be maintained for the notes, that you will be able to sell any
of the notes at a particular time (if at all) or that the prices
you receive if or when you sell the notes will be above their
initial offering price. We do not intend to list the notes on
any national securities exchange or arrange for quotation of the
37
notes on any automated dealer quotation system. The underwriters
have advised us that they intend to make a market in the notes
after this offering is completed, but they have no obligation to
do so and may cease their market-making at any time without
notice. In addition, market-making will be subject to the limits
imposed by the Securities Exchange Act of 1934, as amended (the
Exchange Act). The liquidity of the trading market
in the notes, and the market price quoted for these notes, may
be adversely affected by, among other things:
|
|
|
|
|
changes in the overall market for debt securities;
|
|
|
|
changes in our financial performance or prospects;
|
|
|
|
the prospects for companies in our industry generally;
|
|
|
|
the number of holders of the notes;
|
|
|
|
the interest of securities dealers in making a market for the
notes; and
|
|
|
|
prevailing interest rates.
|
Convertible debt markets experienced unprecedented disruptions
resulting from, among other things, the instability in the
credit and capital markets and the emergency orders on short
selling issued by the SEC on September 17 and 18, 2008 (and
extended on October 1, 2008). These orders were issued as a
stop-gap measure while the U.S. Congress worked to provide
a comprehensive legislative plan to stabilize the credit and
capital markets. Among other things, these orders temporarily
imposed a prohibition on effecting short sales of the common
stock of certain financial companies. As a result, the SEC
orders made the convertible arbitrage strategy that many
convertible note investors employ difficult to execute for
outstanding convertible notes of those companies whose common
stock was subject to the short sale prohibition. The SEC orders
expired at 11:59 p.m., New York City Time, on Wednesday,
October 8, 2008. However, the SEC is currently considering
instituting other limitations on effecting short sales (such as
the uptick rule) and other regulatory organizations may do the
same. Any future governmental actions that interfere with the
ability of convertible note investors to effect short sales on
the underlying common stock would significantly affect the
market value of the notes.
The
price of our common stock, and therefore the price of the notes,
may fluctuate significantly, which may make it difficult for
holders to resell the notes or the shares issuable upon
conversion of the notes when desired or at attractive
prices.
Prior to electing to convert notes, the holder should compare
the price at which our common stock is trading in the market to
the conversion price of the notes. Our common stock is listed on
the NASDAQ Global Select Market under the symbol
RMBS. On June 19, 2009, the last reported sale
price of our common stock on the NASDAQ Global Select Market was
$18.70 per share. The trading price of our common stock has been
subject to wide fluctuations which may continue in the future in
response to, among other things, the following:
|
|
|
|
|
new litigation or developments in current litigation, including
an unfavorable outcome to us from court proceedings relating to
our litigation with Hynix, Micron, Nanya, Samsung and NVIDIA;
|
|
|
|
any progress, or lack of progress, real or perceived, in the
development of products that incorporate our chip interfaces;
|
|
|
|
our signing or not signing new licensees;
|
|
|
|
announcements of our technological innovations or new products
by us, our licensees or our competitors;
|
|
|
|
positive or negative reports by securities analysts as to our
expected financial results; and
|
|
|
|
developments with respect to patents or proprietary rights and
other events or factors.
|
In addition, the stock market in general, and prices for
companies in our industry in particular, have experienced
extreme volatility that often has been unrelated to the
operating performance of such companies.
38
These broad market and industry fluctuations may adversely
affect the price of our common stock, regardless of our
operating performance. Because the notes are convertible into
shares of our common stock, volatility or depressed prices of
our common stock could have a similar effect on the trading
price of our notes. Holders who receive common stock upon
conversion also will be subject to the risk of volatility and
depressed prices of our common stock. In addition, the existence
of the notes may encourage short selling in our common stock by
market participants because the conversion of the notes could
depress the price of our common stock.
Sales of substantial amounts of shares of our common stock in
the public market after this offering, or the perception that
those sales may occur, could cause the market price of our
common stock to decline. Because the notes are convertible into
common stock only at a conversion price in excess of the recent
trading price, such a decline in our common stock price may
cause the value of the notes to decline.
In addition, lack of positive performance in our stock price may
adversely affect our ability to retain key employees.
If
securities or industry analysts change their recommendations
regarding our stock adversely, our stock price and trading
volume could decline.
The trading market for our common stock is influenced by the
research and reports that industry or securities analysts
publish about us, our business or our market. If one or more of
the analysts who cover us change their recommendation regarding
our stock adversely, our stock price would likely decline. If
one or more of these analysts ceases coverage of our company or
fails to regularly publish reports on us, we could lose
visibility in the financial markets, which in turn could cause
our stock price or trading volume to decline.
Conversion
of the notes, or certain other occurrences with respect to our
currently outstanding series of notes, will dilute the ownership
interest of existing stockholders, including holders who had
previously converted their notes.
To the extent we issue common stock upon conversion of the
notes, such conversion would dilute the ownership interests of
existing stockholders, including holders who had previously
converted their notes. Sales of our common stock in the public
market or sales of any of our other securities could dilute
ownership and earnings per share, and even the perception that
such sales could occur and could cause the market price of our
common stock to decline. In addition, the existence of our
outstanding notes may encourage short selling of our common
stock by market participants who expect that the conversion of
the notes could depress the prices of our common stock. The
market price of our common stock could also decline as a result
of sales of shares of our common stock made after this offering
or the perception that such sales could occur.
We
will retain broad discretion in using the net proceeds from this
offering and may spend a substantial portion in ways with which
you do not agree.
We intend to use the net proceeds from this offering for general
corporate purposes, which may include financing potential
acquisitions and strategic transactions, repayment at maturity
of our existing notes, and working capital. As part of our
strategic initiatives, we expect to continue to make investments
in, or acquire, companies, products or technologies or enter
into strategic transactions or other arrangements. Pending these
uses, we expect to invest the net proceeds in short-term
interest-bearing instruments or other investment-grade
securities; however, notwithstanding our current intent, there
are no covenants in the notes or indenture requiring us to use
the proceeds in this manner. Accordingly, our management will
have significant discretion as to the use of the net proceeds of
the offering, and you will not have the opportunity, as part of
your investment decision, to influence the application of the
proceeds. The net proceeds from this offering may be applied to
uses that ultimately may not improve our operating results or
increase our market value.
Sales
of a significant number of shares of our common stock in the
public markets, or the perception of such sales, could depress
the market price of the notes.
Sales of a substantial number of shares of our common stock or
other equity-related securities in the public markets could
depress the market price of the notes, our common stock, or
both, and impair our ability
39
to raise capital through the sale of additional equity
securities. We cannot predict the effect that future sales of
our common stock or other equity-related securities would have
on the market price of our common stock or the value of the
notes. The price of our common stock could be affected by
possible sales of our common stock by investors who view the
notes as a more attractive means of equity participation in our
company and by hedging or arbitrage trading activity which we
expect to occur involving our common stock. This hedging or
arbitrage could, in turn, affect the market price of the notes.
The
notes may not be rated or may receive a lower rating than
anticipated.
We do not intend to seek a rating on the notes from a rating
agency. However, if one or more rating agencies rates the notes
and assigns the notes a rating lower than the rating expected by
investors, or reduces their rating in the future, the market
price of the notes and our common stock could be adversely
affected.
You
may be subject to tax upon an adjustment to the applicable
conversion rate of the notes even though you do not receive a
corresponding cash distribution.
The applicable conversion rate of the notes is subject to
adjustment in certain circumstances, including the payment of
certain cash dividends. If the applicable conversion rate is
adjusted as a result of a distribution that is taxable to our
common stockholders, such as in the case of a cash dividend, you
will be deemed to have received a taxable dividend to the extent
of our earnings and profits that will be subject to
U.S. federal income tax without the receipt of any cash. If
certain fundamental changes occur on or prior to the maturity
date of the notes, we will increase the applicable conversion
rate for notes converted in connection with such fundamental
changes. Such increase may be treated as a distribution subject
to U.S. federal income tax as a dividend. If you are a
non-U.S. holder
(as defined in Certain U.S. Federal Income Tax
Considerations), any such deemed dividend may be subject
to U.S. federal withholding tax at a 30% rate, or such
lower rate as may be specified by an applicable treaty, which
may be set off against subsequent payments on the notes. See
Description of the Notes Conversion of
Notes Conversion Rate Adjustments,
Description of the Notes Conversion of
Notes Adjustment to Conversion Rate upon Certain
Fundamental Changes and Certain U.S. Federal
Income Tax Considerations.
If you
hold notes, you will not be entitled to any rights with respect
to our common stock, but you will be subject to all changes made
with respect to our common stock.
If you hold notes, you will not be entitled to any rights with
respect to our common stock (including, without limitation,
voting rights and rights to receive any dividends or other
distributions on our common stock), but you will be subject to
all changes affecting the common stock. You will be entitled to
rights with respect to the common stock only if and when we
deliver shares of common stock to you upon conversion of your
notes. For example, if an amendment is proposed to our
certificate of incorporation or bylaws requiring stockholder
approval and the record date for determining the stockholders of
record entitled to vote on the amendment occurs prior to your
conversion of notes, you will not be entitled to vote on the
amendment, although you will nevertheless be subject to any
changes in the powers, preferences or special rights of our
common stock or other classes of capital stock.
The
notes initially will be held in book-entry form and, therefore,
you must rely on the procedures and the relevant clearing
systems to exercise your rights and remedies.
Unless and until certificated notes are issued in exchange for
book-entry interests in the notes, owners of the book-entry
interests will not be considered owners or holders of notes.
Instead, DTC, or its nominee, will be the sole holder of the
notes. Payments of principal, interest and other amounts owing
on or in respect of the notes in global form will be made to the
paying agent, which will make payments to DTC. Thereafter, such
payments will be credited to DTC participants accounts
that hold book-entry interests in the notes in global form and
credited by such participants to indirect participants. Unlike
holders of the notes themselves, owners of book-entry interests
will not have the direct right to act upon our solicitations for
consents or requests for waivers or other actions from holders
of the notes. Instead, if you own a book-entry interest, you
will be permitted to act only to the extent you have received
appropriate proxies to do so from DTC or, if applicable,
40
a participant. We cannot assure you that procedures implemented
for the granting of such proxies will be sufficient to enable
you to vote on any requested actions on a timely basis.
Our
restated certificate of incorporation and bylaws, our
stockholder rights plan, and Delaware law contain provisions
that could discourage transactions resulting in a change in
control, which may negatively affect the market price of our
common stock into which the notes are convertible.
Our restated certificate of incorporation, our bylaws, our
stockholder rights plan and Delaware law contain provisions that
might enable our management to discourage, delay or prevent
change in control. In addition, these provisions could limit the
price that investors would be willing to pay in the future for
shares of our common stock into which the notes are convertible.
Pursuant to such provisions:
|
|
|
|
|
our board of directors is authorized, without prior stockholder
approval, to create and issue preferred stock, commonly referred
to as blank check preferred stock, with rights
senior to those of common stock;
|
|
|
|
our board of directors is staggered into two classes, only one
of which is elected at each annual meeting;
|
|
|
|
stockholder action by written consent is prohibited;
|
|
|
|
nominations for election to our board of directors and the
submission of matters to be acted upon by stockholders at a
meeting are subject to advance notice requirements;
|
|
|
|
certain provisions in our bylaws and certificate of
incorporation such as notice to stockholders, the ability to
call a stockholder meeting, advance notice requirements and
action of stockholders by written consent may only be amended
with the approval of stockholders holding
662/3%
of our outstanding voting stock;
|
|
|
|
the ability of our stockholders to call special meetings of
stockholders is prohibited; and
|
|
|
|
our board of directors is expressly authorized to make, alter or
repeal our bylaws.
|
In addition, the provisions in our stockholder rights plan could
make it more difficult for a potential acquirer to consummate an
acquisition of our company. We are also subject to
Section 203 of the Delaware General Corporation Law, which
provides, subject to enumerated exceptions, that if a person
acquires 15% or more of our outstanding voting stock, the person
is an interested stockholder and may not engage in
any business combination with us for a period of
three years from the time the person acquired 15% or more of our
outstanding voting stock.
41
CAUTIONARY
NOTE ON FORWARD-LOOKING STATEMENTS
This prospectus and the documents we incorporate by reference in
this prospectus contain forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Exchange Act. These statements relate to
our expectations for future events and time periods. All
statements other than statements of historical fact are
statements that could be deemed to be forward-looking
statements, including, but not limited to, statements regarding:
|
|
|
|
|
outcome and effect of current and potential future intellectual
property litigation;
|
|
|
|
litigation expenses;
|
|
|
|
final approval of the European Commission preliminary settlement
involving us;
|
|
|
|
protection of intellectual property;
|
|
|
|
announced guidance of our expected financial results;
|
|
|
|
deterioration of financial health of commercial counterparties
and their ability to meet their obligations to us;
|
|
|
|
amounts owed under licensing agreements;
|
|
|
|
terms of our licenses;
|
|
|
|
indemnification and technical support obligations;
|
|
|
|
success in the markets of our or our licensees products;
|
|
|
|
research and development costs and improvements in technology;
|
|
|
|
sources, amounts and concentration of revenue, including
royalties;
|
|
|
|
acquisitions, mergers or strategic transactions;
|
|
|
|
effective tax rates;
|
|
|
|
realization of deferred tax assets/release of deferred tax
valuation allowance;
|
|
|
|
product development;
|
|
|
|
sources of competition;
|
|
|
|
pricing policies of our licensees;
|
|
|
|
success in renewing license agreements;
|
|
|
|
operating results;
|
|
|
|
international licenses and operations, including our design
facility in Bangalore, India;
|
|
|
|
methods, estimates and judgments in accounting policies;
|
|
|
|
growth in our business;
|
|
|
|
ability to identify, attract, motivate and retain qualified
personnel;
|
|
|
|
trading price of our common stock;
|
|
|
|
internal control environment;
|
|
|
|
corporate governance;
|
|
|
|
accounting, tax, regulatory, legal and other outcomes and
effects of the stock option investigation;
|
|
|
|
consequences of the lawsuits related to the stock option
investigation;
|
|
|
|
the level and terms of our outstanding debt;
|
42
|
|
|
|
|
engineering, marketing and general and administration expenses;
|
|
|
|
contract revenue;
|
|
|
|
interest and other income, net;
|
|
|
|
adoption of new accounting pronouncements;
|
|
|
|
likelihood of paying dividends;
|
|
|
|
effects of changes in the economy and credit market on our
industry and business; and
|
|
|
|
restructuring activities.
|
You can identify these and other forward-looking statements by
the use of words such as may, future,
shall, should, expects,
plans, anticipates,
believes, estimates,
predicts, intends,
potential, continue, or the negative of
such terms, or other comparable terminology. Forward-looking
statements also include the assumptions underlying or relating
to any of the foregoing statements. Actual results could differ
materially from those anticipated in these forward-looking
statements as a result of various factors. All forward-looking
statements included in this document are based on our assessment
of information available to us at this time. We assume no
obligation to update any forward-looking statements.
43
USE OF
PROCEEDS
We estimate that the net proceeds from this offering will be
approximately $ million (or
$ million if the underwriters
exercise their over-allotment option to purchase additional
notes in full), after deducting underwriters discounts and
commissions and expenses payable by us.
We intend to use the net proceeds from this offering for general
corporate purposes, which may include financing potential
acquisitions and strategic transactions, repayment of our zero
coupon convertible senior notes due February 2010, and working
capital. As part of our strategic initiatives, we currently are
evaluating, and expect to engage in investments in or
acquisitions of companies, products or technologies and the
entry into strategic transactions or other arrangements. These
acquisitions, investments, transactions or arrangements are
likely to range in size, some of which may be significant.
Accordingly, as described above, a portion of the net proceeds
of this offering may be used for one or more acquisitions,
investments or similar arrangements.
Pending application for the foregoing purposes, the net proceeds
from this offering will be invested in short-term interest
bearing instruments or other investment grade securities. As of
the date of this prospectus, we cannot specify with certainty
all of the particular uses for the net proceeds of the offering.
Accordingly, we will retain broad discretion over the use of
these proceeds.
44
PRICE
RANGE OF OUR COMMON STOCK
Our common stock is listed on the NASDAQ Global Select Market
under the symbol RMBS. The following table sets
forth, for the periods indicated, the range of high and low
sales prices for our common stock.
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2007:
|
|
High
|
|
|
Low
|
|
|
First quarter
|
|
$
|
23.95
|
|
|
$
|
17.31
|
|
Second quarter
|
|
|
22.00
|
|
|
|
17.67
|
|
Third quarter
|
|
|
19.60
|
|
|
|
12.05
|
|
Fourth quarter
|
|
|
22.20
|
|
|
|
17.64
|
|
|
|
|
|
|
|
|
|
|
Year Ended December 31, 2008:
|
|
High
|
|
|
Low
|
|
|
First quarter
|
|
$
|
26.41
|
|
|
$
|
14.64
|
|
Second quarter
|
|
|
24.85
|
|
|
|
18.61
|
|
Third quarter
|
|
|
18.90
|
|
|
|
12.29
|
|
Fourth quarter
|
|
|
16.59
|
|
|
|
4.95
|
|
|
|
|
|
|
|
|
|
|
Year Ending December 31, 2009:
|
|
High
|
|
|
Low
|
|
|
First quarter
|
|
$
|
18.70
|
|
|
$
|
5.99
|
|
Second quarter (through June 19, 2009)
|
|
|
19.65
|
|
|
|
9.07
|
|
As of May 31, 2009, there were approximately 755 registered
holders of record of our common stock. A substantially greater
number of holders of our common stock are in street
name or beneficial holders, whose shares are held of
record by banks, brokers and other financial institutions.
The last reported sale price of our common stock on the NASDAQ
Global Select Market on June 19, 2009 was $18.70 per share.
DIVIDEND
POLICY
We have never paid or declared any cash dividends on our common
stock or other securities and have no current plans to do so.
45
RATIO OF
EARNINGS TO FIXED CHARGES
The ratio of earnings to fixed charges for each of the periods
indicated is as follows.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ended
|
|
|
|
Year Ended December 31,
|
|
|
March 31,
|
|
|
|
2004
|
|
|
2005
|
|
|
2006
|
|
|
2007
|
|
|
2008
|
|
|
2009
|
|
|
|
(In thousands, except amounts expressed as ratios)
|
|
|
Ratio of earnings to fixed charges(1)
|
|
|
18
|
x
|
|
|
1
|
x
|
|
|
n/a
|
|
|
|
n/a
|
|
|
|
n/a
|
|
|
|
n/a
|
|
Deficiency of earnings available to cover fixed charges
|
|
|
n/a
|
|
|
|
n/a
|
|
|
$
|
32,743
|
|
|
$
|
59,367
|
|
|
$
|
85,319
|
|
|
$
|
17,433
|
|
|
|
|
(1) |
|
For the purpose of calculating such ratios, earnings
consist of income from continuing operations before income taxes
and noncontrolling interests plus fixed charges and fixed
charges consist of interest expense (net of capitalized
portion), capitalized interest, amortization of debt discount
and the portion of rental expense representative of interest
expense. Earnings before fixed charges were inadequate to cover
total fixed charges by approximately $32.7 million,
$59.4 million, $85.3 million and $17.4 million
for the years ended December 31, 2006 through 2008 and the
three months ended March 31, 2009, respectively. |
46
CAPITALIZATION
The following table sets forth our unaudited cash, cash
equivalents, zero coupon convertible senior notes due February
2010 and capitalization as of March 31, 2009:
|
|
|
|
|
on an actual basis; and
|
|
|
|
on an as-adjusted basis to give effect to the issuance and sale
of the notes in this offering, after deducting the underwriting
discounts and commissions and estimated offering expenses
payable by us (assuming no exercise of the underwriters
over-allotment option to purchase additional notes).
|
You should read this table in conjunction with Use of
Proceeds as well as our Managements Discussion
and Analysis of Financial Condition and Results of
Operations and our consolidated financial statements,
including the related notes, incorporated by reference into this
prospectus and our Quarterly Report on
Form 10-Q
for the three months ended March 31, 2009, and our Current
Report on
Form 8-K
filed with the SEC on June 22, 2009, each incorporated by
reference herein.
|
|
|
|
|
|
|
|
|
|
|
March 31, 2009
|
|
|
|
Actual
|
|
|
As Adjusted
|
|
|
|
(In thousands, except share amounts)
|
|
|
|
(Unaudited)
|
|
|
Cash, cash equivalents and marketable securities
|
|
$
|
347,928
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
Zero coupon convertible senior notes due February 2010
|
|
$
|
128,034
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
Long term debt:
|
|
|
|
|
|
|
|
|
Notes offered hereby(1)
|
|
$
|
|
|
|
$
|
|
|
Stockholders equity:
|
|
|
|
|
|
|
|
|
Convertible preferred stock, $0.001 par value.
5,000,000 shares authorized, no shares issued or
outstanding, actual and as adjusted
|
|
|
|
|
|
|
|
|
Common stock, $0.001 par value. 500,000,000 shares
authorized, 104,446,738 shares issued and outstanding,
actual, shares
issued and outstanding as adjusted(2)
|
|
|
104
|
|
|
|
|
|
Additional paid-in capital(1)
|
|
|
716,908
|
|
|
|
|
|
Accumulated deficit
|
|
|
(489,098
|
)
|
|
|
|
|
Accumulated other comprehensive income
|
|
|
333
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stockholders equity
|
|
|
228,247
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total capitalization
|
|
$
|
356,281
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
|
Amounts shown reflect the application of FSP APB
14-1, which
requires issuers to separately account for the debt and equity
components of convertible debt instruments that allow for cash
settlement. In accordance with FSP APB
14-1, we
estimated that $ million of
the aggregate principal amount of the notes will be recognized
(and, to the extent applicable, reflected in the table above) as
follows (in thousands): |
|
|
|
|
|
Equity component
|
|
$
|
|
|
|
|
|
|
|
Liability component:
|
|
|
|
|
Principal
|
|
$
|
|
|
Less: debt discount
|
|
|
|
|
|
|
|
|
|
Net carrying amount
|
|
$
|
|
|
|
|
|
|
|
|
|
|
(2) |
|
Outstanding common stock does not include
(i) 16,069,032 shares of common stock that will be
issued upon the exercise of outstanding stock options under our
stock plans as of March 31, 2009, at a weighted average
exercise price of $20.17 per share,
(ii) 1,081,712 shares of common stock available for
grant under our stock option plans,
(iii) 1,265,071 shares reserved for issuance under our
Employee Stock Purchase Plan, (iv) zero shares of common
stock issuable upon the conversion of our zero coupon
convertible senior notes due February 2010 currently
outstanding, and
(v) shares of
common stock issuable upon conversion of the notes offered
hereby. |
47
DESCRIPTION
OF THE NOTES
We will issue the notes under an indenture to be dated as of
June , 2009 between us and U.S. Bank
National Association, as trustee. The terms of the notes include
those expressly set forth in the indenture and the notes and
those made part of the indenture by reference to the
Trust Indenture Act of 1939, as amended (the
Trust Indenture Act).
The following description is only a summary of the material
provisions of the notes and the indenture. It does not purport
to be complete. We urge you to read those documents in their
entirety because they, and not this description, define the
rights of holders of the notes. You may request copies of those
documents from us upon written request at our address, which is
listed in this prospectus under Incorporation of Certain
Information by Reference and Where You Can Find More
Information.
For purposes of this section, references to we,
us, our, the Company and
Rambus refer solely to Rambus Inc. and not to its
subsidiaries.
General
The
Notes
The notes will:
|
|
|
|
|
initially be limited to $150,000,000 aggregate principal amount
(or $172,500,000 if the underwriters exercise in full their
over-allotment option to purchase additional notes);
|
|
|
|
bear interest at a rate of % per
year, payable semi-annually in arrears, on June 15 and
December 15 of each year, commencing on December 15,
2009;
|
|
|
|
subject to the fulfillment of certain conditions and during the
periods described below, be convertible by you into cash and, if
applicable, shares of our common stock as described below under
Conversion of Notes;
|
|
|
|
subject to the fulfillment of certain conditions and during the
periods described below, be redeemable, in whole or in part, by
us at any time on or after June 15, 2012, at a redemption
price in cash equal to 100% of the principal amount of the notes
we redeem, plus accrued and unpaid interest to, but excluding,
the redemption date, as described below under
Optional Redemption;
|
|
|
|
be subject to repurchase by us for cash at the option of the
holders upon the occurrence of a fundamental change (as defined
below under Repurchase of Notes at the Option
of Holders upon a Fundamental Change), at a repurchase
price in cash equal to 100% of the principal amount of the notes
to be repurchased, plus accrued and unpaid interest, if any, to,
but excluding, the repurchase date as described below under
Repurchase of Notes at the Option of Holders
upon a Fundamental Change;
|
|
|
|
mature on June 15, 2014, unless earlier converted or
repurchased by us at your option or redeemed; and
|
|
|
|
initially be represented by one or more registered securities in
global form, but in certain circumstances may be represented in
certificated form, as described below under
Book-Entry Delivery and Form.
|
The indenture will not contain any financial covenants and will
not restrict us or our subsidiaries from paying dividends,
incurring additional indebtedness or issuing or repurchasing
securities. The indenture will contain no covenants or other
provisions to afford protection to holders of notes in the event
of highly leveraged transactions or a fundamental change of
Rambus, except to the extent described under
Adjustment to Conversion Rate upon Certain
Fundamental Changes, Repurchase of Notes
at the Option of Holders upon a Fundamental Change and
Consolidation, Merger and Sale of Assets.
The notes will be our general unsecured senior obligations,
ranking equally in right of payment with all of our existing and
future unsecured senior indebtedness, and senior in right of
payment to any of our future indebtedness that is expressly
subordinated to the notes. The notes will be effectively
subordinated to all of our existing and future secured
indebtedness to the extent of the value of the collateral
securing those
48
obligations and structurally subordinated to all indebtedness
and liabilities of our subsidiaries, including trade credit. As
of March 31, 2009, we had approximately $137 million
aggregate principal amount of unsecured senior indebtedness
outstanding (excluding the notes). In addition, as of
March 31, 2009, our subsidiaries had approximately
$1.4 million of liabilities, excluding inter-company
obligations.
No sinking fund is provided for the notes.
We will maintain an office where the notes may be presented for
registration, transfer, exchange or conversion. This office will
initially be an office or agency of the trustee. Except under
limited circumstances described below, the notes will be issued
only in fully registered book-entry form, without coupons, in
denominations of $1,000 principal amount and multiples thereof,
and will be represented by one or more global notes. We may pay
interest (including additional interest, if any) by means of a
check mailed to each holder at its address as it appears in the
note register; provided, however, that holders with notes in an
aggregate principal amount in excess of $2,000,000 will be paid,
at their written election, by wire transfer in immediately
available funds; provided further, however, that payments to DTC
will be made by wire transfer of immediately available funds to
the account of DTC or its nominee. There will be no service
charge for any registration of transfer or exchange of notes. We
may, however, require holders to pay a sum sufficient to cover
any tax or other governmental charge payable in connection with
certain transfers or exchanges.
Neither we nor the registrar nor the trustee is required to
register a transfer or exchange of any notes for which the
holder has delivered, and not validly withdrawn, a fundamental
change repurchase notice, except, in the case of a partial
repurchase, with respect to that portion of the notes not being
repurchased.
Certain material U.S. federal income tax consequences of
the purchase, ownership and disposition of the notes and any
shares of our common stock received upon conversion of the notes
are summarized in the prospectus under the heading Certain
U.S Federal Income Tax Considerations.
We may, without the consent of the holders of the notes,
increase the principal amount of the notes by issuing additional
notes in the future on the same terms, except for any
differences in the issue price and interest accrued, if any,
prior to the issue date of such additional notes; provided that
no such additional notes may be issued unless fungible with the
notes offered hereby for U.S. federal income tax purposes;
and provided further that the additional notes have the same
CUSIP number as the notes offered hereby. The notes offered by
this prospectus and any additional notes would rank equally and
ratably and would be treated as a single class for all purposes
under the indenture.
We may also from time to time purchase the notes in open market
purchases or negotiated transactions without prior notice to
holders.
Principal;
Maturity
The indenture will provide for the issuance by us of notes in an
amount initially limited to $150,000,000 aggregate principal
amount (or $172,500,000 aggregate principal amount if the
underwriters exercise in full their over-allotment option to
purchase additional notes). The notes and any additional notes
will mature on June 15, 2014, unless earlier converted,
redeemed or repurchased.
Interest
The notes will bear interest at a rate
of % per annum on the principal
amount from June , 2009. We will pay interest
semi-annually, in arrears, on each June 15 and December 15,
beginning on December 15, 2009, to holders of record at the
close of business on the immediately preceding June 1 and
December 1, respectively; provided, however, that:
|
|
|
|
|
we will not pay accrued interest on any notes when they are
converted, except as described under
Conversion of Notes, and
|
|
|
|
on the maturity date, we will pay accrued interest to the person
to whom we pay the principal amount, regardless of whether such
person is the holder of record.
|
49
Interest on the notes will accrue from the most recent date to
which interest has been paid or, if no interest has been paid,
from June , 2009. Interest will be computed on
the basis of a
360-day year
comprised of twelve
30-day
months. If a payment date is not a business day, payment will be
made on the next succeeding business day, and no additional
interest will accrue thereon.
Interest will cease to accrue on a note upon its maturity,
conversion, redemption or repurchase by us at the option of the
holder.
We will pay additional interest on the notes under the
circumstances described under Events of
Default.
Conversion
of Notes
General
At any time prior to the close of business on the maturity date,
a holder may convert its notes into cash and, if applicable,
shares of our common stock, only if the conditions described
below are satisfied, with settlement to occur as set forth below
under Payment upon Conversion
Settlement Method. Holders may only convert notes with a
principal amount of $1,000 or a multiple of $1,000. The
conversion rate is
initially shares
of our common stock per $1,000 principal amount of notes
(equivalent to a conversion price of
$ per share of common stock). The
conversion rate is subject to adjustment as described below
under Conversion Rate Adjustments.
Except as provided in the immediately following sentence and in
the next paragraph, no separate payment or adjustment will be
made for accrued and unpaid interest and additional interest, if
any, on a converted note or for dividends or distributions on
any of our common stock issued upon conversion of a note. By
delivering to the holder the cash and shares, if any, of our
common stock issuable upon conversion, together with a cash
payment in lieu of fractional shares, if any, we will satisfy
our obligation with respect to the conversion of the notes. Any
accrued but unpaid interest and additional interest, if any,
will be deemed paid in full upon conversion, rather than
cancelled, forfeited or extinguished.
If a holder converts notes after the record date for an interest
payment but prior to the corresponding interest payment date, it
will receive on the corresponding interest payment date the
interest accrued and unpaid and additional interest, if any,
payable on those notes, notwithstanding the conversion of those
notes prior to the interest payment date, assuming such holder
was the holder of record on the corresponding record date.
However, except as provided in the next sentence, a holder who
converts notes after the record date for an interest payment but
prior to the corresponding interest payment date must pay us an
amount equal to the accrued and unpaid interest and additional
interest, if any, payable on the notes being converted on the
corresponding interest payment date. Such payment is not
required to be made:
|
|
|
|
|
if we have specified a redemption date that is after a record
date and on or prior to the corresponding interest payment date;
|
|
|
|
if the conversion is in connection with a fundamental change and
we have specified a fundamental change repurchase date that is
after a record date and on or prior to the corresponding
interest payment date;
|
|
|
|
with respect to any notes converted after the record date
immediately preceding the maturity date of the notes; or
|
|
|
|
to the extent of any overdue interest, if overdue interest
exists at the time of conversion with respect to the notes being
converted.
|
No fractional shares will be issued upon conversion; in lieu
thereof, a holder that otherwise would be entitled to fractional
shares of our common stock will receive a cash payment of the
fractional amount based upon the applicable stock price as
described below under Payment upon
Conversion Settlement Method.
50
If a holder exercises its right to require us to repurchase its
notes as described under Repurchase of Notes
at the Option of Holders upon a Fundamental Change, such
holder may convert its notes only if it withdraws its applicable
repurchase notice in accordance with the indenture or if we
default in the payment of the repurchase price.
Payment
upon Conversion
Settlement Method. We will deliver to holders
surrendering notes for conversion, in respect of each $1,000
principal amount of notes being converted, a settlement
amount equal to the sum of the daily settlement amounts
for each of the 20 trading days during the conversion reference
period. The daily settlement amount, for each of the
20 trading days during the conversion reference period, shall
consist of:
|
|
|
|
|
cash equal to the lesser of $50 and the daily conversion
value; and
|
|
|
|
to the extent the daily conversion value exceeds $50, a number
of shares (the daily share amount) equal to
(i) the difference between the daily conversion value and
$50, divided by (ii) the daily VWAP for such day.
|
The conversion date with respect to a note means the
date on which the holder of the notes has complied with all
requirements under the indenture to convert such note.
The conversion reference period means:
|
|
|
|
|
for notes that are converted on or after March 15, 2014,
the 20 consecutive trading days beginning on the
22nd
scheduled trading day prior to the maturity date; and
|
|
|
|
in all other instances, the 20 consecutive trading days
beginning on the third trading day following the conversion date.
|
The daily conversion value means, for each of the 20
consecutive trading days during the conversion reference period,
one-twentieth (1/20th) of the product of (i) the conversion
rate on such day and (ii) the daily VWAP of our common
stock on such day.
The daily VWAP means, for each of the 20 consecutive
trading days during the conversion reference period, the per
share volume-weighted average price as displayed under the
heading Bloomberg VWAP on Bloomberg
page RMBS.UQ <EQUITY> AQR <GO> (or its
equivalent successor if such page is not available) in respect
of the period from 9:30 a.m. to 4:00 p.m., New York
City time, on such trading day (or if such volume-weighted
average price is unavailable, the market value of one share of
our common stock on such trading day determined, using a
volume-weighted average method, by a nationally recognized
independent investment banking firm retained for this purpose by
us); provided that after the occurrence or effectiveness of a
fundamental change (as defined below under
Repurchase of Notes at the Option of Holders
upon a Fundamental Change) in which the holders of our
common stock receive only cash, the daily VWAP will be
determined to be the cash price per share received by holders of
our common stock in such fundamental change.
The term market disruption event means (1) a
failure by the primary U.S. exchange or quotation system on
which our common stock trades or is quoted to open for trading
during its regular trading session or (2) the occurrence or
existence prior to 1:00 p.m., New York City time, on any
trading day for our common stock of an aggregate one
half-hour
period, of any suspension or limitation imposed on trading (by
reason of movements in price exceeding limits permitted by the
stock exchange or otherwise) in our common stock or in any
options, contracts or future contracts relating to our common
stock traded in the United States.
The term scheduled trading day means any day that is
scheduled to be a trading day on the primary U.S. exchange
or quotation system on which our common stock is listed or
admitted for trading, or if our common stock is not so listed or
admitted for trading, scheduled trading day means a
business day.
The term trading day means a day on which
(i) trading in our common stock generally occurs on the
NASDAQ Global Select Market or, if our common stock is not then
listed on the NASDAQ Global Select Market, on the primary other
U.S. national or regional securities exchange on which our
common stock is then
51
listed or, if our common stock is not then listed on a
U.S. national or regional securities exchange, on the
primary other market on which our common stock is then traded
and (ii) there is no market disruption event. If our common
stock is not so listed or traded, trading day shall
mean a business day.
We will deliver cash in lieu of any fractional share of common
stock issuable in connection with payment of the settlement
amount based on the daily VWAP for the final trading day of the
applicable conversion reference period.
The daily conversion value and the number of shares, if any, to
be delivered upon conversion of the notes will be determined by
us promptly after the end of the conversion reference period.
Except as set forth below under Adjustment to
Conversion Rate upon Certain Fundamental Changes, we will
pay the cash and deliver the shares of common stock, if any, no
later than the third business day after the end of such period.
The ability to surrender notes for conversion will expire at the
close of business on the third business day immediately
preceding the maturity date.
Exchange in Lieu of Conversion. When a holder
surrenders notes for conversion, we may direct the conversion
agent to surrender, on or prior to the commencement of the
applicable conversion reference period, such notes to a
financial institution designated by us for exchange in lieu of
conversion, which shall be a direct or indirect DTC participant.
In order to accept any notes surrendered for conversion, the
designated institution must agree to deliver, in exchange for
such notes, all cash and shares of our common stock due upon
conversion, if any, all as provided above under
Payment upon Conversion, at the sole
option of the designated financial institution and as is
designated to the conversion agent by us. By the close of
business on the second trading day after the applicable
conversion date, we will notify the holder surrendering notes
for conversion that we have directed the designated financial
institution to make an exchange in lieu of conversion and such
financial institution will be required to notify the conversion
agent whether it will deliver, upon exchange, the cash and
shares of common stock, if any, due in respect of such
conversion.
If the designated institution accepts any such notes, it will
deliver cash and shares of our common stock, if any, to the
conversion agent and the conversion agent will deliver such cash
and shares of our common stock, if any, to such holder on the
third business day immediately following the last day of the
applicable conversion reference period. Any notes exchanged by
the designated institution will remain outstanding. If the
designated institution agrees to accept any notes for exchange
but does not timely deliver the related consideration, or if
such designated financial institution does not accept the notes
for exchange, we will convert the notes into cash and shares of
our common stock, if any, as described above under
Conversion of Notes.
Our designation of an institution to which the notes may be
submitted for exchange does not require the institution to
accept any notes. We will not pay any consideration to, or
otherwise enter into any agreement with, the designated
institution for or with respect to such designation.
Conversion Based on Common Stock Price. A
holder may surrender notes for conversion during any calendar
quarter beginning after September 30, 2009, and only during
such calendar quarter, if the closing sale price of our common
stock for 20 or more trading days in a period of 30 consecutive
trading days ending on the last trading day of such preceding
calendar quarter is more than 130% of the conversion price, as
defined below, per share of common stock on the last trading day
of such preceding calendar quarter, which we refer to as the
conversion trigger price.
The closing sale price of our common stock on any
trading day means the reported last sale price per share (or, if
no last sale price is reported, the average of the bid and ask
prices per share or, if more than one in either case, the
average of the average bid and the average ask prices per share)
on such date reported by the NASDAQ Global Select Market or, if
our common stock is not quoted or listed for trading on the
NASDAQ Global Select Market, as reported by the principal
U.S. national or regional securities exchange on which our
common stock is listed.
The conversion price per share of common stock as of
any time means $1,000 divided by the then-applicable conversion
rate, rounded to the nearest cent.
52
The conversion trigger price is approximately
$ , which is 130% of the initial
conversion price per share of common stock, subject to
adjustment upon occurrence of any of the events in respect of
which the conversion rate would be subject to adjustment as
described under Conversion Rate
Adjustments below.
The conversion agent will, on our behalf, determine at the
beginning of each calendar quarter commencing at any time after
September 30, 2009 whether the notes are convertible as a
result of the price of our common stock and notify us and the
trustee.
Conversion Based on Trading Price of Notes. A
holder may surrender notes for conversion prior to maturity
during the five business day period following any 10 consecutive
trading day period in which the trading price per $1,000
principal amount of notes, as determined by the bid solicitation
agent, which shall initially be the trustee, following a request
by us in accordance with the procedures described below, for
each trading day of such 10 consecutive trading day period was
less than 98% of the product of the closing sale price of our
common stock for such trading day and the applicable conversion
rate (determined for this purpose in the manner described below).
The trading price of the notes on any date of
determination means the average of the secondary market bid
quotations per note obtained by the bid solicitation agent for
$2,000,000 aggregate principal amount of notes at approximately
3:30 p.m., New York City time, on the determination date
from three independent nationally recognized securities dealers
that we select, which may include any of the underwriters;
provided that if three such bids cannot reasonably be obtained
by the bid solicitation agent, but two such bids are obtained,
then the average of the two bids shall be used, and if only one
such bid can reasonably be obtained by the bid solicitation
agent, that one bid shall be used. If the bid solicitation agent
cannot reasonably obtain at least one bid for $2,000,000
principal amount of the notes from a nationally recognized
securities dealer, then the trading price per $1,000 principal
amount of the notes will be deemed to be less than 98% of the
product of the closing sale price of our common stock for such
trading day and the applicable conversion rate for such date of
determination.
In connection with any conversion upon satisfaction of the
trading price condition, the bid solicitation agent shall have
no obligation to determine the trading price of the notes for
this purpose unless we have requested such determination in
writing, and we shall have no obligation to make such request
unless a holder of at least $2,000,000 principal amount of notes
provides us with reasonable evidence that the trading price of
the notes on any date would be less than 98% of the product of
the closing sale price and the applicable conversion rate on
such date and such holder requests that we request the bid
solicitation agent determine the trading price of the notes. At
such time, we shall instruct the bid solicitation agent to
determine the trading price of the notes beginning on the next
trading day and on each successive trading day until the trading
price per $1,000 principal amount of notes is greater than or
equal to 98% of the product of the closing sale price and the
applicable conversion rate on such date. If we do not, when
obligated to, instruct the bid solicitation agent to determine
the trading price of the notes as provided in the preceding
sentence, then the trading price per $1,000 principal amount of
notes will be deemed to be less than 98% of the product of the
closing sale price and the applicable conversion rate on each
day that we fail to so instruct the bid solicitation agent.
Conversion
Based on Distributions to Holders of Our Common Stock
If we elect to:
|
|
|
|
|
distribute, to all or substantially all holders of our common
stock, rights, warrants or options (other than pursuant to our
preferred stock rights plan or any successor plan thereto)
entitling such holders to, for a period expiring not more than
60 calendar days from the record date of such distribution,
subscribe for or purchase shares of our common stock at a price
per share less than the average of the closing sale prices of
our common stock for the 10 consecutive trading days immediately
preceding the date that such distribution was first publicly
announced; or
|
|
|
|
distribute, to all or substantially all holders of our common
stock, cash or other assets, debt securities or certain rights
or warrants to purchase our securities (excluding distributions
described in clauses (1) and (2) under
Conversion Rate Adjustments), which distribution has
a per share value exceeding 15%
|
53
|
|
|
|
|
of the average of the closing sale prices of our common stock
for the 10 consecutive trading days immediately preceding the
date that such distribution was first publicly announced,
|
we will notify the holders of notes and the trustee at least 25
scheduled trading days prior to the ex date (as defined below
under Conversion Rate Adjustments
Adjustment Events) for such distribution. Once we have
given such notice, holders may surrender their notes for
conversion until the earlier of the close of business on the
business day immediately prior to the ex date and our
announcement that such distribution will not take place. Holders
of the notes, however, may not surrender their notes for
conversion if they are otherwise able to participate in such
distribution due to the participation of holders of the notes in
such distribution.
Conversion
Based on a Fundamental Change
If a transaction or event that constitutes a fundamental change
(as defined below under Repurchase of Notes at
the Option of Holders upon a Fundamental Change, and
without giving effect to the exception regarding publicly traded
securities contained in the paragraph immediately following that
definition) occurs, regardless of whether a holder has the right
to require us to repurchase the notes as described under
Repurchase of Notes at the Option of Holders
upon a Fundamental Change, we must notify holders of the
notes (1) as soon as practicable and in any event at least
25 scheduled trading days prior to its anticipated effective
date of such transaction, in the case of a transaction that is
known to us, or within two trading days after we become aware of
such transaction, in the case of a transaction that is not known
to us prior to such 25th scheduled trading day and
(2) within 15 business days after the effective date of
such transaction. Once we have given such notice, holders may
surrender notes for conversion at any time beginning 10 trading
days before the anticipated effective date of such transaction
until 35 calendar days after the actual effective date of such
transaction (or if such transaction also constitutes a
fundamental change, until the close of business on the business
day immediately preceding the related fundamental change
repurchase date, if later).
Conversion
upon Notice of Redemption
If we call any or all of the notes for redemption, holders may
convert notes into our common stock at any time prior to the
close of business on the business day immediately preceding the
redemption date, even if the notes are not otherwise convertible
at such time. If the holder already has delivered a fundamental
change repurchase notice with respect to a note, however, the
holder may not surrender that note for conversion until the
holder has withdrawn the repurchase notice in accordance with
the indenture. See Repurchase of Notes at the
Option of Holders upon a Fundamental Change.
Conversion
Prior to Maturity
A holder may surrender notes for conversion at any time during
the period beginning March 15, 2014, and ending at the
close of business on the third business day immediately
preceding the maturity date.
Adjustment
to Conversion Rate upon Certain Fundamental
Changes
If a holder elects to convert its notes in connection with a
fundamental change described under clause (1) or
(2) of the definition of a fundamental change (as
described, and subject to the conditions set forth, below under,
Repurchase of Notes at the Option of Holders
upon a Fundamental Change (each such fundamental change, a
make-whole fundamental change)), we will increase
the conversion rate as described below for notes so surrendered
for conversion. The number of additional shares by which the
conversion rate is increased (the additional shares)
will be determined by reference to the table below, based on the
date on which the make-whole fundamental change becomes
effective (the effective date) and the price (the
stock price) paid, or deemed to be paid, per share
for our common stock in the transaction or series of related
transactions constituting such make-whole fundamental change,
subject to adjustment as described in the second paragraph
following this paragraph, below. If holders of our common stock
receive only cash in such transaction, the stock price will be
the cash amount paid per share. Otherwise, the stock price will
be the average of the closing sale prices of our common stock on
the five trading days prior to but excluding the effective date
of such make-whole fundamental change. We will notify you of the
anticipated effective date of any make-whole
54
fundamental change resulting in an adjustment as soon as
practicable and if possible at least 10 trading days prior to
such date.
A conversion of the notes by a holder will be deemed for these
purposes to be in connection with a make-whole
fundamental change if the conversion notice is received by the
conversion agent during the period that begins on (and includes)
the first public announcement of an event constituting a
make-whole fundamental change and ends at the close of business
on the business day immediately preceding the related repurchase
date (as specified in the repurchase notice described under
Repurchase of Notes at the Option of Holders
upon a Fundamental Change).
The number of additional shares issuable upon conversion will be
adjusted in the same manner as and as of any date on which the
conversion rate of the notes is adjusted as described above
under Conversion Rate Adjustments. The
stock prices set forth in the first row of the table below
(i.e., the column headers) will be simultaneously adjusted to
equal the stock prices immediately prior to such adjustment,
multiplied by a fraction, the numerator of which is the
conversion rate immediately prior to the adjustment and the
denominator of which is the conversion rate as so adjusted.
The following table sets forth an indicative number of
additional shares to be received per $1,000 principal amount of
notes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Price
|
|
Effective Date
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
$
|
|
|
June , 2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 15, 2010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 15, 2011
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 15, 2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 15, 2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 15, 2014
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The exact stock price and effective dates may not be set forth
on the table, in which case, if the stock price is:
|
|
|
|
|
between two stock price amounts on the table or the effective
date is between two dates on the table, the number of additional
shares will be determined by straight-line interpolation between
the number of additional shares set forth for the higher and
lower stock price amounts and the two dates, as applicable,
based on a
360-day year;
|
|
|
|
in excess of $ per share (subject
to adjustment), no additional shares will be issued upon
conversion; or
|
|
|
|
less than $ per share (subject to
adjustment), no additional shares will be issued upon conversion.
|
Notwithstanding the foregoing, in no event will the total number
of additional shares of our common stock issuable upon
conversion exceed per $1,000
principal amount of the notes, subject to adjustments in the
same manner as the conversion rate.
Our obligation to deliver the additional shares to holders that
convert their notes in connection with a fundamental change
could be considered a penalty, in which case the enforceability
thereof would be subject to general equitable principles of
reasonableness of economic remedies.
If, as described above, we are required to increase the
conversion rate by the additional shares as a result of a
make-whole fundamental change, notes surrendered for conversion
will be settled as follows (subject in all respects to the
provisions set forth above under Payment upon
Conversion Settlement Method):
|
|
|
|
|
If the last day of the applicable conversion reference period
related to notes surrendered for conversion is prior to the
third scheduled trading day preceding the anticipated effective
date of such make-whole fundamental change, we will settle such
conversion as described under Payment upon
Conversion Settlement Method above by
delivering the amount of consideration due (as described above
under
|
55
|
|
|
|
|
Payment upon Conversion Settlement
Method, based on the conversion rate without regard to the
number of additional shares to be added to the conversion rate
as described above) on the third trading day immediately
following the last day of the applicable conversion reference
period. In addition, as soon as practicable following the
effective date of such make-whole fundamental change, we will
deliver the increase in such amount of cash, shares of our
common stock or a combination of cash and shares or reference
property (as defined below), if any, as the case may be, as if
the conversion rate had been increased by such number of
additional shares during the related conversion reference period
(and based upon the relevant daily conversion value during such
conversion reference period). We will not increase the
conversion rate by the number of additional shares, or otherwise
deliver any increase to such amount of cash, shares of our
common stock or reference property if the fundamental change
does not become effective.
|
|
|
|
|
|
Otherwise, if the last day of the applicable conversion
reference period related to the notes surrendered for conversion
is on or following the third scheduled trading day preceding the
anticipated effective date of the fundamental change, we will
settle such conversion as described under Payment upon
Conversion Settlement Method above (based on
the conversion rate as increased by the additional shares
described above) on the later to occur of (1) the effective
date of the transaction and (2) the third trading day
immediately following the last day of the applicable conversion
period.
|
Because we may not deliver the consideration due solely as a
result of the increase in the conversion rate described above
until after the effective date of the make-whole fundamental
change, the non-cash consideration due in respect of the excess
of the daily conversion value over $50, if any, may not consist
of shares of our common stock as a result of the provisions
described below under the caption Conversion
Rate Adjustments Treatment of Reference
Property. Accordingly, to the extent the daily conversion
value on any trading day during the conversion reference period
exceeds $50, the non-cash consideration due in respect of such
excess may be paid in reference property.
Conversion
Rate Adjustments
Adjustment Events. The conversion rate will be
adjusted as described below, except that we will not make any
adjustments to the conversion rate if holders of the notes
participate, as a result of holding the notes, in any of the
transactions described below without having to convert their
notes.
|
|
|
|
(1)
|
If we issue shares of our common stock as a dividend or
distribution on shares of our common stock, which dividend or
distribution consists exclusively of shares of our common stock,
or subdivide or combine our outstanding common stock, the
conversion rate will be adjusted based on the following formula:
|
|
|
|
|
|
where,
|
|
|
|
|
|
CR0
|
|
=
|
|
the conversion rate in effect immediately prior to the opening
of business on the ex date of such dividend or distribution, or
the effective date of such share split or combination, as
applicable;
|
CR1
|
|
=
|
|
the conversion rate in effect immediately after the opening of
business on such ex date or effective date;
|
OS0
|
|
=
|
|
the number of shares of our common stock outstanding immediately
prior to such ex date or effective date; and
|
OS1
|
|
=
|
|
the number of shares of our common stock outstanding immediately
after the opening of business on such ex date or effective date
after giving effect to such dividend, distribution, subdivision
or share combination.
|
Any adjustment made pursuant to this clause (1) shall
become effective immediately after the opening of business on
the ex date for such dividend or distribution, or the effective
date for such subdivision or
56
combination. If any dividend or distribution of the type
described in this clause (1) is declared but not paid or
made, or the outstanding shares of common stock are not
subdivided or combined, as the case may be, the conversion rate
shall be immediately readjusted, effective as of the date our
board of directors determines not to pay such dividend or
distribution, or to effect such subdivision or combination to
the conversion rate that would then be in effect if such
dividend, distribution, or subdivision or combination had not
been declared or announced.
|
|
|
|
(2)
|
If we issue, to all or substantially all holders of our common
stock, rights, warrants or options (other than pursuant to our
preferred stock rights plan or any successor plan thereto)
entitling them for a period of not more than 60 calendar days
after the announcement of such issuance to subscribe for or
purchase shares of our common stock, at a price per share or a
conversion price per share less than the average of the closing
sale prices of our common stock for the 10 consecutive trading
days immediately preceding the date that such distribution was
first publicly announced, the conversion rate will be adjusted
based on the following formula (provided that the conversion
rate will be readjusted to the extent that such rights, warrants
or options are not exercised prior to their expiration):
|
|
|
|
|
|
|
|
|
|
|
|
CR1
|
|
=
|
|
CR0
x
|
|
|
OS0
+ X
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OS0
+ Y
|
|
|
|
|
|
|
|
|
where,
|
|
|
|
|
|
CR0
|
|
=
|
|
the conversion rate in effect immediately prior to the opening
of business on the ex date for such issuance;
|
CR1
|
|
=
|
|
the conversion rate in effect immediately after the opening of
business on such ex date;
|
OS0
|
|
=
|
|
the number of shares of our common stock outstanding immediately
prior to the opening of business on such ex date;
|
X
|
|
=
|
|
the total number of shares of our common stock issuable pursuant
to such rights, warrants or options; and
|
Y
|
|
=
|
|
the number of shares of our common stock equal to the aggregate
price payable to exercise such rights or warrants divided by the
average of the closing sale prices of our common stock for the
10 consecutive trading days immediately preceding the date that
the distribution of such rights, warrants or options was first
publicly announced.
|
The foregoing adjustment shall be successively made whenever any
such rights, warrants or options are distributed and shall
become effective immediately after the opening of business on
the ex date for such issuance. If such rights, warrants or
options are not so issued, the conversion rate will be adjusted
to be the conversion rate that would then be in effect if such
ex date for such issuance had not been fixed. In addition, to
the extent that shares of our common stock are not delivered
after the expiration of such rights, warrants or options, the
conversion rate shall be readjusted to the conversion rate that
would then be in effect had the adjustments made upon the
issuance of such rights, warrants or options been made on the
basis of only the number of shares of common stock actually
delivered.
In determining whether any rights, warrants or options entitle
the holders to subscribe for or purchase shares of common stock
at less than such average of the closing sale prices, and in
determining the aggregate offering price of such shares of
common stock, there shall be taken into account any
consideration received by us for such rights, warrants or
options and any amount payable on exercise or conversion
thereof, with the value of such consideration, if other than
cash, to be determined by our board of directors.
|
|
|
|
(3)
|
If we distribute to all or substantially all holders of our
common stock shares of our capital stock, evidences of
indebtedness or other non-cash assets, including securities,
rights or warrants, but excluding:
|
|
|
|
|
|
dividends or distributions and rights, warrants or options
referred to in clause (1) or clause (2) above;
|
57
|
|
|
|
|
rights issued pursuant to our preferred stock rights plan or any
successor plan thereto, or the detachment of such rights under
the terms of any such plan;
|
|
|
|
dividends or distributions paid exclusively in cash; and
|
|
|
|
spin-offs to which the provisions set forth below in this
clause (3) shall apply;
|
then the conversion rate will be adjusted based on the following
formula:
|
|
|
|
|
|
|
|
|
CR1
|
|
=
|
|
CR0
x
|
|
SP0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SP0
− FMV
|
|
|
|
|
|
|
|
where,
|
|
|
|
|
|
CR0
|
|
=
|
|
the conversion rate in effect immediately prior to the opening
of business on the ex date for such distribution;
|
CR1
|
|
=
|
|
the conversion rate in effect immediately after the opening of
business on such ex date;
|
SP0
|
|
=
|
|
the average of the closing sale prices of our common stock for
the 10 consecutive trading days immediately preceding the ex
date for such distribution; and
|
FMV
|
|
=
|
|
the fair market value (as determined by our board of directors)
of the shares of capital stock, evidences of indebtedness,
assets, or property distributed with respect to each outstanding
share of our common stock on the ex date for such distribution.
|
With respect to an adjustment pursuant to this clause (3)
where there has been a payment of a dividend or other
distribution on our common stock of shares of capital stock of
any class or series, or similar equity interest, of or relating
to a subsidiary or other business unit, which we refer to as a
spin-off, the conversion rate in effect immediately
before 5:00 p.m., New York City time, on the effective date
of the spin-off will be increased based on the following formula:
|
|
|
|
|
|
|
|
|
CR1
|
|
=
|
|
CR0
x
|
|
FMV0
+
MP0
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MP0
|
|
|
|
|
|
|
|
where,
|
|
|
|
|
|
CR0
|
|
=
|
|
the conversion rate in effect immediately prior to the end of
the valuation period (as defined below);
|
CR1
|
|
=
|
|
the conversion rate in effect immediately after the end of the
valuation period;
|
FMV0
|
|
=
|
|
the average of the closing sale prices of the capital stock or
similar equity interest distributed to holders of our common
stock applicable to one share of our common stock over the first
10 consecutive trading day period after, and including, the
effective date of the spin-off (the valuation
period); and
|
MP0
|
|
=
|
|
the average of the closing sale prices of our common stock over
the valuation period.
|
The adjustment to the conversion rate under the preceding
paragraph will occur on the last day of the valuation period;
provided that in respect of any conversion during the valuation
period, references with respect to 10 trading days shall be
deemed replaced with such lesser number of trading days as have
elapsed between the effective date of such spin-off and the
conversion date in determining the applicable conversion rate.
If any dividend or distribution described in this
clause (3) is not so paid or made, the conversion rate
shall again be adjusted to the conversion rate that would then
be in effect if such dividend or distribution had not been
declared.
58
|
|
|
|
(4)
|
If we pay any dividend or make any distribution (other than in
connection with a liquidation, dissolution or winding up of our
company) consisting exclusively of cash to all or substantially
all holders of our common stock, the conversion rate will be
adjusted based on the following formula:
|
|
|
|
|
|
where,
|
|
|
|
|
|
CR0
|
|
=
|
|
the conversion rate in effect immediately prior to the opening
of business on the ex date for such dividend or distribution;
|
CR1
|
|
=
|
|
the conversion rate in effect immediately after the opening of
business on the ex date for such dividend or distribution;
|
SP0
|
|
=
|
|
the closing sale price of our common stock on the trading day
immediately preceding the ex date for such dividend or
distribution; and
|
C
|
|
=
|
|
the amount in cash per share we distribute to holders of our
common stock.
|
The adjustment to the conversion rate under clause (4) will
become effective immediately after the opening of business on
the ex date for such dividend or distribution. If such dividend
or distribution is not so paid or made, the conversion rate
shall again be adjusted to be the conversion rate that would
then be in effect if such dividend or distribution had not been
declared.
|
|
|
|
(5)
|
If we or any of our subsidiaries purchases shares of our common
stock pursuant to a tender offer or exchange offer made at a
price per share in excess of the closing sale price for one
share of our common stock on the trading day next succeeding the
last date on which tenders or exchanges may be made pursuant to
such tender or exchange offer, the conversion rate will be
increased based on the following formula:
|
|
|
|
|
|
|
|
|
|
CR1
|
|
=
|
|
CR0
x
|
|
AC +
(SP1
x
OS1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OS0
x
SP1
|
|
|
|
|
|
|
|
where,
|
|
|
|
|
|
CR0
|
|
=
|
|
the conversion rate in effect immediately prior to the effective
date of the adjustment;
|
CR1
|
|
=
|
|
the conversion rate in effect immediately after the effective
date of the adjustment;
|
AC
|
|
=
|
|
the aggregate value of all cash and any other consideration (as
determined by our board of directors) paid or payable for shares
purchased in such tender or exchange offer;
|
OS0
|
|
=
|
|
the number of shares of our common stock outstanding immediately
prior to the date such tender or exchange offer expires;
|
OS1
|
|
=
|
|
the number of shares of our common stock outstanding immediately
after the date such tender or exchange offer expires (after
giving effect to the purchase of all shares accepted for
purchase or exchange in such tender or exchange offer); and
|
SP1
|
|
=
|
|
the average of the closing sale prices of our common stock over
the 10 consecutive trading day period commencing on the trading
day next succeeding the date such tender or exchange offer
expires.
|
The adjustment to the conversion rate under the preceding
paragraph will occur at the close of business on the
10th trading day from, and including, the trading day next
succeeding the date such tender or exchange offer expires;
provided that in respect of any conversion within 10 trading
days immediately following, and including, the expiration date
of any tender or exchange offer, references with respect to 10
trading days shall be deemed replaced with such lesser number of
trading days as have elapsed between the expiration date of such
tender or exchange offer and the conversion date in determining
the applicable conversion rate.
Except as stated herein, we will not adjust the conversion rate
for the issuance of shares of our common stock or any securities
convertible into or exchangeable for shares of our common stock
or the right to purchase shares of our common stock or such
convertible or exchangeable securities. If, however, the
59
application of the foregoing formulas would result in a decrease
in the conversion rate, no adjustment to the conversion rate
will be made (other than as a result of a share split or share
combination).
As used in this section, ex date means the first
date on which the shares of our common stock trade on the
applicable exchange or in the applicable market, regular way,
without the right to receive the issuance, dividend or
distribution in question.
To the extent that we have a preferred stock rights plan in
effect upon conversion of the notes, we will be required under
the indenture to provide that the holders of the notes who
receive shares of common stock upon such conversion will receive
rights upon conversion of the notes, unless those rights were
separated from the common stock prior to conversion, in which
case, and only in such case, the conversion rate will be
adjusted at the time of separation as if we issued rights,
warrants or options to all or substantially all holders of our
common stock as provided in paragraph (2) above, subject to
readjustment in the event of the expiration, termination or
redemption of such rights, subject to certain limited
exceptions. For a description of our rights plan, see the
section of this prospectus captioned, Description of
Capital Stock.
You may, in some circumstances, be deemed to have received a
distribution or dividend subject to U.S. federal income tax
as a result of an adjustment or the nonoccurrence of an
adjustment to the conversion rate. See Certain
U.S. Federal Income Tax Considerations below for a
relevant discussion.
We are permitted to increase the conversion rate of the notes by
any amount for a period of at least 20 days if our board of
directors determines that such increase would be in our best
interest. We may also increase the conversion rate to avoid or
diminish income tax to holders of our common stock in connection
with a dividend or distribution of stock or similar event.
No adjustment in the conversion rate shall be required unless
the adjustment would result in a change in the conversion rate
of at least 1.0%; provided, however, that any adjustment
which by reason of the foregoing is not required to be made
shall be carried forward and taken into account in determining
any subsequent adjustment or in connection with any conversion
of notes. Adjustments to the applicable conversion rate will be
calculated to the nearest
1/10,000th
of a share. Except as stated above, we will not adjust the
conversion rate on the notes for the issuance of our common
stock or any securities convertible into or exchangeable for our
common stock or the right to purchase our common stock or such
convertible or exchangeable securities.
Treatment of Reference Property. In the event
of:
|
|
|
|
|
any reclassification of our common stock,
|
|
|
|
a consolidation, merger or combination involving us,
|
|
|
|
a sale or conveyance to another person of our property and
assets as an entirety or substantially as an entirety, or
|
|
|
|
statutory share exchange,
|
in which holders of our outstanding common stock would be
entitled to receive shares of stock, or other securities,
property, assets or cash (or any combination thereof) for their
common stock, then, at the effective time of the transaction,
we, or such successor, purchasing or transferee person, as the
case may be, shall execute and deliver to the trustee a
supplemental indenture providing that a holder shall have the
right to convert such note into the kind and amount of shares of
stock, or other securities, property, assets or cash (or
combination thereof) that a holder of a number of shares of
common stock equal to the conversion rate prior to such
transaction would have owned or been entitled to receive (the
reference property) in connection with such
transaction. However, at and after the effective time of such
transaction (x) the amount otherwise payable in cash upon
conversion of the notes as set forth under
Payment upon Conversion above will
continue to be payable in cash, (y) the number of shares of
our common stock otherwise deliverable upon the conversion of
the notes as set forth under Payment upon
Conversion above will instead be deliverable in the amount
and type of reference property that a holder of that number of
shares of our common stock would have received in such
transaction and (z) the daily VWAP will be calculated based
on the value of a unit of reference property that a holder of
one share of our common stock would have received in such
transaction. If
60
the transaction causes our common stock to be converted into the
right to receive more than a single type of consideration
(determined based in part upon any form of stockholder
election), the reference property into which the notes will be
convertible will be deemed to be the weighted average of the
types and amounts of consideration received by the holders of
our common stock that affirmatively make such election.
Events That Will Not Result in Adjustment. The
conversion rate will not be adjusted, among other things:
|
|
|
|
|
upon the issuance of any shares of our common stock pursuant to
any existing or future plan providing for the reinvestment of
dividends or interest payable on our securities and the
investment of additional optional amounts in shares of our
common stock under any plan;
|
|
|
|
upon the issuance of any shares of our common stock or options
or rights to purchase shares of our common stock pursuant to any
existing or future employee, director or consultant benefit plan
or program of or assumed by us or any of our subsidiaries;
|
|
|
|
upon the issuance of any shares of our common stock pursuant to
any option, warrant, right or exercisable, exchangeable or
convertible security not described in the preceding bullet and
outstanding as of the date the notes were first issued;
|
|
|
|
for a change in the par value of our common stock; or
|
|
|
|
for accrued and unpaid interest (including additional interest,
if any).
|
Conversion
Procedures
The right of conversion attaching to any note may be exercised
(1) if such note is represented by a global note, by
book-entry transfer to the conversion agent (which will
initially be the trustee) through the facilities of DTC, or
(2) if such note is represented by a certificated security,
by delivery of such note at the specified office of the
conversion agent, accompanied, in either case, by a duly signed
and completed conversion notice and appropriate endorsements and
transfer documents if required by the conversion agent. In each
case, a conversion notice must also be accompanied by the
payment of any funds required to be paid in respect of accrued
and unpaid interest (including additional interest, if any)
and/or
taxes, as described further below. Once delivered, a conversion
notice will be irrevocable.
The conversion date will be the date on which the note and all
of the items required for conversion shall have been so
delivered and the requirements for conversion have been met. The
notes will be deemed to have been converted immediately prior to
the close of business on the conversion date.
Except as provided in the immediately following sentence and in
the next paragraph, no separate payment or adjustment will be
made for accrued and unpaid interest on a converted note or for
dividends or distributions on any of our common stock issued
upon conversion of a note. By delivering to the holder the cash
and shares, if any, of our common stock issuable upon
conversion, together with a cash payment in lieu of fractional
shares, if any, we will satisfy our obligation with respect to
the conversion of the notes. Any accrued but unpaid interest
will be deemed paid in full upon conversion, rather than
cancelled, forfeited or extinguished.
If a holder converts notes after the record date for an interest
payment but prior to the corresponding interest payment date, it
will receive on the corresponding interest payment date the
interest accrued and unpaid on those notes, notwithstanding the
conversion of those notes prior to the interest payment date,
assuming such holder was the holder of record on the
corresponding record date. However, except as provided in the
next sentence, a holder who converts notes after the record date
for an interest payment but prior to the corresponding interest
payment date must pay us an amount equal to the interest that
has accrued and will be paid on the notes being converted on the
corresponding interest payment date. Such payment is not
required to be made:
|
|
|
|
|
if we have specified a redemption date that is after a record
date and on or prior to the corresponding interest payment date;
|
|
|
|
if the conversion is in connection with a fundamental change and
we have specified a fundamental change repurchase date that is
after a record date and on or prior to the corresponding
interest payment date;
|
61
|
|
|
|
|
with respect to any notes converted after the record date
immediately preceding the maturity date of the notes; or
|
|
|
|
to the extent of any overdue interest, if overdue interest
exists at the time of conversion with respect to the notes being
converted.
|
Holders of notes are not required to pay any taxes or duties
relating to the issuance or delivery of our common stock upon
exercise of conversion rights, but they are required to pay any
tax or duty which may be payable relating to any transfer
involved in the issuance or delivery of the common stock in a
name other than the name of the holder of the note. Certificates
representing shares of our common stock will be issued or
delivered only after all applicable taxes and duties, if any,
payable by the holder have been paid.
Except as set forth above under Adjustment to
Conversion Rate upon Certain Fundamental Changes, upon
conversion of any notes, we will pay the cash and deliver the
shares of common stock, if any, into which such notes are
convertible no later than the third business day after the
expiration of the conversion reference period.
Delivery of shares will be accomplished by delivery to the
conversion agent of certificates for the relevant number of
shares, other than in the case of holders of notes in book-entry
form with DTC, which shares shall be delivered in accordance
with DTC customary practices. A holder will not be entitled to
any rights as a holder of our common stock, including, among
other things, the right to vote and receive dividends and
notices of stockholder meetings, until the shares are received.
Optional
Redemption
We may not redeem any of the notes at our option prior to
June 15, 2012.
At any time on or after June 15, 2012, we will have the
right, at our option, to redeem the notes in whole or in part
for cash if the closing sale price of our common stock for at
least 20 of the 30 consecutive trading days immediately prior to
any date we give a notice of redemption is greater than 130% of
the conversion price on the date of such notice. The redemption
price will equal 100% of the principal amount of the notes to be
redeemed, together with accrued and unpaid interest (including
additional interest, if any), if any, on the principal amount of
the notes redeemed, to but not including the date of redemption.
However, if the redemption date falls after a record date and on
or prior to the corresponding interest payment date, we will pay
the full amount of accrued and unpaid interest (including
additional interest, if any), if any, due on such interest
payment date to the holder of record at the close of business on
the corresponding record date, and not to the holder submitting
the notes for redemption, if different. We will make at least
six semi-annual interest payments (including the interest
payments due on December 15, 2009 and June 15,
2012) in the full amount required by the indenture before
we redeem the notes at our option.
If fewer than all of the notes are to be redeemed, the trustee
will select the notes to be redeemed (in principal amounts of
$1,000 or a multiple of $1,000) by lot, on a pro rata basis or
by any other method the trustee considers fair and appropriate.
If any note is to be redeemed in part only, a new note in
principal amount equal to the unredeemed principal portion will
be issued. If a portion of a holders notes is selected for
partial redemption and the holder converts a portion of its
notes, the converted portion will be deemed to be from the
portion selected for redemption.
We are required to give notice of redemption on a date that is
not less than 20 nor more than 60 calendar days before the
redemption date to each holder of notes to be redeemed.
In the event of any redemption in part, we will not be required
to:
|
|
|
|
|
issue, register the transfer of or exchange any note during a
period of 15 days before the mailing of the redemption
notice; or
|
|
|
|
register the transfer of or exchange any note so selected for
redemption, in whole or in part, except the unredeemed portion
of any note being redeemed in part.
|
No sinking fund is provided for the notes.
62
Repurchase
of Notes at the Option of Holders upon a Fundamental
Change
In the event of a fundamental change (as defined below in this
section) each holder will have the right, at its option, subject
to the terms and conditions of the indenture, to require us to
repurchase, in whole or in part, the holders notes in
multiples of $1,000 principal amount, at a price in cash for
each $1,000 principal amount of such notes equal to 100% of the
principal amount of such notes tendered, plus any accrued and
unpaid interest (including any additional interest), if any, to,
but excluding, the repurchase date. However, if the repurchase
date is after a regular record date but on or prior to the
corresponding interest payment date, the interest will be paid
on the repurchase date to the holder of record on such record
date. We will be required to repurchase the notes on the date
specified by us that is not less than 20 nor more than 45
business days after the date we give you notice.
Within 15 business days after a fundamental change has become
effective, we must mail to all holders of notes at their
addresses shown in the register of the registrar and to
beneficial owners as required by applicable law a notice
regarding the fundamental change, which notice must state, among
other things:
|
|
|
|
|
the events that caused such a fundamental change;
|
|
|
|
the effective date of such fundamental change;
|
|
|
|
the last date on which a holder may exercise the repurchase
right;
|
|
|
|
the repurchase price;
|
|
|
|
the repurchase date;
|
|
|
|
the name and address of the paying and conversion agents;
|
|
|
|
the then-applicable conversion rate, and any adjustments to the
conversion rate that will result from the fundamental change;
|
|
|
|
that notes with respect to which a repurchase notice is given by
the holder may be converted only if the repurchase notice has
been withdrawn in accordance with the terms of the
indenture; and
|
|
|
|
the procedures that holders must follow to exercise these rights.
|
To exercise this right, the holder must transmit to the paying
agent a written notice, and such repurchase notice must be
received by the paying agent no later than the close of business
on the business day immediately preceding the repurchase date.
The repurchase notice must state:
|
|
|
|
|
the certificate numbers of the notes to be delivered by the
holder, if applicable;
|
|
|
|
the portion of the principal amount of notes to be repurchased,
which portion must be $1,000 or a multiple of $1,000; and
|
|
|
|
that such notes are being tendered for repurchase pursuant to
the fundamental change provisions of the indenture.
|
A holder may withdraw any repurchase notice (in whole or in
part) by delivering to the paying agent a written notice of
withdrawal prior to the close of business on the business day
immediately preceding the repurchase date. The notice of
withdrawal must state:
|
|
|
|
|
the certificate numbers of the notes being withdrawn, if
applicable;
|
|
|
|
the principal amount of notes being withdrawn; and
|
|
|
|
the principal amount, if any, of the notes that remain subject
to a repurchase notice.
|
If the notes are not in certificated form, the foregoing notices
from holders must comply with the applicable DTC procedures.
63
In connection with any repurchase, we will, to the extent
applicable:
|
|
|
|
|
comply with the provisions of
Rule 13e-4,
Rule 14e-1
and any other tender offer rules under the Exchange Act that may
then be applicable; and
|
|
|
|
otherwise comply with all federal and state securities laws in
connection with any offer by us to repurchase the notes upon a
fundamental change.
|
Our obligation to pay the repurchase price for a note for which
a repurchase notice has been delivered and not validly withdrawn
is conditioned upon delivery of the note, together with
necessary endorsements, to the paying agent at any time after
the delivery of such repurchase notice. We will cause the
repurchase price for such note to be paid promptly following the
later of the repurchase date or the time of delivery of such
note.
If the paying agent holds money sufficient to pay the repurchase
price of a note for which a repurchase notice has been delivered
on the repurchase date in accordance with the terms of the
indenture, then, immediately after the repurchase date, the
notes will cease to be outstanding, whether or not the notes are
delivered to the paying agent. Thereafter, all other rights of
the holder shall terminate, other than the right to receive the
repurchase price upon delivery of the note.
A fundamental change will be deemed to have occurred
upon the occurrence of any of the following:
(1) any person or group (other than
us, our subsidiaries or our respective employee benefit plans)
files a Schedule 13D or Schedule TO, or any successor
schedule, form or report under the Exchange Act, disclosing, or
we otherwise become aware, that such person is or has become the
beneficial owner, directly or indirectly, of shares
of our voting stock representing 50% or more of the total voting
power of all outstanding classes of our voting stock or has the
power, directly or indirectly, to elect a majority of the
members of our board of directors;
(2) we consolidate with, or merge with or into, another
person or we sell, assign, convey, transfer, lease or otherwise
dispose of all or substantially all of our assets, or any person
consolidates with, or merges with or into, us, in any such event
other than pursuant to a transaction in which (a) our
common stock is not changed or exchanged except to the extent
necessary to reflect a change in the jurisdiction of our
organization or (b) the persons that beneficially
owned directly or indirectly, the shares of our voting
stock immediately prior to such transaction beneficially own,
directly or indirectly, shares of voting stock representing a
majority of the total voting power of all outstanding classes of
voting stock of the surviving or transferee person;
(3) the common stock into which the notes are then
convertible ceases to be listed for trading on the NASDAQ Global
Select Market, the New York Stock Exchange or another
U.S. national securities exchange and is not then quoted on
an established automated
over-the-counter
trading market in the United States; or
(4) the adoption of a plan relating to our liquidation or
dissolution.
However, a fundamental change will not be deemed to have
occurred if in the case of a merger or consolidation, at least
90% of the consideration (excluding cash payments for fractional
shares and cash payments pursuant to dissenters appraisal
rights) in the merger or consolidation constituting the
fundamental change consists of common stock or depositary
receipts traded or quoted on a U.S. national securities
exchange (or which will be so traded or quoted when issued or
exchanged in connection with such fundamental change) and as a
result of such transaction or transactions the notes become
convertible solely into such common stock.
For purposes of this fundamental change definition:
|
|
|
|
|
a beneficial owner will be determined in
accordance with
Rule 13d-3
under the Exchange Act, as in effect on the date of the
indenture;
|
|
|
|
beneficially own and beneficially
owned have meanings correlative to that of beneficial
owner;
|
64
|
|
|
|
|
board of directors means the board of
directors or other governing body charged with the ultimate
management of any person;
|
|
|
|
capital stock means: (1) in the case of
a corporation, corporate stock; (2) in the case of an
association or business entity, any and all shares, interests,
participations, rights or other equivalents (however designated)
of corporate stock; (3) in the case of a partnership or
limited liability company, partnership interests (whether
general or limited) or membership interests; or (4) any
other interest or participation that confers on a person the
right to receive a share of the profits and losses of, or
distributions of assets of, the issuing person;
|
|
|
|
person and group shall
have the meanings given to them for purposes of Sections 13(d)
and 14(d) of the Exchange Act or any successor provisions, and
the term group includes any group acting for the
purpose of acquiring, holding or disposing of securities within
the meaning of
Rule 13d-5(b)(1)
under the Exchange Act, or any successor provision; and
|
|
|
|
voting stock means any class or classes of
capital stock or other interests then outstanding and normally
entitled (without regard to the occurrence of any contingency)
to vote in the election of the board of directors, managers or
trustees.
|
The term all or substantially all as used in the
definition of fundamental change will likely be interpreted
under applicable state law and will be dependent upon particular
facts and circumstances. There may be a degree of uncertainty in
interpreting this phrase. As a result, we cannot assure holders
how a court would interpret this phrase under applicable law if
holders elect to exercise their rights following the occurrence
of a transaction which such holders believe constitutes a
transfer of all or substantially all of our assets.
This fundamental change repurchase feature may make more
difficult or discourage a takeover of us and the removal of
incumbent management. We are not, however, aware of any specific
effort to accumulate shares of our common stock or to obtain
control of us by means of a merger, tender offer, solicitation
or otherwise. In addition, the fundamental change repurchase
feature is not part of a plan by management to adopt a series of
anti-takeover provisions. Instead, the fundamental change
repurchase feature is a result of negotiations between us and
the underwriters.
We could, in the future, enter into certain transactions,
including recapitalizations, that would not constitute a
fundamental change but would increase the amount of debt,
including other senior indebtedness, outstanding or otherwise
adversely affect a holder. Neither we nor our subsidiaries are
prohibited from incurring debt, including other senior
indebtedness, under the indenture. The incurrence of significant
amounts of additional debt could adversely affect our ability to
service our debt, including the notes.
We may be unable to repurchase the notes at your option upon the
occurrence of a fundamental change. Any future credit agreements
or other agreements relating to our indebtedness may contain
provisions prohibiting repurchase of the notes under certain
circumstances, or expressly prohibit our repurchase of the notes
upon a fundamental change or may provide that a fundamental
change constitutes a default under that agreement. If a
repurchase date occurs at a time that we are prohibited from
repurchasing notes, we would be required to seek the consent of
our lenders to repurchase the notes or attempt to refinance this
debt. If we were unable to obtain consent, we would not be
permitted to repurchase the notes. Our failure to repurchase
tendered notes would constitute an event of default under the
indenture, which might constitute a default under the terms of
our other indebtedness.
Reports
The indenture governing the notes will provide that any document
or report that we are required to file with the SEC pursuant to
Section 13 or 15(d) of the Exchange Act will be delivered
to the trustee within 30 days after such document or report
is required to be filed with the SEC.
65
Events of
Default
Each of the following constitutes an event of default with
respect to the notes:
(1) default in the payment when due of any principal of any
of the notes at maturity, upon redemption or upon exercise of a
repurchase right or otherwise;
(2) default in the payment of any interest, including
additional interest, if any, on any of the notes, when the
interest becomes due and payable, and continuance of such
default for a period of 30 days;
(3) our failure to deliver cash or cash and shares of our
common stock (including any additional shares deliverable as a
result of a conversion in connection with a make-whole
fundamental change) when required to be delivered upon the
conversion of any note;
(4) default in our obligation to provide notice of the
occurrence of a fundamental change when required by the
indenture;
(5) our failure to comply with any of our other agreements
in the notes or the indenture (other than those referred to in
clauses (1) through (4) above) for 60 days after
our receipt of written notice to us of such default from the
trustee or to us and the trustee of such default from holders of
not less than 25% in aggregate principal amount of the notes
then outstanding;
(6) our failure to pay when due the principal of, or
acceleration of, any indebtedness for money borrowed by us or
any of our subsidiaries in excess of $30,000,000 principal
amount, if such indebtedness is not discharged, or such
acceleration is not annulled, by the end of a period of ten days
after written notice to us by the trustee or to us and the
trustee by the holders of at least 25% in aggregate principal
amount of the notes then outstanding; and
(7) certain events of bankruptcy, insolvency or
reorganization relating to us or any of our material
subsidiaries (as defined in the indenture).
If an event of default, other than an event of default described
in clause (7) above with respect to us occurs and is
continuing, either the trustee or the holders of at least 25% in
aggregate principal amount of the notes then outstanding may
declare the principal amount of, and accrued and unpaid
interest, including additional interest, if any, on the notes
then outstanding to be immediately due and payable. If an event
of default described in clause (7) above occurs with
respect to us the principal amount of and accrued and unpaid
interest, including additional interest, if any, on the notes
will automatically become immediately due and payable.
Notwithstanding the foregoing, the indenture will provide that,
to the extent elected by us, the sole remedy for an event of
default relating to the failure to file any documents or reports
that we are required to file with the SEC pursuant to
Section 13 or 15(d) of the Exchange Act, after taking into
account any grace period afforded by
Rule 12b-25
of the Exchange Act, and for any failure to comply with the
requirements of Section 314(a)(1) of the
Trust Indenture Act or of the covenant described above in
Reports, will (i) for the first
120 days after the occurrence of such an event of default
consist exclusively of the right to receive additional interest
on the notes at an annual rate equal to 0.25% of the principal
amount of the notes and (ii) for the next 90 days
after the expiration of such 120 day period consist
exclusively of the right to receive additional interest on the
notes at an annual rate equal to 0.50% of the principal amount
of the notes. If we so elect, such additional interest will be
payable on all outstanding notes from and including the date on
which such event of default first occurs to but excluding the
210th day thereafter (or such earlier date on which the
event of default relating to a failure to comply with such
requirements has been cured or waived). On the 210th day
after such event of default (or earlier, if the event of default
is cured or waived prior to such 210th day), additional
interest will cease to accrue and, if the event of default has
not been cured or waived, the notes will be subject to the
acceleration as provided above. The provisions of the indenture
described in this paragraph will not affect the rights of
holders of notes in the event of the occurrence of any other
event of default. To the extent we elect to pay additional
interest, it will be payable at the same time, in the same
manner and to the same persons as ordinary interest. If we do
not elect to pay additional interest upon an event of default in
accordance with this paragraph, the notes will be subject to
acceleration as provided above.
66
In order to elect to pay additional interest as the sole remedy
during the first 210 days after the occurrence of an event
of default relating to the failure to comply with the reporting
obligations in accordance with the immediately preceding
paragraph, we must notify all holders of notes and the trustee
and paying agent of such election on or before the close of
business on the date on which such event of default occurs. Upon
our failure to timely give such notice, the notes will be
subject to acceleration as provided above.
At any time after a declaration of acceleration has been made,
but before a judgment or decree for payment of money has been
obtained by the trustee, and subject to applicable law and
certain other provisions of the indenture, the holders of a
majority in aggregate principal amount of the notes then
outstanding may, under certain circumstances, rescind and annul
such acceleration.
Subject to the indenture, applicable law and the trustees
indemnification, the holders of a majority in aggregate
principal amount of the outstanding notes will have the right to
direct the time, method and place of conducting any proceeding
for any remedy available to the trustee or exercising any trust
or power conferred on the trustee with respect to the notes.
No holder will have any right to institute any proceeding under
the indenture, or for the appointment of a receiver or a
trustee, or for any other remedy under the indenture unless:
|
|
|
|
|
the holder has previously given the trustee written notice of a
continuing event of default;
|
|
|
|
the holders of at least 25% in aggregate principal amount of the
notes then outstanding have made a written request and have
provided indemnity or security reasonably satisfactory to the
trustee against any loss, liability or expense to the trustee to
institute such proceeding as trustee; and
|
|
|
|
the trustee has failed to institute such proceeding within
60 days after such notice, request and offer, and has not
received from the holders of a majority in aggregate principal
amount of the notes then outstanding a direction inconsistent
with such request within 60 days after such notice, request
and offer.
|
However, the above limitations do not apply to a suit instituted
by a holder for the enforcement of payment of the principal of
or any accrued and unpaid interest, including additional
interest, if any, on any note on or after the applicable due
date or the right to convert the note in accordance with the
indenture.
Generally, the holders of not less than a majority of the
aggregate principal amount of outstanding notes may waive any
default or event of default other than:
|
|
|
|
|
our failure to pay principal or any accrued and unpaid interest,
including additional interest, if any, on any note when due or
the payment of any redemption price or repurchase price;
|
|
|
|
our failure to convert any note into shares of our common stock
as required by the indenture; or
|
|
|
|
our failure to comply with any of the provisions of the
indenture that would require the consent of the holder of each
outstanding note affected.
|
We are required to furnish the trustee, on an annual basis, a
statement by our officers as to whether or not we, to the
officers knowledge, are in default in the performance or
observance of any of the terms, provisions and conditions of the
indenture, specifying any known defaults.
Consolidation,
Merger and Sale of Assets
We may not, in a single transaction or series of related
transactions, consolidate with or merge with or into any person
or sell, convey, transfer or lease all or substantially all of
our properties and assets to another person, unless:
|
|
|
|
|
we are the surviving person or the resulting, surviving or
transferee person, if other than us, is organized and validly
existing under the laws of the United States of America, any
state of the United States, or the District of Columbia and
assumes our obligations on the notes and under the
indenture; and
|
67
|
|
|
|
|
immediately after giving effect to the transaction, no default
or event of default shall have occurred and be continuing.
|
When such a person assumes our obligations in such
circumstances, subject to certain exceptions we shall be
discharged from all obligations under the notes and the
indenture. Although the indenture permits these transactions,
some of the transactions described above could constitute a
fundamental change of Rambus and permit each holder to require
us to repurchase the notes of such holder as described above
under Repurchase of Notes at the Option of
Holders upon a Fundamental Change.
An assumption by any person of Rambus obligations under
the notes and the indenture might be deemed for
U.S. federal income tax purposes to be an exchange of the
notes for new notes by the holders thereof, resulting in
recognition of gain or loss for such purposes and possibly other
adverse tax consequences to the holders. Holders should consult
their own tax advisors regarding the tax consequences of such an
assumption.
Modification
and Waiver
Except as described below, we and the trustee may amend or
supplement the indenture or the notes with the consent of the
holders of at least a majority in aggregate principal amount of
the outstanding notes. In addition, subject to certain
exceptions, the holders of a majority in aggregate principal
amount of the outstanding notes may waive our compliance in any
instance with any provision of the indenture without notice to
the holders. However, no amendment, supplement or waiver may be
made without the consent of the holder of each outstanding note
if such amendment, supplement or waiver would:
(1) change the stated maturity of the principal of the
notes;
(2) reduce the rate or extend the time for payment of
interest, including any additional interest, if any, on any
notes;
(3) reduce the principal amount of any notes;
(4) reduce any amount payable upon redemption or repurchase
of any notes;
(5) impair the right of a holder to institute suit for
payment of any notes;
(6) change the currency in which the principal of or
redemption price or repurchase price or rate of interest,
including additional interest, if any, with respect to the notes
is payable;
(7) change our obligation to repurchase any notes at the
option of the holder after the occurrence of a fundamental
change in a manner adverse to the holders;
(8) affect the right of a holder to convert any notes into
shares of our common stock or reduce the number of share of our
common stock receivable upon conversion pursuant to the terms of
the indenture; or
(9) subject to specified exceptions, modify certain
provisions of the indenture relating to modification of the
indenture or waiver under the indenture.
We and the trustee may amend or supplement the indenture or the
notes without notice to, or the consent of the holders to, among
other things:
(1) provide for conversion rights of holders of the notes
and our repurchase obligations in connection with a fundamental
change, in the event of any reclassification of our common
stock, merger or consolidation, or sale, conveyance, transfer or
lease of our properties and assets substantially as an entirety;
(2) secure the notes;
(3) provide for the assumption of our obligations to the
holders of the notes in the event of a merger or consolidation,
or sale, conveyance, transfer or lease of all or substantially
all of our properties and assets;
68
(4) surrender any right or power conferred upon us;
(5) add to our covenants for the benefit of the holders of
the notes;
(6) cure any ambiguity or correct or supplement any
inconsistent or otherwise defective provision contained in the
indenture, so long as such modification or amendment does not
adversely affect the interests of the holders of the notes in
any material respect; provided that any such modification or
amendment made solely to conform the provisions of the indenture
to the description of the notes contained in this prospectus
will be deemed not to adversely affect the interests of the
holders of the notes;
(7) make any provision with respect to matters or questions
arising under the indenture that we may deem necessary or
desirable and that shall not be inconsistent with provisions of
the indenture; provided that such change or modification does
not, in the good faith opinion of our board of directors,
adversely affect the interests of the holders of the notes in
any material respect; provided, further, that any amendment made
solely to conform the provisions of the indenture to the
description of the notes contained in this prospectus will be
deemed not to adversely affect the interests of the holders of
the notes;
(8) increase the conversion rate;
(9) comply with the requirements of the SEC in order to
effect or maintain the qualification of the indenture under the
Trust Indenture Act;
(10) comply with the rules of any applicable securities
depositary, including DTC;
(11) add guarantees of obligations under the notes; and
(12) provide for a successor trustee in accordance with the
terms of the indenture or to otherwise comply with any
requirement of the indenture.
The consent of the holders of notes is not necessary under the
indenture to approve the particular form of any proposed
modification or amendment. It is sufficient if such consent
approves the substance of the proposed modification or
amendment. After a modification or amendment under the indenture
becomes effective, we are required to mail to the holders a
notice briefly describing such modification or amendment.
However, the failure to give such notice to all the holders, or
any defect in the notice, will not impair or affect the validity
of the modification or amendment.
Any notes held by us or by any person directly or indirectly
controlling or controlled by or under direct or indirect common
control with us shall be disregarded (from both the numerator
and the denominator) for purposes of determining whether the
holders of the requisite aggregate principal amount of the
outstanding notes have consented to a modification, amendment or
waiver of the terms of the indenture, except that for the
purposes of determining whether the trustee shall be protected
in relying on any such consent, only notes that the trustee
knows are so owned shall be so disregarded.
Satisfaction
and Discharge
We may satisfy and discharge our obligations under the indenture
by delivering to the trustee for cancellation all outstanding
notes or by depositing with the paying agent or conversion
agent, as the case may be, after the notes have become due and
payable, whether at maturity or any redemption date or
repurchase date or by delivery of a notice of conversion or
otherwise, cash or shares of common stock (as applicable under
the terms of the indenture) sufficient to pay all of the
outstanding notes and paying all other sums payable under the
indenture. Such discharge is subject to terms contained in the
indenture.
Calculations
in Respect of the Notes
We or our agents will be responsible for making all calculations
called for under the notes. These calculations include, but are
not limited to, determination of the trading price of the notes
and closing sale price of our common stock, accrued interest
payable on the notes, the conversion rate and conversion price
69
and the projected payment schedule. We or our agents will make
all these calculations in good faith and, absent manifest error,
our and their calculations will be final and binding on holders
of notes. We or our agents will provide a schedule of these
calculations to the trustee, and the trustee is entitled to
conclusively rely upon the accuracy of these calculations
without independent verification.
Governing
Law
The indenture and the notes are governed by, and construed in
accordance with, the laws of the State of New York.
Concerning
the Trustee
U.S. Bank National Association is the trustee under the
indenture. The trustee will be the paying agent, conversion
agent and registrar for the notes. The trustee can be contacted
at the address set forth below regarding transfer or conversion
of the notes:
U.S. Bank National Association
633 West Fifth Street,
24th
Floor
LM-CA-T24T
Los Angeles, CA 90071
Attn: Corporate Trust Services
(Rambus % Convertible Senior
Notes due 2014)
If the trustee becomes a creditor of the Company, the indenture
limits the right of the trustee to obtain payment of claims in
certain cases, or to realize on certain property received in
respect of any such claims as security or otherwise. The trustee
will be permitted to engage in other transactions; however, if
it acquires any conflicting interest it must eliminate such
conflict with 90 days, apply to the SEC for permission to
continue as trustee (it the indenture has been qualified under
the Trust Indenture Act) or resign.
The trustee also serves as the trustee under the indenture
governing the zero coupon convertible senior notes due 2010.
Computershare Investor Services, LLC is the transfer agent and
registrar for our common stock.
Book-Entry
Delivery and Form
We will initially issue the notes in the form of one or more
global notes. The global note will be deposited with the trustee
as custodian for DTC and registered in the name of
Cede & Co., as DTCs nominee. Except as set forth
below, the global note may be transferred, in whole and not in
part, only to DTC or another nominee of DTC. Holders may hold
their beneficial interests in the global note directly through
DTC if they have an account with DTC or indirectly through
organizations that have accounts with DTC. Notes in definitive
certificated form (called certificated securities)
will be issued only in certain limited circumstances described
below.
DTC has advised us that it is:
|
|
|
|
|
a limited purpose trust company organized under the laws of the
State of New York;
|
|
|
|
a member of the Federal Reserve System;
|
|
|
|
a clearing corporation within the meaning of the New
York Uniform Commercial Code; and
|
|
|
|
a clearing agency registered pursuant to the
provisions of Section 17A of the Exchange Act.
|
DTC was created to hold securities of institutions that have
accounts with DTC (called participants) and to
facilitate the clearance and settlement of securities
transactions among its participants in such securities through
electronic book-entry changes in accounts of the participants,
thereby eliminating the need for physical movement of securities
certificates. DTCs participants include securities brokers
and dealers, which may include the underwriters, banks, trust
companies, clearing corporations and certain other
organizations.
70
Access to DTCs book-entry system is also available to
others such as banks, brokers, dealers and trust companies
(called the indirect participants) that clear
through or maintain a custodial relationship with a participant,
whether directly or indirectly.
Ownership of beneficial interests in the global note will be
limited to participants or persons that may hold interests
through participants. Ownership of beneficial interests in the
global note will be shown on, and the transfer of those
beneficial interests will be effected only through, records
maintained by DTC (with respect to participants
interests), the participants and the indirect participants. The
laws of some jurisdictions may require that certain purchasers
of securities take physical delivery of such securities in
definitive form. These limits and laws may impair the ability to
transfer or pledge beneficial interests in the global note.
Owners of beneficial interests in global notes who desire to
convert their interests into common stock should contact their
brokers or other participants or indirect participants through
whom they hold such beneficial interests to obtain information
on procedures, including proper forms and cut-off times, for
submitting requests for conversion.
So long as DTC, or its nominee, is the registered owner or
holder of a global note, DTC or its nominee, as the case may be,
will be considered the sole owner or holder of the notes
represented by the global note for all purposes under the
indenture and the notes. In addition, no owner of a beneficial
interest in a global note will be able to transfer that interest
except in accordance with the applicable procedures of DTC.
Except as set forth below, as an owner of a beneficial interest
in the global note, holders will not be entitled to have the
notes represented by the global note registered in their name,
will not receive or be entitled to receive physical delivery of
certificated securities and will not be considered to be the
owner or holder of any notes under the global note. We
understand that, under existing industry practice, if an owner
of a beneficial interest in the global note desires to take any
action that DTC, as the holder of the global note, is entitled
to take, DTC would authorize the participants to take such
action, and the participants would authorize beneficial owners
owning through such participants to take such action or would
otherwise act upon the instructions of beneficial owners owning
through them.
We will make payments of principal of, premium, if any, and any
interest (including any additional interest), if any, on the
notes represented by the global note registered in the name of
and held by DTC or its nominee to DTC or its nominee, as the
case may be, as the registered owner and holder of the global
note. We expect that DTC or its nominee, upon receipt of any
payment of principal of, premium, if any, or interest (including
any additional interest), if any, on the global note, will
credit participants accounts with payments in amounts
proportionate to their respective beneficial interests in the
principal amount of the global note as shown on the records of
DTC or its nominee. We also expect that payments by participants
or indirect participants to owners of beneficial interests in
the global note held through such participants or indirect
participants will be governed by standing instructions and
customary practices and will be the responsibility of such
participants or indirect participants. Neither we, the trustee
nor any paying agent or conversion agent will have any
responsibility or liability for any aspect of the records
relating to, or payments made on account of, beneficial
interests in the global note for any note or for maintaining,
supervising or reviewing any records relating to such beneficial
interests or for any other aspect of the relationship between
DTC and its participants or indirect participants or the
relationship between such participants or indirect participants
and the owners of beneficial interests in the global note owning
through such participants.
Transfers between participants in DTC will be effected in the
ordinary way in accordance with DTC rules and will be settled in
same-day
funds.
DTC has advised us that it will take any action permitted to be
taken by a holder of notes only at the direction of one or more
participants to whose account the DTC interests in the global
note is credited, and only in respect of such portion of the
aggregate principal amount of notes as to which such participant
or participants has or have given such direction. However, if
DTC notifies us that it is unwilling to be a depository for the
global note or ceases to be a clearing agency and no successor
to DTC is appointed within 90 days, DTC will exchange the
global note for certificated securities, which it will
distribute to its participants. In addition, the owner of a
beneficial interest in a global note will be entitled to receive
a note in certificated form in exchange for such interest if an
event of default has occurred and is continuing.
71
Although DTC is expected to follow the foregoing procedures in
order to facilitate transfers of interests in the global note
among participants of DTC, it is under no obligation to perform
or continue to perform such procedures, and such procedures may
be discontinued at any time. Neither we nor the trustee will
have any responsibility or liability for the performance by DTC
or the participants or indirect participants of their respective
obligations under the rules and procedures governing their
respective operations.
72
DESCRIPTION
OF CAPITAL STOCK
General
Our authorized capital stock consists of 500,000,000 shares
of common stock, $0.001 par value, and
5,000,000 shares of preferred stock, $0.001 par value,
of which 160,000 shares have been designated as
Series E Participating Preferred Stock (the
Series E Preferred).
Common
Stock
As of May 31, 2009, there were 104,730,216 shares of
common stock outstanding. Subject to preferences that may be
applicable to any preferred stock outstanding at the time, the
holders of common stock are entitled to:
Dividends. The holders of common stock are
entitled to receive ratably such dividends, if any, as may be
declared by the board of directors out of funds legally
available for the payment of dividends. There are no redemption
or sinking fund provisions applicable to the common stock.
Voting. Our bylaws provide that each
stockholder has the right to one vote for each share of common
stock registered in the stockholders name on each matter
submitted to a stockholder vote. Our bylaws specify that, other
than the election of directors and except as otherwise provided
by our certificate of incorporation or Delaware General
Corporation Law, all matters to be voted on by stockholders will
be approved by a majority of the quorum then present (in person
or by proxy) at a meeting. Unless otherwise provided in our
certificate of incorporation and bylaws, directors are elected
by a plurality of the votes cast by shares entitled to vote in
the election at a meeting at which a quorum is present. Neither
our certificate nor bylaws provide for cumulative voting.
Preemptive Rights, Conversion and
Redemption. The common stock is not entitled to
preemptive rights and is not subject to conversion or redemption.
Liquidation, Dissolution and Winding up. Upon
our liquidation, dissolution or winding up, the holders of
common stock are entitled to share ratably in all assets
remaining after payment of liabilities and the liquidation
preferences of any preferred stock.
Preferred
Stock
The board of directors is authorized, without action by the
stockholders, to designate and issue up to 4,840,000 shares
of preferred stock in one or more series. The board of directors
can fix the rights, preferences and privileges of the shares of
each Series and any qualifications, limitations or restrictions
on these shares.
The board of directors may authorize the issuance of preferred
stock with voting or conversion rights that could adversely
affect the voting power or other rights of the holders of common
stock.
The issuance of preferred stock could delay, defer or prevent a
change in control of us. As of May 31, 2009 there were no
shares of preferred stock outstanding and we have no current
plans to issue any shares of preferred stock.
Anti-takeover
Provisions
Rights Plan. We have a preferred shares rights
agreement that allows certain holders of our common stock to
purchase from us one one-thousandth of a share of Series E
Preferred, for each share of common held, at an exercise price
of $60.00, subject to adjustment, upon the occurrence of certain
events described in the rights agreement (such as a person (or
group of people) acquiring 15% or more of our outstanding shares
of common stock). Each share of Series E Preferred will be
entitled to an aggregate dividend of 1,000 times the dividend
declared per share of common stock. In the event of liquidation,
the holders of the Series E Preferred will be entitled to
1,000 times the amount paid per share of common stock plus an
amount equal to accrued and unpaid dividends and distributions
thereon, whether or not declared, to the date of such payment.
Each share of Series E Preferred will have 1,000 votes,
voting together with the common stock. In addition,
73
upon exercise of the right a holder has the ability to receive
that number of shares of our common stock equal to two times the
exercise price. Our rights plan could delay, defer or prevent a
change in control of us.
Certificate of Incorporation and Bylaws. Our
certificate of incorporation and bylaws provide the following
protections:
|
|
|
|
|
our board of directors is authorized, without prior stockholder
approval, to create and issue preferred stock, commonly referred
to as blank check preferred stock, with rights
senior to those of common stock;
|
|
|
|
our board of directors is staggered into two classes, only one
of which is elected at each annual meeting;
|
|
|
|
stockholder action by written consent is prohibited;
|
|
|
|
nominations for election to our board of directors and the
submission of matters to be acted upon by stockholders at a
meeting are subject to advance notice requirements;
|
|
|
|
certain provisions in our bylaws and certificate such as notice
to stockholders, the ability to call a stockholder meeting,
advance notice requirements and action of stockholders by
written consent may only be amended with the approval of
stockholders holding 66
2/3%
of our outstanding voting stock;
|
|
|
|
stockholders do not have the ability to call special meetings of
stockholders; and
|
|
|
|
our board of directors is expressly authorized to make, alter or
repeal our bylaws.
|
The provisions of our certificate of incorporation and bylaws
and our preferred shares rights agreement could discourage
potential acquisition proposals and could delay or prevent a
change in control of us or management.
Delaware Takeover Statute. We are subject to
the provisions of Section 203 of the Delaware General
Corporation Law. In general, the statute prohibits a publicly
held Delaware corporation from engaging in a business
combination with an interested stockholder for a period of three
years after the date of the transaction in which the person
became an interested stockholder, unless the business
combination is approved in a prescribed manner. For purposes of
Section 203, a business combination includes a merger,
asset sale or other transaction resulting in a financial benefit
to the interested stockholder, and an interested stockholder is
a person who, together with affiliates and associates, owns (or
within three years prior, did own) 15% or more of the
corporations voting stock.
Transfer
Agent and Registrar
The transfer agent and registrar for our common stock is
Computershare Investor Services, LLC.
NASDAQ
Global Select Market Listing
Our common stock is quoted on the NASDAQ Global Select Market
under the symbol RMBS. The notes will not be listed
on any securities exchange.
74
CERTAIN
U.S. FEDERAL INCOME TAX CONSIDERATIONS
This section is a discussion of certain U.S. federal income
tax considerations relating to the purchase, ownership and
disposition of the notes and the common stock into which the
notes may be converted. This summary does not provide a complete
analysis of all potential tax considerations. The information
provided below is based on existing U.S. federal income tax
authorities, all of which are subject to change or differing
interpretations, possibly with retroactive effect. There can be
no assurances that the Internal Revenue Service (the
IRS) will not challenge one or more of the tax
consequences described herein, and we have not obtained, nor do
we intend to obtain, a ruling from the IRS with respect to the
U.S. federal income tax consequences of purchasing, owning
or disposing of the notes or common stock. The summary generally
applies only to beneficial owners of the notes that purchase
their notes in this offering for an amount equal to the issue
price of the notes, which is the first price at which a
substantial amount of the notes is sold for money to the public
(not including sales to bond houses, brokers or similar persons
or organizations acting in the capacity of underwriters,
placement agents or wholesalers), and that hold the notes and
common stock as capital assets (generally, for
investment). This discussion does not purport to deal with all
aspects of U.S. federal income taxation that may be
relevant to a particular beneficial owner in light of the
beneficial owners circumstances (for example, persons
subject to the alternative minimum tax provisions of the
Internal Revenue Code of 1986, as amended (the
Code), or a U.S. holder (as defined below)
whose functional currency is not the
U.S. dollar). Also, it is not intended to be wholly
applicable to all categories of investors, some of which may be
subject to special rules (such as dealers in securities, traders
in securities that elect to use a
mark-to-market
method of accounting, banks, thrifts, regulated investment
companies, real estate investment trusts, insurance companies,
tax-exempt entities, tax-deferred or other retirement accounts,
certain former citizens or residents of the United States,
persons holding notes or common stock as part of a hedging or
conversion transaction or a straddle, or persons deemed to sell
notes or common stock under the constructive sale provisions of
the Code). Finally, the summary does not describe the effects of
the U.S. federal estate and gift tax laws or the effects of
any applicable foreign, state or local laws.
INVESTORS CONSIDERING THE PURCHASE OF NOTES SHOULD CONSULT
THEIR OWN TAX ADVISORS REGARDING THE APPLICATION OF THE
U.S. FEDERAL INCOME TAX LAWS TO THEIR PARTICULAR SITUATIONS
AND THE CONSEQUENCES OF U.S. FEDERAL ESTATE OR GIFT TAX
LAWS, FOREIGN, STATE AND LOCAL LAWS, AND TAX TREATIES.
U.S.
Holders
As used herein, the term U.S. holder means a
beneficial owner of the notes or the common stock into which the
notes may be converted that, for U.S. federal income tax
purposes is (1) an individual citizen or resident of the
United States, (2) a corporation, or an entity treated as a
corporation for U.S. federal income tax purposes, created
or organized in or under the laws of the United States or any
state of the United States, including the District of Columbia,
(3) an estate the income of which is subject to
U.S. federal income taxation regardless of its source, or
(4) a trust if it (x) is subject to the primary
supervision of a U.S. court and the control of one of more
U.S. persons or (y) has a valid election in effect
under applicable U.S. Treasury regulations to be treated as
a U.S. person.
A
non-U.S. holder
is a beneficial owner of the notes or the common stock into
which the notes may be converted (other than a partnership or an
entity or arrangement treated as a partnership for
U.S. federal income tax purposes) that is not a
U.S. holder.
If a partnership (including for this purpose an entity or
arrangement, domestic or foreign, treated as a partnership for
U.S. federal income tax purposes) is a beneficial owner of
a note or common stock acquired upon conversion of a note, the
tax treatment of a partner in the partnership will depend upon
the status of the partner and the activities of the partnership.
A beneficial owner of a note or common stock acquired upon
conversion of a note that is a partnership, and partners in such
partnership, should consult their own tax advisors about the
U.S. federal income tax consequences of purchasing, owning
and disposing of the notes and the common stock into which the
notes may be converted.
75
Taxation
of Interest
U.S. holders will be required to recognize as ordinary
income any stated interest paid or accrued on the notes, in
accordance with their regular method of tax accounting.
In general, if the terms of a debt instrument entitle a holder
to receive payments (other than fixed periodic interest) that
exceed the issue price of the instrument by more than a de
minimis amount, the holder will be required to include such
excess in income as original issue discount over the
term of the instrument, irrespective of the holders
regular method of tax accounting. We believe that the notes will
not be issued with original issue discount for U.S. federal
income tax purposes.
We may be required to make payments of additional interest to
holders of the notes if we do not make certain filings, as
described under Description of the Notes
Events of Default above. We believe that there is only a
remote possibility that we would be required to pay additional
interest, or that if such additional interest were required to
be paid, it would be an incidental amount, and therefore we do
not intend to treat the notes as subject to the special rules
governing certain contingent payment debt instruments (which, if
applicable, would affect the timing, amount and character of
income with respect to a note). Our determination in this
regard, while not binding on the IRS, is binding on
U.S. holders unless they disclose their contrary position.
If, contrary to expectations, we pay additional interest,
although it is not free from doubt, such additional interest
should be taxable to a U.S. holder as ordinary interest
income at the time it accrues or is paid in accordance with the
U.S. holders regular method of tax accounting. In the
event we pay additional interest on the notes, U.S. holders
should consult their own tax advisors regarding the treatment of
such amounts.
Sale,
Exchange, Redemption or Other Taxable Disposition of
Notes
A U.S. holder generally will recognize capital gain or loss
if the holder disposes of a note in a sale, exchange, redemption
or other taxable disposition (other than conversion of a note
into cash and shares of our common stock, the U.S. federal
income tax consequences of which are described under
U.S. Holders Conversion of
Notes below). The U.S. holders gain or loss
will equal the difference between the proceeds received by the
holder (other than amounts attributable to accrued but unpaid
interest) and the holders tax basis in the note. The
U.S. holders tax basis in the note will generally
equal the amount the holder paid for the note. The portion of
any proceeds that is attributable to accrued interest will not
be taken into account in computing the U.S. holders
capital gain or loss. Instead, that portion will be recognized
as ordinary interest income to the extent that the
U.S. holder has not previously included the accrued
interest in income. The gain or loss recognized by the
U.S. holder on the disposition of the note will be
long-term capital gain or loss if the holder held the note for
more than one year, or short-term capital gain or loss if the
holder held the note for one year or less, at the time of the
transaction. Long-term capital gains of non-corporate taxpayers
currently are taxed at a maximum 15% federal rate. Short-term
capital gains are taxed at ordinary income rates. The
deductibility of capital losses is subject to limitations.
Conversion
of Notes
The tax consequences of the conversion of a note into cash and
shares of our common stock are not entirely clear. A
U.S. holder may be treated as exchanging the note for our
common stock and cash in a recapitalization for
U.S. federal income tax purposes. In such case, the
U.S. holder would not be permitted to recognize loss, but
would be required to recognize capital gain. The amount of
capital gain recognized by a U.S. holder would equal the
lesser of (i) the excess (if any) of (A) the amount of
cash received (excluding any cash received in lieu of a
fractional share of our common stock and any cash received
attributable to accrued and unpaid interest) plus the fair
market value of our common stock received (treating a fractional
share of our common stock as issued and received for this
purpose and excluding any such common stock that is attributable
to accrued and unpaid interest) upon conversion over
(B) the U.S. holders tax basis in the converted
note, and (ii) the amount of cash received upon conversion
(other than any cash received in lieu of a fractional share of
our common stock and any cash received attributable to accrued
and unpaid interest). Subject to the discussion under
U.S. Holders Constructive
Distributions below regarding the possibility
76
that the adjustment to the conversion rate of a note converted
in connection with a fundamental change may be treated as a
taxable stock dividend, the gain recognized by a
U.S. holder upon conversion of a note will be long-term
capital gain if the holder held the note for more than one year,
or short-term capital gain if the holder held the note for one
year or less, at the time of the conversion. Long-term capital
gains of non-corporate taxpayers currently are taxed at a
maximum 15% federal rate. Short-term capital gains are taxed at
ordinary income rates. The U.S. holders tax basis in
the common stock received (including any fractional share for
which cash is paid, but excluding shares attributable to accrued
and unpaid interest) generally would equal the tax basis of the
converted note, decreased by the amount of cash received (other
than cash in lieu of a fractional share of common stock and any
cash attributable to accrued and unpaid interest), and increased
by the amount of gain (if any) recognized upon conversion (other
than any gain recognized as a result of cash received in lieu of
a fractional share of common stock). The U.S. holders
holding period in the common stock (other than shares
attributable to accrued and unpaid interest) would include the
holding period in the converted note.
Alternatively, the conversion of a note into cash and shares of
our common stock may be treated as in part a payment in
redemption for cash of a portion of the note and in part a
conversion of a portion of the note into common stock. In such
case, a U.S. holders aggregate tax basis in the note
would be allocated between the portion of the note treated as
redeemed and the portion of the note treated as converted into
common stock on a pro rata basis. The U.S. holder generally
would recognize capital gain or loss with respect to the portion
of the note treated as redeemed equal to the difference between
the amount of cash received by the U.S. holder (other than
amounts attributable to accrued and unpaid interest) and the
U.S. holders tax basis in the portion of the note
treated as redeemed. See
U.S. Holders Sale, Exchange,
Redemption or Other Taxable Disposition of Notes above.
With respect to the portion of the note treated as converted, a
U.S. holder generally would not recognize any gain or loss
(except with respect to cash received in lieu of a fractional
share of common stock and common stock received attributable to
accrued and unpaid interest), subject to the discussion under
U.S. Holders Constructive
Distributions below regarding the possibility that the
adjustment to the conversion rate of a note converted in
connection with a fundamental change may be treated as a taxable
stock dividend. The tax basis allocated to the portion of the
note treated as converted into common stock would be the
U.S. holders tax basis in the common stock (including
any fractional share for which cash is paid, but excluding
shares attributable to accrued interest). The
U.S. holders holding period in the common stock
(other than shares attributable to accrued interest) would
include the holding period in the converted note.
With respect to cash received in lieu of a fractional share of
our common stock, a U.S. holder will be treated as if the
fractional share were issued and received and then immediately
redeemed for cash. Accordingly, the U.S. holder generally
will recognize gain or loss equal to the difference between the
cash received and that portion of the holders tax basis in
the common stock (determined as discussed above) attributable to
the fractional share.
Any cash and the value of any portion of our common stock that
is attributable to accrued and unpaid interest on the notes not
yet included in income by a U.S. holder will be taxed as
ordinary income. The basis in any shares of common stock
attributable to accrued and unpaid interest will equal the fair
market value of such shares when received. The holding period in
any shares of common stock attributable to accrued and unpaid
interest will begin on the day after the date of conversion.
A U.S. holder that converts a note between a record date
for an interest payment and the next interest payment date and
consequently receives a payment of cash interest, as described
in Description of the Notes Conversion of
Notes General, should consult its own tax
advisor concerning the appropriate treatment of such payment.
U.S. holders are urged to consult their own tax advisors
with respect to the U.S. federal income tax consequences of
converting their notes into cash or a combination of cash and
our common stock.
If we undergo a business combination as described under
Description of the Notes Conversion of
Notes Conversion Rate Adjustments
Treatment of Reference Property, the conversion obligation
may be adjusted so that holders would be entitled to convert the
notes into the type of consideration that they would
77
have been entitled to receive upon such business combination had
the notes been converted into our common stock immediately prior
to such business combination, except that such holders will not
be entitled to receive a make whole premium unless such notes
are converted in connection with the relevant fundamental
change. Depending on the facts and circumstances at the time of
such business combination, such adjustment may result in a
deemed exchange of the outstanding notes, which may be a taxable
event for U.S. federal income tax purposes.
U.S. holders are urged to consult their own tax advisors
regarding the U.S. federal income tax consequences of such
an adjustment upon a business combination.
Distributions
If, after a U.S. holder acquires our common stock upon a
conversion of a note, we make a distribution in respect of such
common stock from our current or accumulated earnings and
profits (as determined under U.S. federal income tax
principles), the distribution will be treated as a dividend and
will be includible in a U.S. holders income when
paid. If the distribution exceeds our current and accumulated
earnings and profits, the excess will be treated first as a
tax-free return of the U.S. holders investment, up to
the U.S. holders tax basis in its common stock, and
any remaining excess will be treated as capital gain from the
sale or exchange of the common stock. If the U.S. holder is
a U.S. corporation, it would generally be able to claim a
dividends received deduction on a portion of any distribution
taxed as a dividend, provided that certain holding period
requirements are satisfied. Subject to certain exceptions,
dividends received by non-corporate U.S. holders currently
are taxed at a maximum rate of 15%, provided that certain
holding period requirements are met.
Constructive
Distributions
The terms of the notes allow for changes in the conversion rate
of the notes under certain circumstances. A change in conversion
rate that allows holders of notes to receive more shares of
common stock on conversion may increase such holders
proportionate interests in our earnings and profits or assets.
In that case, the holders of notes may be treated as though they
received a taxable distribution in the form of our common stock.
A taxable constructive stock distribution would result, for
example, if the conversion rate is adjusted to compensate
holders of notes for distributions of cash or property to our
stockholders. The adjustment to the conversion rate of notes
converted in connection with a non-stock change of control, as
described under Description of the Notes
Conversion of Notes Adjustment to Conversion Rate
upon Certain Fundamental Changes above, also may be
treated as a taxable stock distribution. If an event occurs that
dilutes the interests of stockholders and the conversion rate of
the notes is not adjusted (or not adequately adjusted), this
also could be treated as a taxable stock distribution to holders
of the notes. Conversely, if an event occurs that dilutes the
interests of holders of the notes and the conversion rate is not
adjusted (or not adequately adjusted), the resulting increase in
the proportionate interests of our stockholders could be treated
as a taxable stock distribution to the stockholders. Not all
changes in the conversion rate that result in holders of notes
receiving more common stock on conversion, however, increase
such holders proportionate interests in us. For instance,
a change in conversion rate could simply prevent the dilution of
the holders interests upon a stock split or other change
in capital structure. Changes of this type, if made pursuant to
a bona fide reasonable adjustment formula, are not treated as
constructive stock distributions. Any taxable constructive stock
distribution resulting from a change to, or failure to change,
the conversion rate that is treated as a distribution of common
stock would be treated for U.S. federal income tax purposes
in the same manner as a distribution on our common stock paid in
cash or other property. It would result in a taxable dividend to
the recipient to the extent of our current or accumulated
earnings and profits (with the recipients tax basis in its
note or common stock (as the case may be) being increased by the
amount of such dividend), with any excess treated as a tax-free
return of the holders investment in its note or common
stock (as the case may be) or as capital gain. U.S. holders
should consult their own tax advisors regarding whether any
taxable constructive stock dividend on notes would be eligible
for the current maximum 15% rate or the dividends received
deduction described in the previous paragraph, as the requisite
applicable holding period requirements might not be considered
to be satisfied.
78
Sale,
Exchange or Other Disposition of Common Stock
A U.S. holder generally will recognize capital gain or loss
on a sale, exchange or other disposition of common stock. The
U.S. holders gain or loss will equal the difference
between the proceeds received by the holder and the
holders tax basis in the stock. The proceeds received by
the U.S. holder will include the amount of any cash and the
fair market value of any other property received for the stock.
The gain or loss recognized by a U.S. holder on a sale or
exchange of common stock will be long-term capital gain or loss
if the holders holding period in the common stock is more
than one year, or short-term capital gain or loss if the
holders holding period in the common stock is one year or
less, at the time of the transaction. Long-term capital gains of
non-corporate taxpayers are currently taxed at a maximum 15%
federal rate. Short-term capital gains are taxed at ordinary
income rates. The deductibility of capital losses is subject to
limitations.
Non-U.S.
Holders
The following discussion is limited to the U.S. federal
income tax consequences relevant to a
non-U.S. holder
(as defined above).
Taxation
of Interest
Payments of interest to nonresident persons or entities are
generally subject to U.S. federal income tax at a rate of
30% (or a reduced or zero rate under the terms of an applicable
income tax treaty between the United States and the
recipients country of residence), collected by means of
withholding by the payor. Payments of interest on the notes to
most
non-U.S. holders,
however, will qualify as portfolio interest, and
thus will be exempt from U.S. federal income tax, including
withholding of such tax, if the
non-U.S. holders
certify their nonresident status as described below.
The portfolio interest exemption will not apply to payments of
interest to a
non-U.S. holder
that:
|
|
|
|
|
owns, actually or constructively, shares of our stock
representing at least 10% of the total combined voting power of
all classes of our stock entitled to vote;
|
|
|
|
is a controlled foreign corporation that is related,
directly or indirectly, to us through stock ownership; or
|
|
|
|
is engaged in the conduct of a trade or business in the United
States, if such interest payments are effectively connected with
such trade or business, and, generally, if an income tax treaty
applies, such interest payments also are attributable to a
U.S. permanent establishment maintained by the
non-U.S. holder
(see the discussion under
Non-U.S. Holders
Income or Gains Effectively Connected with a U.S. Trade or
Business below).
|
In general, a foreign corporation is a controlled foreign
corporation if more than 50% of its stock is owned, actually or
constructively, by one or more U.S. persons that each owns,
actually or constructively, at least 10% of the
corporations voting stock.
The portfolio interest exemption, reduction of the withholding
rate pursuant to the terms of applicable income tax treaty and
several of the special rules for
non-U.S. holders
described below apply only if the holder certifies its
nonresident status. A
non-U.S. holder
can meet this certification requirement by providing a properly
executed IRS
Form W-8BEN
or appropriate substitute form to us or our paying agent prior
to the payment. If the
non-U.S. holder
holds the note through a financial institution or other agent
acting on the holders behalf, the holder will be required
to provide appropriate documentation to the agent. The
non-U.S. holders
agent will then be required to provide certification to us or
our paying agent, either directly or through other
intermediaries.
Sale,
Exchange, Redemption, Conversion or Other Disposition of Notes
or Common Stock
Non-U.S. holders
generally will not be subject to U.S. federal income or
withholding tax on any gain realized on the sale, exchange,
redemption, conversion or other disposition of notes or common
stock (other
79
than with respect to payments attributable to accrued interest,
which will be taxed as described under
Non-U.S. Holders
Taxation of Interest above), unless:
|
|
|
|
|
the gain is effectively connected with the conduct by the
non-U.S. holder
of a U.S. trade or business (and, generally, if an income
tax treaty applies, the gain is attributable to a
U.S. permanent establishment maintained by the
non-U.S. holder),
in which case the gain would be subject to tax as described
below under
Non-U.S. holders
Income or Gains Effectively Connected with a U.S. Trade or
Business;
|
|
|
|
the
non-U.S. holder
is an individual who is present in the United States for
183 days or more in the year of disposition and certain
other conditions apply, in which case, except as otherwise
provided by an applicable income tax treaty, the gain, which may
be offset by U.S. source capital losses, would be subject
to a flat 30% tax, even though the individual is not considered
a resident of the United States; or
|
|
|
|
the rules of the Foreign Investment in Real Property Tax Act (or
FIRPTA) (described below) treat the gain as
effectively connected with a U.S. trade or business.
|
The FIRPTA rules may apply to a sale, exchange, redemption or
other disposition of notes or common stock by a
non-U.S. holder
if we currently are, or were at any time within five years
before the sale, exchange, redemption, conversion or other
disposition (or, if shorter, the
non-U.S. holders
holding period for the notes or common stock disposed of), a
U.S. real property holding corporation (or
USRPHC). In general, we would be a USRPHC if
interests in U.S. real estate comprised at least 50% of our
assets. We believe that we currently are not, and will not
become in the future, a USRPHC.
Dividends
Dividends paid to a
non-U.S. holder
on common stock received on conversion of a note, including any
taxable constructive stock dividends resulting from certain
adjustments (or failures to make adjustments) to the number of
shares of common stock to be issued on conversion (as described
under U.S. Holders
Constructive Distributions above) generally will be
subject to U.S. withholding tax at a 30% rate. Withholding
tax applicable to any taxable constructive stock dividends
received by a
non-U.S. holder
may be withheld from interest on the notes, distributions on the
common stock, shares of common stock or proceeds subsequently
paid or credited to the
non-U.S. holder.
The withholding tax on dividends (including any taxable
constructive stock dividends), however, may be reduced under the
terms of an applicable income tax treaty between the United
States and the
non-U.S. holders
country of residence. A
non-U.S. holder
should demonstrate its eligibility for a reduced rate of
withholding under an applicable income tax treaty by timely
delivering a properly executed IRS
Form W-8BEN
or appropriate substitute form. A
non-U.S. holder
that is eligible for a reduced rate of withholding under the
terms of an applicable income tax treaty may obtain a refund of
any excess amounts withheld by timely filing an appropriate
claim for refund with the IRS. Dividends on the common stock
that are effectively connected with a
non-U.S. holders
conduct of a U.S. trade or business are discussed below
under
Non-U.S. Holders
Income or Gains Effectively Connected with a U.S. Trade or
Business.
Income
or Gains Effectively Connected With a U.S. Trade or
Business
The preceding discussion of the U.S. federal income and
withholding tax considerations of the purchase, ownership or
disposition of notes or common stock by a
non-U.S. holder
assumes that the holder is not engaged in a U.S. trade or
business. If any interest on the notes, dividends on common
stock, or gain from the sale, exchange, redemption, conversion
or other disposition of the notes or common stock is effectively
connected with a U.S. trade or business conducted by the
non-U.S. holder,
then the income or gain will be subject to U.S. federal
income tax on a net income basis at the regular graduated rates
and in the same manner applicable to U.S. holders. If the
non-U.S. holder
is eligible for the benefits of a tax treaty between the United
States and the holders country of residence, any
effectively connected income or gain generally will
be subject to U.S. federal income tax only if it is also
attributable to a permanent establishment or fixed base
maintained by the holder in the United States. Payments of
interest or dividends that are effectively connected
80
with a U.S. trade or business (and, if a tax treaty
applies, attributable to a permanent establishment or fixed
base), and therefore included in the gross income of a
non-U.S. holder,
will not be subject to 30% withholding, provided that the holder
claims exemption from withholding by timely filing a properly
executed IRS
Form W-8ECI
or appropriate substitute form. If the
non-U.S. holder
is a corporation (or an entity treated as a corporation for
U.S. federal income tax purposes), that portion of its
earnings and profits that is effectively connected with its
U.S. trade or business generally also would be subject to a
branch profits tax. The branch profits tax rate is
generally 30%, although an applicable income tax treaty might
provide for a lower rate.
Backup
Withholding and Information Reporting
The Code and the Treasury regulations require those who make
specified payments to report the payments to the IRS. Among the
specified payments are interest, dividends, and proceeds paid by
brokers to their customers. This reporting regime is reinforced
by backup withholding rules, which require the payor
to withhold from payments subject to information reporting if
the recipient has failed to provide a taxpayer identification
number to the payor, furnished an incorrect identification
number, or repeatedly failed to report interest or dividends on
tax returns. The backup withholding rate is currently 28%.
Payments of interest or dividends to U.S. holders of notes
or common stock generally will be subject to information
reporting, and will be subject to backup withholding, unless the
holder (1) is an exempt payee, such as a corporation, or
(2) provides the payor with a correct taxpayer
identification number and complies with applicable certification
requirements. Payments made to U.S. holders by a broker
upon a sale of notes or common stock will generally be subject
to information reporting and backup withholding. If the sale is
made through a foreign office of a foreign broker, however, the
sale will generally not be subject to either information
reporting or backup withholding. This exception may not apply if
the foreign broker is owned or controlled by U.S. persons,
or is engaged in a U.S. trade or business.
We must report annually to the IRS the interest
and/or
dividends paid to each
non-U.S. holder
and the tax withheld, if any, with respect to such interest
and/or
dividends, including any tax withheld pursuant to the rules
described under
Non-U.S. Holders
Taxation of Interest and
Non-U.S. Holders
Dividends above. Copies of these reports may be made
available to tax authorities in the country where the
non-U.S. holder
resides. Payments to
non-U.S. holders
of dividends on our common stock or interest on the notes may be
subject to backup withholding unless the
non-U.S. holder
certifies its
non-U.S. status
on a properly executed IRS
Form W-8BEN
or appropriate substitute form. Payments made to
non-U.S. holders
by a broker upon a sale of the notes or our common stock will
not be subject to information reporting or backup withholding as
long as the
non-U.S. holder
certifies its
non-U.S. status
or otherwise establishes an exemption.
Any amounts withheld from a payment to a U.S. holder or
non-U.S. holder
of notes or common stock under the backup withholding rules
generally can be credited against any U.S. federal income
tax liability of the holder, provided the required information
is timely furnished to the IRS.
81
UNDERWRITING
Under the terms and subject to the conditions contained in an
underwriting agreement dated June , 2009, we
have agreed to sell to Credit Suisse Securities (USA) LLC and
J.P. Morgan Securities Inc., who are referred to in this
prospectus as underwriters and who are acting as
joint book-running managers, the following respective principal
amounts of the notes:
|
|
|
|
|
|
|
Principal
|
|
Underwriter
|
|
Amount of Notes
|
|
|
Credit Suisse Securities (USA) LLC
|
|
$
|
|
|
J.P. Morgan Securities Inc.
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
150,000,000
|
|
|
|
|
|
|
The underwriting agreement provides that the underwriters are
obligated to purchase all of the notes if any are purchased,
other than those covered by the over-allotment option described
below. The obligations of the underwriters to purchase the notes
depend on the satisfaction of certain conditions contained in
the underwriting agreement. The underwriting agreement also
provides that if an underwriter defaults, the purchase
commitments of non-defaulting underwriters may be increased or
the offering of notes may be terminated.
We have granted to the underwriters a
12-day
option to purchase on a pro rata basis up to an additional
$22,500,000 principal amount of notes at the initial public
offering price less the underwriting discounts and commissions.
The option may be exercised only to cover any over-allotments in
the sale of the notes.
The underwriters propose to offer the notes initially at the
public offering price on the cover page of this prospectus.
After the initial public offering, the underwriters may change
the public offering price.
The following table summarizes the compensation and estimated
expenses that we will pay.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Per Note
|
|
Total
|
|
|
Without
|
|
With
|
|
Without
|
|
With
|
|
|
Over-Allotment
|
|
Over-Allotment
|
|
Over-Allotment
|
|
Over-Allotment
|
|
Underwriting discounts and commissions paid by us
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
Expenses payable by us
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
The notes are a new issue of securities with no established
trading market. One or more of the underwriters intends to make
a secondary market for the notes; however, they are not
obligated to do so and may discontinue making a secondary market
for the notes at any time without notice. No assurance can be
given as to how liquid the trading market for the notes will be.
We have agreed that we will not offer, sell, contract to sell,
pledge or otherwise dispose of, directly or indirectly, or file
with the SEC a registration statement under the Securities Act
relating to, any U.S. dollar-denominated debt securities
issued or guaranteed by the Company and having a maturity of
more than one year from the date of issue, or any shares of
common stock or securities convertible into or exchangeable or
exercisable for any shares of our common stock, including notes
or warrants or other rights to purchase shares of common stock,
or publicly disclose our intention to make any offer, sale,
pledge, disposition or filing, without the prior written consent
of the underwriters for a period of 60 days after the date
of this prospectus; provided that such restriction shall not
apply to: (i) the notes; (ii) shares of our common
stock issued upon conversion of the notes or upon the exercise
or conversion of options, warrants or convertible securities, in
each case outstanding on the date of the underwriting agreement;
(iii) employee stock options granted and shares of common
stock issued under plans existing on the date of the
underwriting agreement; (iv) the filing of any registration
statement on
Form S-8
to register shares of common stock reserved for issuance under
our equity compensation plans; (v) the issuance of shares
of common stock which we may issue or agree to issue in
connection with the acquisition of one or more businesses,
products or technologies (whether by means of merger, stock
purchase or asset purchase); provided that we will not
issue or agree to issue any shares of
82
common stock in connection with such an acquisition during the
30 days after the date of the underwriting agreement;
provided, further, that the aggregate number of shares of
common stock that we may issue or agree to issue in connection
with such an acquisition during the period from the 31st to the
60th day after the date of this prospectus may not exceed
1,000,000 shares or (vi) any existing obligations as
may be required by the Amended and Restated Information and
Registration Rights Agreement, dated January 7, 1997,
between us and the parties indicated therein or the Registration
Rights Agreement dated February 1, 2005, among us, Credit
Suisse First Boston LLC and Deutsche Bank Securities Inc.
Our executive officers and directors have agreed that they will
not offer, sell, contract to sell, pledge or otherwise dispose
of, directly or indirectly, any shares of our common stock or
securities convertible into or exchangeable or exercisable for
any shares of our common stock, enter into a transaction which
would have the same effect, or enter into any swap, hedge or
other arrangement that transfers, in whole or in part, any of
the economic consequences of ownership of our common stock,
whether any of these transactions are to be settled by delivery
of our common stock or such other securities, in cash or
otherwise, or publicly disclose the intention to make any offer,
sale, pledge, or disposition, or to enter into any transaction,
swap, hedge or other arrangement, or make any demand for or
exercise any right with respect to, the registration of any of
our common stock or any security convertible into or exercisable
or exchangeable for our common stock, without, in each case, the
prior written consent of the representatives. Any of our common
stock received by any of our executive officers and directors
upon exercise of options or vesting of restricted stock units
granted to such executive officer or director also will be
subject to the foregoing agreement; provided that,
notwithstanding the foregoing, from the 31st day through
the 60th day following the date of this prospectus, each
executive officer and director, individually, may
(1) together with all other executive officers and
directors subject to such an agreement, offer, sell or otherwise
dispose of up to an aggregate of 50,000 shares of our
common stock issued upon the exercise of options that will
expire prior to December 31, 2009, (2) together with
all other executive officers and directors subject to such an
agreement, offer, sell or otherwise dispose of up to an
aggregate of 125,000 shares of our common stock that is
issued upon the vesting of restricted stock units during the
60-day
period following the date of this prospectus and (3) offer,
sell or otherwise dispose of shares of our common stock to us
upon a vesting event to pay required withholding taxes. Offers,
sales or other dispositions of our common stock pursuant to a
written plan (a plan) for trading securities in
effect on the date hereof will not be subject to the foregoing
agreement if such plan was established pursuant to and in
accordance with
Rule 10b5-1(c)
under the Exchange Act and is not amended or modified during the
60-day
period following the date of this prospectus. A transfer of our
common stock as a bona fide gift or to a family member or
trust may be made, provided the donee or transferee, as
applicable, agrees to be bound in writing by the terms of the
foregoing agreement prior to such transfer and no filing by any
party (donor, donee, transferor or transferee) under the
Exchange Act shall be required or shall be voluntarily made in
connection with such transfer (other than a filing on a
Form 5 made after the 60th day following the date of
this prospectus). A transfer of our common stock by will or
intestate succession to the immediate family of one of the
companys executive officers or directors shall not be
subject to the foregoing agreement.
We have agreed to indemnify the several underwriters against
liabilities under the Securities Act, or contribute to payments
which the underwriters may be required to make in that respect.
The underwriters and their affiliates have from time to time
performed and may in the future perform various financial
advisory, commercial banking and investment banking services for
us in the ordinary course of business, for which they received
or will receive customary fees.
In connection with the offering, the underwriters may engage in
stabilizing transactions, over-allotment transactions, syndicate
covering transactions and passive market making in accordance
with Regulation M under the Exchange Act, including:
|
|
|
|
|
Stabilizing transactions permit bids to purchase the underlying
security so long as the stabilizing bids do not exceed a
specified maximum.
|
|
|
|
Over-allotment transactions involve sales by the underwriters of
the notes in excess of the principal amount of the notes the
underwriters are obligated to purchase, which creates a
syndicate short position. The short position may be either a
covered short position or a naked short position. In a covered
short position, the principal amount of the notes over-allotted
by the underwriters is not greater than the
|
83
|
|
|
|
|
principal amount of the notes, that they may purchase in the
over-allotment option. In a naked short position, the principal
amount of the notes involved is greater than the principal
amount of the notes in the over-allotment option. The
underwriters may close out any short position by either
exercising their over-allotment option
and/or
purchasing the notes shares in the open market.
|
|
|
|
|
|
Syndicate covering transactions involve purchases of the notes
in the open market after the distribution has been completed in
order to cover syndicate short positions. In determining the
source of the notes to close out the short position, the
underwriters will consider, among other things, the price of the
notes available for purchase in the open market as compared to
the price at which they may purchase the notes through the
over-allotment option. If the underwriters sell more notes than
could be covered by the over-allotment option, a naked short
position, that position can only be closed out by buying the
notes in the open market. A naked short position is more likely
to be created if the underwriters are concerned that there may
be downward pressure on the price of the notes in the open
market after pricing that could adversely affect investors who
purchase in the offering.
|
|
|
|
Penalty bids permit the underwriters to reclaim a selling
concession from a syndicate member when the notes originally
sold by the syndicate member are purchased in a stabilizing
transaction or a syndicate covering transaction to cover
syndicate short positions.
|
|
|
|
In passive market making, market makers in the notes who are
underwriters or prospective underwriters may, subject to
limitations, make bids for or purchases of the notes until the
time, if any, at which a stabilizing bid is made.
|
These stabilizing transactions, syndicate covering transactions
and penalty bids may have the effect of raising or maintaining
the market price of the notes or preventing or retarding a
decline in the market price of the notes. As a result the price
of the notes may be higher than the price that might otherwise
exist in the open market. These transactions, if commenced, may
be discontinued at any time.
A prospectus in electronic format may be made available on the
web sites maintained by one or more of the underwriters
participating in this offering and one or more of the
underwriters participating in this offering may distribute
prospectuses electronically. The underwriters may agree to
allocate securities to underwriters for sale to their online
brokerage account holders. Internet distributions will be
allocated by the underwriters that will make internet
distributions on the same basis as other allocations.
84
SELLING
RESTRICTIONS
European
Economic Area
In relation to each Member State of the European Economic Area
which has implemented the Prospectus Directive (each, a
Relevant Member State), each Underwriter represents
and agrees that with effect from and including the date on which
the Prospectus Directive is implemented in that Relevant Member
State (the Relevant Implementation Date) it has not
made and will not make an offer of the notes which are the
subject of the offering contemplated by this prospectus to the
public in that Relevant Member State other than:
(a) to legal entities which are authorized or regulated to
operate in the financial markets or, if not so authorized or
regulated, whose corporate purpose is solely to invest in
securities;
(b) to any legal entity which has two or more of
(1) an average of at least 250 employees during the
last financial year; (2) a total balance sheet of more than
43,000,000 and (3) an annual net turnover of more
than 50,000,000, as shown in its last annual or
consolidated accounts;
(c) to fewer than 100 natural or legal persons (other than
qualified investors as defined in the Prospectus Directive)
subject to obtaining the prior consent of the manager for any
such offer; or
(d) in any other circumstances which do not require the
publication by the Issuer of a prospectus pursuant to
Article 3 of the Prospectus Directive.
For the purposes of this provision, the expression an
offer of notes to the public in relation to any
notes in any Relevant Member State means the communication in
any form and by any means of sufficient information on the terms
of the offer and the notes to be offered so as to enable an
investor to decide to purchase or subscribe the notes, as the
same may be varied in that Member State by any measure
implementing the Prospectus Directive in that Member State and
the expression Prospectus Directive means Directive
2003/71/EC and includes any relevant implementing measure in
each Relevant Member State.
Notice to
Investors in the United Kingdom
Each of the underwriters severally represents, warrants and
agrees as follows:
(a) it has only communicated or caused to be communicated
and will only communicate or cause to be communicated an
invitation or inducement to engage in investment activity
(within the meaning of section 21 of FSMA) to persons who
have professional experience in matters relating to investments
falling with Article 19(5) of the Financial Services and
Markets Act 2000 (Financial Promotion) Order 2005 or in
circumstances in which section 21 of FSMA does not apply to
the company; and
(b) it has complied with, and will comply with all
applicable provisions of FSMA with respect to anything done by
it in relation to the notes in, from or otherwise involving the
United Kingdom.
85
NOTICE TO
CANADIAN RESIDENTS
Resale
Restrictions
The distribution of notes in Canada is being made only on a
private placement basis exempt from the requirement that we
prepare and file a prospectus with the securities regulatory
authorities in each province where trades of the notes are made.
Any resale of the notes in Canada must be made under applicable
securities laws which will vary depending on the relevant
jurisdiction, and which may require resales to be made under
available statutory exemptions or under a discretionary
exemption granted by the applicable Canadian securities
regulatory authority. Purchasers are advised to seek legal
advice prior to any resale of the notes.
Representations
of Purchasers
By purchasing notes in Canada and accepting a purchase
confirmation, a purchaser is representing to us and the dealer
from whom the purchase confirmation is received that:
|
|
|
|
|
the purchaser is entitled under applicable provincial securities
laws to purchase the notes without the benefit of a prospectus
qualified under those securities laws,
|
|
|
|
where required by law, that the purchaser is purchasing as
principal and not as agent,
|
|
|
|
the purchaser has reviewed the text above under Resale
Restrictions, and
|
|
|
|
the purchaser acknowledges and consents to the provision of
specified information concerning its purchase of the notes to
the regulatory authority that by law is entitled to collect the
information.
|
Further details concerning the legal authority for this
information is available on request.
Rights of
Action Ontario Purchasers Only
Under Ontario securities legislation, certain purchasers who
purchase a security offered by this prospectus during the period
of distribution will have a statutory right of action for
damages, or while still the owner of the notes, for rescission
against us in the event that this prospectus supplement contains
a misrepresentation without regard to whether the purchaser
relied on the misrepresentation. The right of action for damages
is exercisable not later than the earlier of 180 days from
the date the purchaser first had knowledge of the facts giving
rise to the cause of action and three years from the date on
which payment is made for the notes. The right of action for
rescission is exercisable not later than 180 days from the
date on which payment is made for the notes. If a purchaser
elects to exercise the right of action for rescission, the
purchaser will have no right of action for damages against us.
In no case will the amount recoverable in any action exceed the
price at which the notes were offered to the purchaser and if
the purchaser is shown to have purchased the securities with
knowledge of the misrepresentation, we will have no liability.
In the case of an action for damages, we will not be liable for
all or any portion of the damages that are proven to not
represent the depreciation in value of the notes as a result of
the misrepresentation relied upon. These rights are in addition
to, and without derogation from, any other rights or remedies
available at law to an Ontario purchaser. The foregoing is a
summary of the rights available to an Ontario purchaser. Ontario
purchasers should refer to the complete text of the relevant
statutory provisions.
Enforcement
of Legal Rights
All of our directors and officers as well as the experts named
herein may be located outside of Canada and, as a result, it may
not be possible for Canadian purchasers to effect service of
process within Canada upon us or those persons. All or a
substantial portion of our assets and the assets of those
persons may be located outside of Canada and, as a result, it
may not be possible to satisfy a judgment against us or those
persons in Canada or to enforce a judgment obtained in Canadian
courts against us or those persons outside of Canada.
Taxation
and Eligibility for Investment
Canadian purchasers of notes should consult their own legal and
tax advisors with respect to the tax consequences of an
investment in the notes in their particular circumstances and
about the eligibility of the notes for investment by the
purchaser under relevant Canadian legislation.
86
LEGAL
MATTERS
The validity of the issuance of the notes offered hereby will be
passed upon for us by the law firm of Wilson Sonsini
Goodrich & Rosati, Professional Corporation, Palo
Alto, California. The underwriters are represented by Davis
Polk & Wardwell LLP, Menlo Park, California.
EXPERTS
The financial statements incorporated in this prospectus by
reference to Rambus Inc.s Current Report on Form
8-K dated
June 22, 2009 and managements assessment of the
effectiveness of internal control over financial reporting
(which is included in Managements Report on Internal
Control over Financial Reporting) incorporated in this
prospectus by reference to the Annual Report on Form
10-K of
Rambus Inc. for the year ended December 31, 2008 have been
so incorporated in reliance on the report of
PricewaterhouseCoopers LLP, an independent registered public
accounting firm, given on the authority of said firm as experts
in auditing and accounting.
INCORPORATION
OF CERTAIN INFORMATION BY REFERENCE
The SEC allows us to incorporate by reference the
information we file with them, which means that we can disclose
important information to you by referring you to those
documents. The information incorporated by reference is
considered to be part of this prospectus, and information that
we file later with the SEC will automatically update and
supersede information included or previously incorporated by
reference in this prospectus from the date we file the document
containing such information. Except to the extent furnished and
not filed with the SEC pursuant to Item 2.02 or
Item 7.01 of
Form 8-K
or as otherwise permitted by the SEC rules, we incorporate by
reference the documents listed below and any future filings we
will make with the SEC under Sections 13(a), 13(c), 14 or
15(d) of the Exchange Act, from the date of this prospectus
until the completion of the offering to which this prospectus
relates or the termination of this offering.
The documents we incorporate by reference into this prospectus
are:
|
|
|
|
|
our Annual Report on
Form 10-K
for the year ended December 31, 2008, including portions of
our Proxy Statement for our 2008 Annual Meeting of Stockholders
held on April 30, 2009 to the extent specifically
incorporated by reference into such Form
10-K;
|
|
|
|
our Quarterly Report on
Form 10-Q
for the three months ended March 31, 2009;
|
|
|
|
our Current Reports on
Form 8-K,
filed with the SEC on January 9, February 4,
February 23, February 24, March 10,
March 11, April 28, May 4, May 14,
May 27, June 12 (two reports) and June 22,
2009; and
|
|
|
|
the description of our common stock, $0.001 par value per
share, contained in the Registration Statement on
Form 8-A
(file
no. 000-22339)
declared effective by the SEC on April 2, 1997, including
any amendments or reports filed for the purpose of updating that
description.
|
Any statements made in this prospectus or in a document
incorporated or deemed to be incorporated by reference into this
prospectus will be deemed to be modified or superseded for
purposes of this prospectus to the extent that a statement
contained in this prospectus or in any other subsequently filed
document that is also incorporated or deemed to be incorporated
by reference into this prospectus modifies or supersedes the
statement. Any statement so modified or superseded will not be
deemed, except as so modified or superseded, to constitute a
part of this prospectus.
87
You may request a copy of these filings (excluding exhibits,
unless specifically incorporated by reference), at no cost, by
writing or calling us at the following address or telephone
number:
Investor Relations
Rambus Inc.
4440 El Camino Real
Los Altos, California 94022
(650) 947-5000
WHERE YOU
CAN FIND MORE INFORMATION
We are subject to the informational requirements of the Exchange
Act. We therefore file periodic reports, current reports, proxy
statements and other information with the SEC. The public may
read and copy any materials filed with the SEC at the SECs
Public Reference Room at 100 F Street, N.E.,
Washington, D.C. 20549. Information on the operations
of the Public Reference Room may be obtained by calling the SEC
at
1-800-SEC-0330.
In addition, the SEC maintains an internet site
(http://www.sec.gov)
that contains reports, proxy and information statements and
other information regarding issuers that file electronically.
Our Internet address is www.rambus.com. We make available, free
of charge, through our website copies of our recent filings with
the SEC pursuant to Section 13(a) or 15(d) of the Exchange
Act, as soon as reasonably practicable after filing such
material electronically or otherwise furnishing it to the SEC.
Information contained on our website is not incorporated by
reference to this prospectus.
Our common stock is listed on the NASDAQ Global Select Market
under the symbol RMBS and you may inspect reports
and other information concerning us at the offices of the NASDAQ
Global Select Market, One Liberty Plaza, 165 Broadway, New York,
New York 10006.
We have filed a registration statement on
Form S-3
regarding this offering with the SEC under the Securities Act of
1933. This prospectus, which constitutes a part of the
registration statement, does not contain all the information
contained in the registration statement, certain items of which
are contained in exhibits to the registration statement as
permitted by the rules and regulations of the SEC. You should
refer to the registration statement and its exhibits to read
that information. Statements made in this prospectus as to the
content of any contract, agreement or other document are not
necessarily complete and you should refer to the contracts,
agreements and other documents attached exhibits to the
registration statement for a more complete description of the
agreements, contracts and other documents.
88
PART II.
INFORMATION NOT REQUIRED IN THE PROSPECTUS
|
|
Item 14.
|
Other
Expenses of Issuance and Distribution
|
The following table sets forth the costs and expenses payable by
the registrant in connection with the offerings described in
this registration statement, other than underwriting discounts
and commissions. In addition to the costs and expenses set forth
below, the registrant will pay any selling commissions and
brokerage fees and any applicable taxes, fees and disbursements
with respect to securities registered hereby sold by the
registrant. The registrant is deferring payment of the
registration fee in reliance on Rule 456(b) and
Rule 457(r) under the Securities Act of 1933. All of the
amounts shown, other than the registration fee, are estimates.
|
|
|
|
|
Securities and Exchange Commission registration and other
listing fees
|
|
$
|
|
*
|
Trustees and transfer agents fees and expenses
|
|
|
100,000
|
|
Legal fees and expenses (including Blue Sky fees)
|
|
|
250,000
|
|
Accounting fees and expenses
|
|
|
150,000
|
|
Printing and engraving expenses
|
|
|
50,000
|
|
Miscellaneous expenses
|
|
|
50,000
|
|
|
|
|
|
|
Total
|
|
$
|
|
*
|
|
|
|
|
|
|
|
|
* |
|
Omitted because the registration fee is being deferred in
accordance with Rule 456(b). |
|
|
Item 15.
|
Indemnification
of Directors and Officers
|
Our certificate of incorporation and bylaws provide for the
indemnification of present and former directors, officers,
employees and agents of ours and persons serving as directors,
employees or agents of another corporation or entity at our
request to the fullest extent permitted by the Delaware General
Corporation Law. In addition, we enter into indemnification
agreements with each of our directors and executive officers
pursuant to which such persons are indemnified for costs and
expenses actually and reasonably incurred by such persons in
connection with a threatened, pending or completed claim arising
out of service as a director, officer, employee, trustee
and/or agent
of ours or another entity at our request. We maintain an
insurance policy insuring our directors and officers against
liability for certain acts and omissions while acting in their
official capacities.
II-1
|
|
|
|
|
Exhibit
|
|
|
Number
|
|
Description of Exhibit
|
|
|
1
|
.1
|
|
Form of Underwriting Agreement.
|
|
3
|
.1
|
|
Amended and Restated Certificate of Incorporation of Registrant
(incorporated herein by reference to Exhibit 3.1 to the
Companys Annual Report on Form 10-K filed on December 15,
1997).
|
|
3
|
.2
|
|
Certificate of Amendment of Amended and Restated Certificate of
Incorporation of Registrant (incorporated herein by reference to
Exhibit 3.1 to the Companys Quarterly Report on Form 10-Q
filed on May 4, 2001).
|
|
3
|
.3
|
|
Amended and Restated Bylaws of Registrant (incorporated herein
by reference to Exhibit 3.3 to the Companys Quarterly
Report on Form 10-Q filed on August 4, 2008).
|
|
4
|
.1
|
|
Form of Convertible Senior Note Indenture.
|
|
4
|
.2
|
|
Form of Convertible Senior Debt Security (included in Exhibit
4.1).
|
|
4
|
.3
|
|
Amended and Restated Information and Registration Rights
Agreement, dated as of January 7, 1997, between Registrant and
the parties indicated therein (incorporated herein by reference
to Exhibit 4.2 to the Companys Registration Statement on
Form S-1 (file no. 333-22885) filed on March 6, 1997).
|
|
4
|
.4.1
|
|
Amended and Restated Preferred Stock Rights Agreement, dated as
of July 31, 2000, between Registrant and Fleet National Bank
(incorporated herein by reference to Exhibit 4.3.1 to the
Companys Registration Statement on Form 8-A12G/A filed on
August 3, 2000).
|
|
4
|
.4.2
|
|
First Amendment to the Amended and Restated Preferred Stock
Rights Agreement, dated as of April 23, 2003, between
Registrant and Equiserve Trust Company, N.A., as successor to
Fleet National Bank (incorporated herein by reference to Exhibit
4.3.2 to the Companys Registration Statement on Form
8-A12G/A filed on August 5, 2003).
|
|
5
|
.1
|
|
Opinion of Wilson Sonsini Goodrich & Rosati, Professional
Corporation.
|
|
12
|
.1
|
|
Computation of ratio of earnings to fixed charges.
|
|
23
|
.1
|
|
Consent of PricewaterhouseCoopers LLP.
|
|
23
|
.2
|
|
Consent of Wilson Sonsini Goodrich & Rosati, Professional
Corporation (included in the opinion filed as Exhibit 5.1 to
this registration statement).
|
|
24
|
.1
|
|
Power of Attorney (see page II-6 of this registration
statement).
|
|
25
|
.1
|
|
Form T-1 Statement of Eligibility of Trustee for Convertible
Senior Note Indenture under the Trust Indenture Act of 1939.
|
(a) The undersigned registrant hereby undertakes:
(1) To file, during any period in which offers or sales are
being made, a post-effective amendment to this registration
statement:
(i) To include any prospectus required by
Section 10(a)(3) of the Securities Act of 1933;
(ii) To reflect in the prospectus any facts or events
arising after the effective date of the registration statement
(or the most recent post-effective amendment thereof) which,
individually or in the aggregate, represent a fundamental change
in the information set forth in the registration statement.
Notwithstanding the foregoing, any increase or decrease in
volume of securities offered (if the total dollar value of
securities offered would not exceed that which was registered)
and any deviation from the low or high end of the estimated
maximum offering range may be reflected in the form of
prospectus filed with the Commission pursuant to
Rule 424(b) if, in the aggregate, the changes in volume and
price represent no more than a 20% change in the maximum
aggregate offering price set forth in the Calculation of
Registration Fee table in the effective registration
statement; and
II-2
(iii) To include any material information with respect to
the plan of distribution not previously disclosed in the
registration statement or any material change to such
information in the registration statement;
provided, however, that paragraphs (a)(1)(i),
(a)(1)(ii) and (a)(1)(iii) of this section do not apply if the
registration statement is on
Form S-3
or
Form F-3
and the information required to be included in a post-effective
amendment by those paragraphs is contained in reports filed with
or furnished to the Commission by the registrant pursuant to
Section 13 or Section 15(d) of the Securities Exchange
Act of 1934 that are incorporated by reference in the
registration statement, or is contained in a form of prospectus
filed pursuant to Rule 424(b) that is part of the
registration statement.
(2) That, for the purpose of determining any liability
under the Securities Act of 1933, each such post-effective
amendment shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of
such securities at that time shall be deemed to be the initial
bona fide offering thereof.
(3) To remove from registration by means of a
post-effective amendment any of the securities being registered
which remain unsold at the termination of the offering.
(4) That, for the purpose of determining liability under
the Securities Act of 1933 to any purchaser:
(i) Each prospectus filed by the registrant pursuant to
Rule 424(b)(3) shall be deemed to be part of the
registration statement as of the date the filed prospectus was
deemed part of and included in the registration
statement; and
(ii) Each prospectus required to be filed pursuant to
Rule 424(b)(2), (b)(5) or (b)(7) as part of a registration
statement in reliance on Rule 430B relating to an offering
made pursuant to Rule 415(a)(1)(i), (vii) or
(x) for the purpose of providing the information required
by Section 10(a) of the Securities Act of 1933 shall be
deemed to be part of and included in the registration statement
as of the earlier of the date such form of prospectus is first
used after effectiveness or the date of the first contract of
sale of securities in the offering described in the prospectus.
As provided in Rule 430B, for liability purposes of the
issuer and any person that is at that date an underwriter, such
date shall be deemed to be a new effective date of the
registration statement relating to the securities in the
registration statement to which that prospectus relates, and the
offering of such securities at that time shall be deemed to be
the initial bona fide offering thereof. Provided,
however, that no statement made in a registration statement
or prospectus that is part of the registration statement or made
in a document incorporated or deemed incorporated by reference
into the registration statement or prospectus that is part of
the registration statement will, as to a purchaser with a time
of contract of sale prior to such effective date, supersede or
modify any statement that was made in the registration statement
or prospectus that was part of the registration statement or
made in any such document immediately prior to the effective
date.
(5) That, for the purpose of determining liability of the
registrant under the Securities Act of 1933 to any purchaser in
the initial distribution of the securities, the undersigned
registrant undertakes that in a primary offering of securities
of the undersigned registrant pursuant to this registration
statement, regardless of the underwriting method used to sell
the securities to the purchaser, if the securities are offered
or sold to such purchaser by means of any of the following
communications, the undersigned registrant will be a seller to
the purchaser and will be considered to offer and sell such
securities to such purchaser:
(i) Any preliminary prospectus or prospectus of the
undersigned registrant relating to the offering required to be
filed pursuant to Rule 424;
(ii) Any free writing prospectus relating to the offering
prepared by or on behalf of the undersigned registrant or used
or referred to be the undersigned registrant;
II-3
(iii) The portion of any other free writing prospectus
relating to the offering containing material information about
the undersigned registrant or its securities provided by or on
behalf of the undersigned registrant; and
(iv) Any other communication that is an offer in the
offering made by the undersigned registrant to the purchaser.
(b) The undersigned registrant hereby undertakes that, for
purposes of determining any liability under the Securities Act
of 1933, each filing of the registrants annual report
pursuant to Section 13(a) or Section 15(d) of the
Securities Exchange Act of 1934 (and, where applicable, each
filing of an employee benefit plans annual report pursuant
to Section 15(d) of the Securities Exchange Act of
1934) that is incorporated by reference in the registration
statement shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of
such securities at that time shall be deemed to be the initial
bona fide offering thereof.
(c) Insofar as indemnification for liabilities arising
under the Securities Act of 1933 may be permitted to
directors, officers and controlling persons of the registrant
pursuant to the foregoing provisions, or otherwise, the
registrant has been advised that in the opinion of the
Securities and Exchange Commission such indemnification is
against public policy as expressed in the Securities Act of 1933
and is, therefore, unenforceable. If a claim for indemnification
against such liabilities, (other than the payment by the
registrant of expenses incurred or paid by a director, officer
or controlling person of the registrant in the successful
defense of any action, suit or proceeding), is asserted by such
director, officer or controlling person in connection with the
securities being registered, the registrant will, unless in the
opinion of its counsel the matter has been settled by
controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is
against public policy as expressed in the Securities Act of 1933
and will be governed by the final adjudication of such issue.
(d) File an application for the purpose of determining the
eligibility of the trustee to act under subsection (a) of
Section 310 of the Trust Indenture Act (the
Act) in accordance with the rules and regulations
prescribed by the SEC under Section 305(b)(2) of the Act.
II-4
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant certifies that it has reasonable grounds to believe
that it meets all of the requirements for filing on
Form S-3
and has duly caused this registration statement to be signed on
its behalf by the undersigned, thereunto duly authorized, in the
City of Los Altos, State of California, on the 22nd day of June,
2009.
RAMBUS INC.
Satish Rishi
Senior Vice President, Finance and
Chief Financial Officer
II-5
POWER OF
ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that each person whose signature
appears below hereby constitutes and appoints Satish Rishi as
his true and lawful agent, proxy and attorney-in-fact, with full
power of substitution and resubstitution, for him and in his
name, place and stead, in any and all capacities, to sign any
and all amendments to the registration statement, including
post-effective amendments, and registration statements filed
pursuant to Rule 462 under the Securities Act of 1933, and
to file the same, with all exhibits thereto, and other documents
in connection therewith, with the Securities and Exchange
Commission, and does hereby grant unto said attorney-in-fact and
agent full power and authority to do and perform each and every
act and thing requisite and necessary to be done in and about
the foregoing, as fully to all intents and purposes as he might
or could do in person, hereby ratifying and confirming all that
said attorney-in-fact and agent his substitute, may lawfully do
or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this
registration statement has been duly signed by the following
persons in the capacities and on the dates indicated.
|
|
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
/s/ Harold
Hughes
Harold
Hughes
|
|
Chief Executive Officer, President and Director
(Principal Executive Officer)
|
|
June 22, 2009
|
|
|
|
|
|
/s/ Satish
Rishi
Satish
Rishi
|
|
Senior Vice President, Finance and Chief Financial Officer
(Principal Financial and Accounting Officer)
|
|
June 22, 2009
|
|
|
|
|
|
/s/ Bruce
Dunlevie
Bruce
Dunlevie
|
|
Chairman of the Board of Directors
|
|
June 22, 2009
|
|
|
|
|
|
/s/ J.
Thomas Bentley
J.
Thomas Bentley
|
|
Director
|
|
June 22, 2009
|
|
|
|
|
|
/s/ Sunlin
Chou
Sunlin
Chou
|
|
Director
|
|
June 22, 2009
|
|
|
|
|
|
/s/ P.
Michael Farmwald
P.
Michael Farmwald
|
|
Director
|
|
June 22, 2009
|
|
|
|
|
|
/s/ Penelope
Herscher
Penelope
Herscher
|
|
Director
|
|
June 22, 2009
|
|
|
|
|
|
/s/ Mark
Horowitz
Mark
Horowitz
|
|
Director
|
|
June 22, 2009
|
|
|
|
|
|
/s/ David
Shrigley
David
Shrigley
|
|
Director
|
|
June 22, 2009
|
|
|
|
|
|
/s/ Abraham
D. Sofaer
Abraham
D. Sofaer
|
|
Director
|
|
June 22, 2009
|
|
|
|
|
|
/s/ Eric
Stang
Eric
Stang
|
|
Director
|
|
June 22, 2009
|
II-6
INDEX TO
EXHIBITS
|
|
|
|
|
Exhibit
|
|
|
Number
|
|
Description of Exhibit
|
|
|
1
|
.1
|
|
Form of Underwriting Agreement.
|
|
3
|
.1
|
|
Amended and Restated Certificate of Incorporation of Registrant
(incorporated herein by reference to Exhibit 3.1 to the
Companys Annual Report on Form 10-K filed on
December 15, 1997).
|
|
3
|
.2
|
|
Certificate of Amendment of Amended and Restated Certificate of
Incorporation of Registrant (incorporated herein by reference to
Exhibit 3.1 to the Companys Quarterly Report on Form 10-Q
filed on May 4, 2001).
|
|
3
|
.3
|
|
Amended and Restated Bylaws of Registrant (incorporated herein
by reference to Exhibit 3.3 to the Companys Quarterly
Report on Form 10-Q filed on August 4, 2008).
|
|
4
|
.1
|
|
Form of Convertible Senior Note Indenture.
|
|
4
|
.2
|
|
Form of Convertible Senior Debt Security (included in Exhibit
4.1).
|
|
4
|
.3
|
|
Amended and Restated Information and Registration Rights
Agreement, dated as of January 7, 1997, between Registrant and
the parties indicated therein (incorporated herein by reference
to Exhibit 4.2 to the Companys Registration Statement on
Form S-1 (file no. 333-22885) filed on March 6, 1997).
|
|
4
|
.4.1
|
|
Amended and Restated Preferred Stock Rights Agreement, dated as
of July 31, 2000, between Registrant and Fleet National Bank
(incorporated herein by reference to Exhibit 4.3.1 to the
Companys Registration Statement on Form 8-A12G/A filed on
August 3, 2000).
|
|
4
|
.4.2
|
|
First Amendment to the Amended and Restated Preferred Stock
Rights Agreement, dated as of April 23, 2003, between
Registrant and Equiserve Trust Company, N.A., as successor to
Fleet National Bank (incorporated herein by reference to Exhibit
4.3.2 to the Companys Registration Statement on Form
8-A12G/A filed on August 5, 2003).
|
|
5
|
.1
|
|
Opinion of Wilson Sonsini Goodrich & Rosati, Professional
Corporation.
|
|
12
|
.1
|
|
Computation of ratio of earnings to fixed charges.
|
|
23
|
.1
|
|
Consent of PricewaterhouseCoopers LLP.
|
|
23
|
.2
|
|
Consent of Wilson Sonsini Goodrich & Rosati, Professional
Corporation (included in the opinion filed as Exhibit 5.1 to
this registration statement).
|
|
24
|
.1
|
|
Power of Attorney (see
page II-6
of this registration statement).
|
|
25
|
.1
|
|
Form T-1 Statement of Eligibility of Trustee for Convertible
Senior Note Indenture under the Trust Indenture Act of 1939.
|